<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus - Moelands, SVL - 2018 | Cochrane Library</title> <meta property="og:title" content="Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus - Moelands, SVL - 2018 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005061.pub3/references" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD005061.pub3" /> <meta name="citation_title" content="Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus" /> <meta name="citation_author" content="Suzanne VL Moelands" /> <meta name="citation_author_institution" content="Radboud University Nijmegen Medical Center" /> <meta name="citation_author" content="Peter LBJ Lucassen" /> <meta name="citation_author_institution" content="Radboud University Nijmegen Medical Center" /> <meta name="citation_author" content="Reinier P Akkermans" /> <meta name="citation_author_institution" content="Radboud University Nijmegen Medical Center" /> <meta name="citation_author" content="Wim JC De Grauw" /> <meta name="citation_author_institution" content="Radboud University Nijmegen Medical Center" /> <meta name="citation_author" content="Floris A Van de Laar" /> <meta name="citation_author_institution" content="Radboud University Nijmegen Medical Center" /> <meta name="citation_author_email" content="f.vandelaar@thermion.nl" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="12" /> <meta name="citation_doi" content="10.1002/14651858.CD005061.pub3" /> <meta name="citation_date" content="2018" /> <meta name="citation_online_date" content="2018/12/28" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005061.pub3/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005061.pub3/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005061.pub3/pdf/CDSR/CD005061/CD005061.pdf" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <meta name="citation_keywords" content="Acarbose [adverse effects, *therapeutic use]; Blood Glucose [*drug effects]; Cause of Death; Diabetes Mellitus, Type 2 [epidemiology, *prevention &amp; control]; Diet; Exercise; Fasting [*blood]; Glucose Intolerance [*drug therapy]; Glycoside Hydrolase Inhibitors [adverse effects, *therapeutic use]; Incidence; Inositol [adverse effects, *analogs &amp; derivatives, therapeutic use]; Metformin [adverse effects, therapeutic use]; Prediabetic State [drug therapy]; Randomized Controlled Trials as Topic" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <script type="text/javascript">var o={auth:{customerIds:["P#DRAAEAC","EAL00000056729","DRAA3TITLES","TSINGH009S","EAL0001468","EAL00000045347"],individualId:null,brandedCustomer:"EAL0001468",roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-CN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_TW&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-TW" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1513680834000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718256000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 13},getRevision:function(){return"605.1"},getVersion:function(){return"13.0"},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return true},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="EfT7x5RD";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dreferences\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005061\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005061\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article References"},article:{availableLanguage:["en","es","de","ru","ms","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005061.pub3",title:"Alpha\\u2010glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus",firstPublishedDate:"Dec 28, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-b0f13d7a13ebe8b0b1b00a9f0730a084926e292f.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1581422282000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7XGCZUQPW4C675JNSTYTLUDN7XB/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=EfT7x5RD&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005061.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005061.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<p class="auxiliary-menu-item access">Access provided by: <strong>Tsinghua University</strong></p>
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD005061.pub3/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD005061.pub3/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005061.pub3%2Freferences" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
<div class="access-provider-mobile">
<p class="access">Access provided by: <strong>Tsinghua University</strong></p>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
About the CDSR
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_34" role="presentation">
<a aria-labelledby="layout_34" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochrane&#x2e;org&#x2f;about-us" role="menuitem">
About Cochrane
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;hub&#x2e;wiley&#x2e;com&#x2f;docs&#x2f;cochrane-library&#x2f;cochrane-library-known-issues-DOC-16221&#x3f;referrer&#x3d;cochrane" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <section class="content-language-banner system-message-container" data-content-language="en" data-portal-language="en" style="display: none"> <div class="container"> <a href="#0" class="fa fa-times content-language-banner-close pull-right" aria-label="Close"></a> <i class="fa fa-globe" aria-hidden="true"></i> <div class="system-message-title">Content Language Selection</div> <div class="system-message-description">Your language preference is set to <strong class="language">English</strong>. Where translations are available, article sections will display in this language. Return to <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=reset-content-language&p_p_cacheability=cacheLevelPage" class="language secondary">English</a>.</div> </div> </section> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD005061.PUB3" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD005061.pub3/#" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <span>Read comments on this Review(0)</span> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005061.pub3/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005061.pub3/full"> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-sec1-0007"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-sec1-0001"> Summary of findings </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-sec1-0002"> Background </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-sec1-0003"> Objectives </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-sec1-0004"> Methods </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-sec1-0005"> Results </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-sec1-0006"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/appendices#CD005061-sec1-0012"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/information#history"> History </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/information#keywords"> Keywords </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/table_n/CD005061StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/table_n/CD005061StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article class="information" data-article-id="CD005061.PUB3"> <header> <h1 class="publication-title"><h1 lang="en" class="publication-title">Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus </h1></h1> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div><h2 class="title section-collapse-title"> References <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <section class="references bibliographies" id="references"> <section> <div class="section-header" id="CD005061-bbs1-0001"> <h3 class="title">References to studies included in this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD005061-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0004">additional references</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0005">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_includedStudies" id="CD005061-bbs2-0001"> <div class="reference-title-banner"> <h4 class="title">ABC 2017 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0001"> <div class="citation-journal">Asakura M, Kim J, Asanuma H, Hamasaki T, Tsukahara K, Higashino Y, et al. <span class="citation-title">Does treatment of impaired glucose tolerance improve cardiovascular outcomes in patients with previous myocardial infarction?</span>. <span class="citation"> Cardiovascular Drugs and Therapy </span><span class="pubYear">2017</span>;<span class="volume">31</span>(4):401‐11. <a class="crsref citation-link central-link" data-crsref="9790290" href="" ref="info:x-wiley/crsRef/9790290" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/28779371" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Does+treatment+of+impaired+glucose+tolerance+improve+cardiovascular+outcomes+in+patients+with+previous+myocardial+infarction?+&author=M+Asakura&author=J+Kim&author=H+Asanuma&author=T+Hamasaki&author=K+Tsukahara&author=Y+Higashino&publication_year=2017&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0002"> <div class="citation-other">NCT00212017. <span class="citation-title">Assessment of an alpha‐glucosidase inhibitor to block cardiac events in patients with myocardial infarction and IGT (ABC Study)</span>. www.clinicaltrials.gov/ct2/show/NCT00212017 (accessed 10 July 2018). <a class="crsref citation-link central-link" data-crsref="9790291" href="" ref="info:x-wiley/crsRef/9790291" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005061-bbs2-0002"> <div class="reference-title-banner"> <h4 class="title">ACE 2017 {published data only (unpublished sought but not used)} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0003"> <div class="citation-other">Diabetes Trials Unit, University of Oxford. <span class="citation-title">Acarbose cardiovascular evaluation</span>. www.dtu.ox.ac.uk/ACE (accessed 18 June 2018). <a class="crsref citation-link central-link" data-crsref="9790293" href="" ref="info:x-wiley/crsRef/9790293" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0004"> <div class="citation-journal">Holman RR, Bethel MA, Chan JC, Chiasson J, Doran Z, Junbo G, et al. <span class="citation-title">Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial</span>. <span class="citation"> American Heart Journal </span><span class="pubYear">2014</span>;<span class="volume">168</span>:23‐9. <a class="crsref citation-link central-link" data-crsref="9790294" href="" ref="info:x-wiley/crsRef/9790294" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/24952856" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rationale+for+and+design+of+the+Acarbose+Cardiovascular+Evaluation+(ACE)+trial&author=RR+Holman&author=MA+Bethel&author=JC+Chan&author=J+Chiasson&author=Z+Doran&author=G+Junbo&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0005"> <div class="citation-journal">Holman RR, Coleman RL, Chan JC, Chiasson J, Feng H, Junbo G, et al. for the ACE Study Group. <span class="citation-title">Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double‐blind, placebo‐controlled trial</span>. <span class="citation"> Lancet Diabetes &amp; Endocrinology </span><span class="pubYear">2017</span>;<span class="volume">5</span>:877‐86. <a class="crsref citation-link central-link" data-crsref="9790295" href="" ref="info:x-wiley/crsRef/9790295" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+acarbose+on+cardiovascular+and+diabetes+outcomes+in+patients+with+coronary+heart+disease+and+impaired+glucose+tolerance+(ACE):+a+randomised,+double%E2%80%90blind,+placebo%E2%80%90controlled+trial+&author=RR+Holman&author=RL+Coleman&author=JC+Chan&author=J+Chiasson&author=H+Feng&author=G+Junbo&publication_year=2017&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0006"> <div class="citation-other">ISRCTN91899513. <span class="citation-title">Acarbose Cardiovascular Evaluation trial (ACE)</span>. www.isrctn.com/ISRCTN91899513 (accessed 17 July 2018). <a class="crsref citation-link central-link" data-crsref="9790296" href="" ref="info:x-wiley/crsRef/9790296" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0007"> <div class="citation-other">NCT00829660. <span class="citation-title">Acarbose Cardiovascular Evaluation Trial (ACE)</span>. www.clinicaltrials.gov/ct2/show/NCT00829660 (accessed 10 July 2018). <a class="crsref citation-link central-link" data-crsref="9790297" href="" ref="info:x-wiley/crsRef/9790297" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005061-bbs2-0003"> <div class="reference-title-banner"> <h4 class="title">DAISI 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0008"> <div class="citation-other">ISRCTN33274262. <span class="citation-title">Dutch acarbose intervention trial (DAISI)</span>. www.isrctn.com/ISRCTN33274262 (accessed 6 July 2018). <a class="crsref citation-link central-link" data-crsref="9790299" href="" ref="info:x-wiley/crsRef/9790299" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0009"> <div class="citation-journal">Nijpels G, Boorsma W, Dekker JM, Kostense PJ, Bouter LM, Heine RJ. <span class="citation-title">A study of the effects of acarbose on glucose metabolism in patients predisposed to developing diabetes: the Dutch Acarbose Intervention Study in persons with impaired glucose tolerance (DAISI)</span>. <span class="citation"> Diabetes/metabolism Research and Reviews </span><span class="pubYear">2008</span>;<span class="volume">24</span>(8):611‐6. <a class="crsref citation-link central-link" data-crsref="9790300" href="" ref="info:x-wiley/crsRef/9790300" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+study+of+the+effects+of+acarbose+on+glucose+metabolism+in+patients+predisposed+to+developing+diabetes:+the+Dutch+Acarbose+Intervention+Study+in+persons+with+impaired+glucose+tolerance+(DAISI)+&author=G+Nijpels&author=W+Boorsma&author=JM+Dekker&author=PJ+Kostense&author=LM+Bouter&author=RJ+Heine&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005061-bbs2-0004"> <div class="reference-title-banner"> <h4 class="title">EDIT 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0010"> <div class="citation-journal">Citroën HA, Tunbridge FKE, Holman RR. <span class="citation-title">Possible prevention of type 2 diabetes with acarbose or metformin over three years</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2000</span>;<span class="volume">43</span>(Suppl 1):A73. <a class="crsref citation-link central-link" data-crsref="9790302" href="" ref="info:x-wiley/crsRef/9790302" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Possible+prevention+of+type+2+diabetes+with+acarbose+or+metformin+over+three+years&author=HA+Citro%C3%ABn&author=FKE+Tunbridge&author=RR+Holman&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0011"> <div class="citation-other">Diabetes Trials Unit, University of Oxford. <span class="citation-title">Early diabetes intervention trial (protocol)</span>. www.dtu.ox.ac.uk/EDIT/protocol (accessed 6 July 2018). <a class="crsref citation-link central-link" data-crsref="9790303" href="" ref="info:x-wiley/crsRef/9790303" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0012"> <div class="citation-journal">Holman RR, Blackwell L, Manley SE, Tucker L, Frighi V, Stratton IM. <span class="citation-title">Results from the Early Diabetes Intervention Trial</span>. <span class="citation"> Diabetes </span><span class="pubYear">2003</span>;<span class="volume">52</span>(Suppl 1):A16. <a class="crsref citation-link central-link" data-crsref="9790304" href="" ref="info:x-wiley/crsRef/9790304" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Results+from+the+Early+Diabetes+Intervention+Trial&author=RR+Holman&author=L+Blackwell&author=SE+Manley&author=L+Tucker&author=V+Frighi&author=IM+Stratton&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0013"> <div class="citation-journal">Holman RR, Blackwell L, Stratton IM, Manley SE, Tucker L, Frighi V. <span class="citation-title">Six‐years results from the Early Diabetes Intervention Trial</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2003</span>;<span class="volume">20</span>(Suppl 2):15. <a class="crsref citation-link central-link" data-crsref="9790305" href="" ref="info:x-wiley/crsRef/9790305" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Six%E2%80%90years+results+from+the+Early+Diabetes+Intervention+Trial&author=RR+Holman&author=L+Blackwell&author=IM+Stratton&author=SE+Manley&author=L+Tucker&author=V+Frighi&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0014"> <div class="citation-journal">Holman RR, North BV, Tunbridge FKE. <span class="citation-title">Early Diabetes Intervention Trial</span>. <span class="citation"> Diabetes </span><span class="pubYear">1997</span>;<span class="volume">46</span>(Suppl 1):157A. <a class="crsref citation-link central-link" data-crsref="9790306" href="" ref="info:x-wiley/crsRef/9790306" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Early+Diabetes+Intervention+Trial&author=RR+Holman&author=BV+North&author=FKE+Tunbridge&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0015"> <div class="citation-journal">Holman RR, North BV, Tunbridge FKE. <span class="citation-title">Early Diabetes Intervention Trial</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1997</span>;<span class="volume">40</span>(Suppl 1):A17. <a class="crsref citation-link central-link" data-crsref="9790307" href="" ref="info:x-wiley/crsRef/9790307" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Early+Diabetes+Intervention+Trial&author=RR+Holman&author=BV+North&author=FKE+Tunbridge&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0016"> <div class="citation-journal">Holman RR, North BV, Tunbridge FKE. <span class="citation-title">Possible prevention of type 2 diabetes with acarbose or metformin</span>. <span class="citation"> Diabetes </span><span class="pubYear">2000</span>;<span class="volume">49</span>(Suppl 1: A111):450‐P. <a class="crsref citation-link central-link" data-crsref="9790308" href="" ref="info:x-wiley/crsRef/9790308" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10868968" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Possible+prevention+of+type+2+diabetes+with+acarbose+or+metformin&author=RR+Holman&author=BV+North&author=FKE+Tunbridge&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0017"> <div class="citation-other">ISRCTN96631607. <span class="citation-title">Early diabetes intervention trial (EDIT study)</span>. www.isrctn.com/ISRCTN96631607 (accessed 6 July 2018). <a class="crsref citation-link central-link" data-crsref="9790309" href="" ref="info:x-wiley/crsRef/9790309" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0018"> <div class="citation-journal">Kim JI, Stevens RJ, Holman RR. <span class="citation-title">The haemoglobin glycation index is reproducible in dysglycaemic individual but is not explained by post‐challenge plasma glucose levels [Abstract]</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2004</span>;<span class="volume">47</span>(suppl 1):A122. <a class="crsref citation-link central-link" data-crsref="9790310" href="" ref="info:x-wiley/crsRef/9790310" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+haemoglobin+glycation+index+is+reproducible+in+dysglycaemic+individual+but+is+not+explained+by+post%E2%80%90challenge+plasma+glucose+levels+[Abstract]+&author=JI+Kim&author=RJ+Stevens&author=RR+Holman&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005061-bbs2-0005"> <div class="reference-title-banner"> <h4 class="title">Fang 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0019"> <div class="citation-journal">Fang YS, Li TY, Chen SY. <span class="citation-title">Effect of medicine and non‐medicine intervention on the outcomes of patients with impaired glucose tolerance: 5‐year follow‐up</span>. <span class="citation"> Zhongguo Linchuang Kangfu [Chinese Journal for Clinical Rehabilitation] </span><span class="pubYear">2004</span>;<span class="volume">8</span>(30):6562‐3. <a class="crsref citation-link central-link" data-crsref="3017837" href="" ref="info:x-wiley/crsRef/3017837" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+medicine+and+non%E2%80%90medicine+intervention+on+the+outcomes+of+patients+with+impaired+glucose+tolerance:+5%E2%80%90year+follow%E2%80%90up+&author=YS+Fang&author=TY+Li&author=SY+Chen&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005061-bbs2-0006"> <div class="reference-title-banner"> <h4 class="title">Kawamori 2009 {published data only (unpublished sought but not used)} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0020"> <div class="citation-journal">Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, Koku K, Voglibose Ph‐3 Study Group. <span class="citation-title">Voglibose for prevention of type 2 diabetes mellitus: a randomised, double‐blind trial in Japanese individuals with impaired glucose tolerance</span>. <span class="citation"> Lancet </span><span class="pubYear">2009</span>;<span class="volume">373</span>(9675):1607‐14. <a class="crsref citation-link central-link" data-crsref="9790312" href="" ref="info:x-wiley/crsRef/9790312" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19395079" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Voglibose+for+prevention+of+type+2+diabetes+mellitus:+a+randomised,+double%E2%80%90blind+trial+in+Japanese+individuals+with+impaired+glucose+tolerance+&author=R+Kawamori&author=N+Tajima&author=Y+Iwamoto&author=A+Kashiwagi&author=K+Shimamoto&author=K+Koku&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0021"> <div class="citation-other">UMIN000001109. <span class="citation-title">A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO‐128 on prevention of type 2 diabetes mellitus</span>. upload.umin.ac.jp/cgi‐open‐bin/ctr_e/ctr_view.cgi?recptno=R000001296 (accessed 17 July 2018). <a class="crsref citation-link central-link" data-crsref="9790313" href="" ref="info:x-wiley/crsRef/9790313" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005061-bbs2-0007"> <div class="reference-title-banner"> <h4 class="title">Koyasu 2010 {published data only (unpublished sought but not used)} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0022"> <div class="citation-journal">Koyasu M, Ishii H, Watarai M, Takemoto K, Inden Y, Takeshita K, et al. <span class="citation-title">Impact of acarbose on carotid intima‐media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: a one‐year, prospective, randomized, open‐label, parallel‐group study in Japanese adults with established coronary artery disease</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2010</span>;<span class="volume">32</span>(9):1610‐7. <a class="crsref citation-link central-link" data-crsref="9790315" href="" ref="info:x-wiley/crsRef/9790315" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20974318" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Impact+of+acarbose+on+carotid+intima%E2%80%90media+thickness+in+patients+with+newly+diagnosed+impaired+glucose+tolerance+or+mild+type+2+diabetes+mellitus:+a+one%E2%80%90year,+prospective,+randomized,+open%E2%80%90label,+parallel%E2%80%90group+study+in+Japanese+adults+with+established+coronary+artery+disease+&author=M+Koyasu&author=H+Ishii&author=M+Watarai&author=K+Takemoto&author=Y+Inden&author=K+Takeshita&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0023"> <div class="citation-other">UMIN000000544. <span class="citation-title">Impact of acarbose therapy in abnormal glucose tolerance patients with coronary artery disease</span>. upload.umin.ac.jp/cgi‐open‐bin/ctr_e/ctr_view.cgi?recptno=R000000658 (accessed 17 July 2018). <a class="crsref citation-link central-link" data-crsref="9790316" href="" ref="info:x-wiley/crsRef/9790316" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005061-bbs2-0008"> <div class="reference-title-banner"> <h4 class="title">STOP‐NIDDM 2002 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0024"> <div class="citation-journal">Anonymous. <span class="citation-title">The &quot;STOP NIDDM&quot; program ‐ can diabetes in the aged be prevented? An international long‐term study revisited; does acarbose delay or prevent the manifestations of type II diabetes</span> [STOP NIDDM Programm ‐ Kann man den Altersdiabetes verhindern? Eine internationale Langzeit‐Studie untersucht, ob Acarbose die Manifestation des Typ II‐Diabetes verzögert oder verhindert]. <span class="citation"> Deutsche Medizinische Wochenschrift </span><span class="pubYear">1997</span>;<span class="volume">122</span>(38 Suppl):1‐4. <a class="crsref citation-link central-link" data-crsref="9790318" href="" ref="info:x-wiley/crsRef/9790318" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+" STOP+NIDDM"+program+‐+can+diabetes+in+the+aged+be+prevented?+An+international+long‐term+study+revisited;+does+acarbose+delay+or+prevent+the+manifestations+of+type+II+diabetes+&author=+Anonymous&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0025"> <div class="citation-other">Anonymous. <span class="citation-title">The STOP‐NIDDM trial study to prevent non insulin dependent diabetes mellitus [PowerPoint presentation]</span>. www.stop‐niddm.com/study/slides/htm (accessed 1 August 2006; no longer available)<span class="pubYear">2003</span>. <a class="crsref citation-link central-link" data-crsref="9790319" href="" ref="info:x-wiley/crsRef/9790319" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+STOP%E2%80%90NIDDM+trial+study+to+prevent+non+insulin+dependent+diabetes+mellitus+[PowerPoint+presentation]+&author=+Anonymous&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0026"> <div class="citation-journal">Bridges CM. <span class="citation-title">Acarbose for patients with hypertension and impaired glucose tolerance</span>. <span class="citation"> JAMA </span><span class="pubYear">2003</span>;<span class="volume">290</span>(23):3066‐7. <a class="crsref citation-link central-link" data-crsref="9790320" href="" ref="info:x-wiley/crsRef/9790320" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14679261" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+for+patients+with+hypertension+and+impaired+glucose+tolerance&author=CM+Bridges&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0032"> <div class="citation-journal">Chiasson JL. <span class="citation-title">The potential use of acarbose in the prevention of type 2 diabetes and cardiovascular disease</span>. <span class="citation"> European Heart Journal Supplements </span><span class="pubYear">2000</span>;<span class="volume">2</span>(Supplement D):D35. <a class="crsref citation-link central-link" data-crsref="9790326" href="" ref="info:x-wiley/crsRef/9790326" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+potential+use+of+acarbose+in+the+prevention+of+type+2+diabetes+and+cardiovascular+disease+&author=JL+Chiasson&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0027"> <div class="citation-journal">Chiasson JL, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M. <span class="citation-title">The STOP‐NIDDM Trial: an international study on the efficacy of an alpha‐glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non‐Insulin‐Dependent Diabetes Mellitus</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(10):1720‐5. <a class="crsref citation-link central-link" data-crsref="9790321" href="" ref="info:x-wiley/crsRef/9790321" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9773737" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+STOP%E2%80%90NIDDM+Trial:+an+international+study+on+the+efficacy+of+an+alpha%E2%80%90glucosidase+inhibitor+to+prevent+type+2+diabetes+in+a+population+with+impaired+glucose+tolerance:+rationale,+design,+and+preliminary+screening+data.+Study+to+Prevent+Non%E2%80%90Insulin%E2%80%90Dependent+Diabetes+Mellitus+&author=JL+Chiasson&author=R+Gomis&author=M+Hanefeld&author=RG+Josse&author=A+Karasik&author=M+Laakso&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0028"> <div class="citation-journal">Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. <span class="citation-title">Acarbose for prevention of type 2 diabetes mellitus: the STOP‐NIDDM randomised trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2002</span>;<span class="volume">359</span>(9323):2072‐7. <a class="crsref citation-link central-link" data-crsref="9790322" href="" ref="info:x-wiley/crsRef/9790322" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12086760" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+for+prevention+of+type+2+diabetes+mellitus:+the+STOP%E2%80%90NIDDM+randomised+trial&author=JL+Chiasson&author=RG+Josse&author=R+Gomis&author=M+Hanefeld&author=A+Karasik&author=M+Laakso&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0029"> <div class="citation-journal">Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. <span class="citation-title">Acarbose for the prevention of type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP‐NIDDM Trial data</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2004</span>;<span class="volume">47</span>(6):969‐75. <a class="crsref citation-link central-link" data-crsref="9790323" href="" ref="info:x-wiley/crsRef/9790323" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15164169" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+for+the+prevention+of+type+2+diabetes,+hypertension+and+cardiovascular+disease+in+subjects+with+impaired+glucose+tolerance:+facts+and+interpretations+concerning+the+critical+analysis+of+the+STOP%E2%80%90NIDDM+Trial+data+&author=JL+Chiasson&author=RG+Josse&author=R+Gomis&author=M+Hanefeld&author=A+Karasik&author=M+Laakso&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0030"> <div class="citation-journal">Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. <span class="citation-title">Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP‐NIDDM trial</span>. <span class="citation"> JAMA </span><span class="pubYear">2003</span>;<span class="volume">290</span>(4):486‐96. <a class="crsref citation-link central-link" data-crsref="9790324" href="" ref="info:x-wiley/crsRef/9790324" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12876091" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+treatment+and+the+risk+of+cardiovascular+disease+and+hypertension+in+patients+with+impaired+glucose+tolerance:+the+STOP%E2%80%90NIDDM+trial+&author=JL+Chiasson&author=RG+Josse&author=R+Gomis&author=M+Hanefeld&author=A+Karasik&author=M+Laakso&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0031"> <div class="citation-journal">Chiasson JL, Josse RG, Hanefeld M, Karasik A, Laakso M. <span class="citation-title">Acarbose can prevent type 2 diabetes and cardiovascular disease in subjects with impaired glucose tolerance: the STOP‐NIDDM Trial</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2002</span>;<span class="volume">45</span>(Suppl 2):A104. <a class="crsref citation-link central-link" data-crsref="9790325" href="" ref="info:x-wiley/crsRef/9790325" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+can+prevent+type+2+diabetes+and+cardiovascular+disease+in+subjects+with+impaired+glucose+tolerance:+the+STOP%E2%80%90NIDDM+Trial+&author=JL+Chiasson&author=RG+Josse&author=M+Hanefeld&author=A+Karasik&author=M+Laakso&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0033"> <div class="citation-journal">Delorme S, Chiasson JL. <span class="citation-title">Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus</span>. <span class="citation"> Current Opinion in Pharmacology </span><span class="pubYear">2005</span>;<span class="volume">5</span>(2):184‐9. <a class="crsref citation-link central-link" data-crsref="9790327" href="" ref="info:x-wiley/crsRef/9790327" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15780829" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+in+the+prevention+of+cardiovascular+disease+in+subjects+with+impaired+glucose+tolerance+and+type+2+diabetes+mellitus+&author=S+Delorme&author=JL+Chiasson&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0034"> <div class="citation-journal">Gonzalez‐Clemente JM, Ortega‐Martinez de Victoria E, Gimenez‐Palop O, Mauricio D. <span class="citation-title">Acarbose for patients with hypertension and impaired glucose tolerance</span>. <span class="citation"> JAMA </span><span class="pubYear">2003</span>;<span class="volume">290</span>(23):3067‐9. <a class="crsref citation-link central-link" data-crsref="9790328" href="" ref="info:x-wiley/crsRef/9790328" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14679263" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+for+patients+with+hypertension+and+impaired+glucose+tolerance&author=JM+Gonzalez%E2%80%90Clemente&author=E+Ortega%E2%80%90MartinezdeVictoria&author=O+Gimenez%E2%80%90Palop&author=D+Mauricio&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0035"> <div class="citation-journal">Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova‐Kurktschiev T. <span class="citation-title">Acarbose slows progression of intima‐media thickness of the carotid arteries in subjects with impaired glucose tolerance</span>. <span class="citation"> Stroke </span><span class="pubYear">2004</span>;<span class="volume">35</span>(5):1073‐8. <a class="crsref citation-link central-link" data-crsref="9790329" href="" ref="info:x-wiley/crsRef/9790329" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15073402" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+slows+progression+of+intima%E2%80%90media+thickness+of+the+carotid+arteries+in+subjects+with+impaired+glucose+tolerance+&author=M+Hanefeld&author=JL+Chiasson&author=C+Koehler&author=E+Henkel&author=F+Schaper&author=T+Temelkova%E2%80%90Kurktschiev&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0036"> <div class="citation-journal">Kaiser T, Sawicki PT. <span class="citation-title">Acarbose for patients with hypertension and impaired glucose tolerance</span>. <span class="citation"> JAMA </span><span class="pubYear">2003</span>;<span class="volume">290</span>(23):3066‐9. <a class="crsref citation-link central-link" data-crsref="9790330" href="" ref="info:x-wiley/crsRef/9790330" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14679260" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+for+patients+with+hypertension+and+impaired+glucose+tolerance&author=T+Kaiser&author=PT+Sawicki&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0037"> <div class="citation-journal">Kaiser T, Sawicki PT. <span class="citation-title">Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP‐NIDDM data</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2004</span>;<span class="volume">47</span>(3):575‐80. <a class="crsref citation-link central-link" data-crsref="9790331" href="" ref="info:x-wiley/crsRef/9790331" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14727025" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+for+prevention+of+diabetes,+hypertension+and+cardiovascular+events?+A+critical+analysis+of+the+STOP%E2%80%90NIDDM+data+&author=T+Kaiser&author=PT+Sawicki&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0038"> <div class="citation-journal">Muhlhauser I. <span class="citation-title">Acarbose for type 2 diabetes prevention</span>. <span class="citation"> Lancet </span><span class="pubYear">2002</span>;<span class="volume">360</span>(9344):1517. <a class="crsref citation-link central-link" data-crsref="9790332" href="" ref="info:x-wiley/crsRef/9790332" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12433559" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+for+type+2+diabetes+prevention&author=I+Muhlhauser&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0039"> <div class="citation-journal">Quilici S, Chancellor J, Maclaine G, McGuire A, Andersson D, Chiasson JL. <span class="citation-title">Cost‐effectiveness of acarbose for the management of impaired glucose tolerance in Sweden</span>. <span class="citation"> International Journal of Clinical Practice </span><span class="pubYear">2005</span>;<span class="volume">59</span>(10):1143‐52. <a class="crsref citation-link central-link" data-crsref="9790333" href="" ref="info:x-wiley/crsRef/9790333" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16178980" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Cost%E2%80%90effectiveness+of+acarbose+for+the+management+of+impaired+glucose+tolerance+in+Sweden+&author=S+Quilici&author=J+Chancellor&author=G+Maclaine&author=A+McGuire&author=D+Andersson&author=JL+Chiasson&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0040"> <div class="citation-journal">Rosenthal JH. <span class="citation-title">Acarbose for patients with hypertension and impaired glucose tolerance</span>. <span class="citation"> JAMA </span><span class="pubYear">2003</span>;<span class="volume">290</span>(23):3066. <a class="crsref citation-link central-link" data-crsref="9790334" href="" ref="info:x-wiley/crsRef/9790334" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14679262" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+for+patients+with+hypertension+and+impaired+glucose+tolerance&author=JH+Rosenthal&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0041"> <div class="citation-journal">Sabes R. <span class="citation-title">Cost‐effectiveness analysis of acarbose in the treatment of patients with impaired glucose tolerance</span>. <span class="citation"> Gaceta Sanitaria / S.E.S.P.A.S </span><span class="pubYear">2004</span>;<span class="volume">18</span>(6):431‐9. <a class="crsref citation-link central-link" data-crsref="9790335" href="" ref="info:x-wiley/crsRef/9790335" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15625041" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Cost%E2%80%90effectiveness+analysis+of+acarbose+in+the+treatment+of+patients+with+impaired+glucose+tolerance+&author=R+Sabes&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0042"> <div class="citation-journal">Sawicki PT, Kaiser T. <span class="citation-title">Response to Chiasson et al.: Acarbose for the prevention of type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP‐NIDDM Trial data</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2004</span>;<span class="volume">47</span>(6):976‐7. <a class="crsref citation-link central-link" data-crsref="9790336" href="" ref="info:x-wiley/crsRef/9790336" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15150689" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Response+to+Chiasson+et+al.:+Acarbose+for+the+prevention+of+type+2+diabetes,+hypertension+and+cardiovascular+disease+in+subjects+with+impaired+glucose+tolerance:+facts+and+interpretations+concerning+the+critical+analysis+of+the+STOP%E2%80%90NIDDM+Trial+data+&author=PT+Sawicki&author=T+Kaiser&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0043"> <div class="citation-journal">Scheen AJ. <span class="citation-title">Acarbose for type 2 diabetes prevention</span>. <span class="citation"> Lancet </span><span class="pubYear">2002</span>;<span class="volume">360</span>(9344):1516. <a class="crsref citation-link central-link" data-crsref="9790337" href="" ref="info:x-wiley/crsRef/9790337" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12433557" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+for+type+2+diabetes+prevention&author=AJ+Scheen&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0044"> <div class="citation-journal">Temelkova‐Kurktschiev TS, Koehler C. <span class="citation-title">Lower progression of carotid intima media thickness under acarbose: the STOP‐NIDDM study</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2003</span>;<span class="volume">46</span>(Suppl 2):A122‐3. <a class="crsref citation-link central-link" data-crsref="9790338" href="" ref="info:x-wiley/crsRef/9790338" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lower+progression+of+carotid+intima+media+thickness+under+acarbose:+the+STOP%E2%80%90NIDDM+study+&author=TS+Temelkova%E2%80%90Kurktschiev&author=C+Koehler&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0045"> <div class="citation-journal">Windler E. <span class="citation-title">Acarbose for prevention of diabetes mellitus. STOP‐NIDDM</span> [Acarbose zur diabetes‐mellitus‐pravention]. <span class="citation"> Der Internist </span><span class="pubYear">2003</span>;<span class="volume">44</span>(4):491‐3. <a class="crsref citation-link central-link" data-crsref="9790339" href="" ref="info:x-wiley/crsRef/9790339" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12914407" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+for+prevention+of+diabetes+mellitus.+STOP%E2%80%90NIDDM&author=E+Windler&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0047"> <div class="citation-journal">Zeymer U. <span class="citation-title">Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes</span>. <span class="citation"> International Journal of Cardiology </span><span class="pubYear">2006</span>;<span class="volume">107</span>(1):11‐20. <a class="crsref citation-link central-link" data-crsref="9790341" href="" ref="info:x-wiley/crsRef/9790341" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16337493" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Cardiovascular+benefits+of+acarbose+in+impaired+glucose+tolerance+and+type+2+diabetes&author=U+Zeymer&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0048"> <div class="citation-journal">Zeymer U. <span class="citation-title">Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP‐NIDDM trial electrocardiography substudy</span>. <span class="citation"> International Journal of Cardiology </span><span class="pubYear">2006</span>;<span class="volume">107</span>(1):11‐20. <a class="crsref citation-link central-link" data-crsref="9790342" href="" ref="info:x-wiley/crsRef/9790342" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16337493" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+acarbose+treatment+on+the+risk+of+silent+myocardial+infarctions+in+patients+with+impaired+glucose+tolerance:+results+of+the+randomised+STOP%E2%80%90NIDDM+trial+electrocardiography+substudy+&author=U+Zeymer&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0046"> <div class="citation-journal">Zeymer U, Schwarzmaier‐D'assie A, Petzinna D, Chiasson JL. <span class="citation-title">Acarbose reduces silent myocardial infarctions in patients with impaired glucose tolerance. Results of the randomized STOP‐NIDDM ECG substudy</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2004</span>;<span class="volume">47</span>(Suppl 1):A47. <a class="crsref citation-link central-link" data-crsref="9790340" href="" ref="info:x-wiley/crsRef/9790340" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+reduces+silent+myocardial+infarctions+in+patients+with+impaired+glucose+tolerance.+Results+of+the+randomized+STOP%E2%80%90NIDDM+ECG+substudy+&author=U+Zeymer&author=A+Schwarzmaier%E2%80%90D'assie&author=D+Petzinna&author=JL+Chiasson&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005061-bbs2-0009"> <div class="reference-title-banner"> <h4 class="title">Wang 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0049"> <div class="citation-journal">Wang H, Xu WH, Wang GY. <span class="citation-title">An evalualion on efficacy of acarbose interfering trentment on IGT</span>. <span class="citation"> Shanxi Clinical Medicine Journal </span><span class="pubYear">2000</span>;<span class="volume">9</span>(2):116‐7. <a class="crsref citation-link central-link" data-crsref="3017866" href="" ref="info:x-wiley/crsRef/3017866" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=An+evalualion+on+efficacy+of+acarbose+interfering+trentment+on+IGT&author=H+Wang&author=WH+Xu&author=GY+Wang&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD005061-bbs2-0010"> <div class="reference-title-banner"> <h4 class="title">Yun 2016 {published data only (unpublished sought but not used)} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0050"> <div class="citation-journal">Yun P, Du AM, Chen XJ, Liu JC, Xiao H. <span class="citation-title">Effect of acarbose on long‐term prognosis in acute coronary syndromes patients with newly diagnosed impaired glucose tolerance</span>. <span class="citation"> Journal of Diabetes Research </span><span class="pubYear">2016</span>;<span class="volume">2016</span>:1602083. <a class="crsref citation-link central-link" data-crsref="9790344" href="" ref="info:x-wiley/crsRef/9790344" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/26770983" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+acarbose+on+long%E2%80%90term+prognosis+in+acute+coronary+syndromes+patients+with+newly+diagnosed+impaired+glucose+tolerance+&author=P+Yun&author=AM+Du&author=XJ+Chen&author=JC+Liu&author=H+Xiao&publication_year=2016&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD005061-bbs1-0002"> <h3 class="title">References to studies excluded from this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD005061-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0004">additional references</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0005">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0011"> <div class="reference-title-banner"> <h4 class="title">ABDOMEN study {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0051"> <div class="citation-other">NCT01167231. <span class="citation-title">Prevention of postprandial hyperglycemia by acarbose may be a promising therapeutic strategy for reducing the increased risk for cardiovascular disease (ABDOMEN)</span>. www.clinicaltrials.gov/ct2/show/NCT01167231 (accessed 11 July 2018). <a class="crsref citation-link central-link" data-crsref="9790346" href="" ref="info:x-wiley/crsRef/9790346" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0012"> <div class="reference-title-banner"> <h4 class="title">Aoki 2010 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0052"> <div class="citation-other">UMIN000003170. <span class="citation-title">Effect of miglitol and sitagliptin on incretin levels</span>. upload.umin.ac.jp/cgi‐open‐bin/ctr_e/ctr_view.cgi?recptno=R000003662 (accessed 11 July 2018). <a class="crsref citation-link central-link" data-crsref="9790348" href="" ref="info:x-wiley/crsRef/9790348" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0013"> <div class="reference-title-banner"> <h4 class="title">EDIP {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0053"> <div class="citation-journal">Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD. <span class="citation-title">HbA1c measurement improves the detection of type 2 diabetes in high‐risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP)</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2001</span>;<span class="volume">24</span>(3):465‐71. <a class="crsref citation-link central-link" data-crsref="3017868" href="" ref="info:x-wiley/crsRef/3017868" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11289469" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=HbA1c+measurement+improves+the+detection+of+type+2+diabetes+in+high%E2%80%90risk+individuals+with+nondiagnostic+levels+of+fasting+plasma+glucose:+the+Early+Diabetes+Intervention+Program+(EDIP)+&author=RC+Perry&author=RR+Shankar&author=N+Fineberg&author=J+McGill&author=AD+Baron&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD005061-bib-0054"> <div class="citation-journal">Shankar RR, Shankar SS, Brizendine E, Shen G, McGill J, Baron AD, et al. <span class="citation-title">Acarbose in 'early' diabetes ‐ data from the Early Diabetes Intervention Program (EDIP)</span>. <span class="citation"> Diabetes </span><span class="pubYear">2005</span>;<span class="volume">54</span>(Suppl 1):A132. <a class="crsref citation-link central-link" data-crsref="3017869" href="" ref="info:x-wiley/crsRef/3017869" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+in+'early'+diabetes+‐+data+from+the+Early+Diabetes+Intervention+Program+(EDIP)&author=RR+Shankar&author=SS+Shankar&author=E+Brizendine&author=G+Shen&author=J+McGill&author=AD+Baron&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0014"> <div class="reference-title-banner"> <h4 class="title">JEDIS study {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0055"> <div class="citation-other">UMIN000000681. <span class="citation-title">A randomized comparative clinical study on suppression of progression from early diabetes, diet/exercise standard intervention vs. concurrent pharmacological standard intervention</span>. upload.umin.ac.jp/cgi‐open‐bin/ctr_e/ctr_view.cgi?recptno=R000000817 (accessed 11 July 2018). <a class="crsref citation-link central-link" data-crsref="9790350" href="" ref="info:x-wiley/crsRef/9790350" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0015"> <div class="reference-title-banner"> <h4 class="title">Kataoka 2012 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0056"> <div class="citation-journal">Kataoka Y, Yasuda S, Miyamoto Y, Sase K, Kosuge M, Kimura K, et al. <span class="citation-title">Effects of voglibose and nateglinide on glycemic status and coronary atherosclerosis in early‐stage diabetic patients</span>. <span class="citation"> Circulation Journal </span><span class="pubYear">2012</span>;<span class="volume">76</span>(3):712‐20. <a class="crsref citation-link central-link" data-crsref="9790352" href="" ref="info:x-wiley/crsRef/9790352" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22240597" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+voglibose+and+nateglinide+on+glycemic+status+and+coronary+atherosclerosis+in+early%E2%80%90stage+diabetic+patients+&author=Y+Kataoka&author=S+Yasuda&author=Y+Miyamoto&author=K+Sase&author=M+Kosuge&author=K+Kimura&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0016"> <div class="reference-title-banner"> <h4 class="title">Mangiagli 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0057"> <div class="citation-journal">Mangiagli A, Campisi S, Sanctis V, Nicoletti MC, Cardinale G, Galati MC, et al. <span class="citation-title">Effects of acarbose in patients with beta‐thalassaemia major and abnormal glucose homeostasis</span>. <span class="citation"> Pediatric Endocrinology Reviews </span><span class="pubYear">2004</span>;<span class="volume">2</span>(Suppl 2):276‐8. <a class="crsref citation-link central-link" data-crsref="3017871" href="" ref="info:x-wiley/crsRef/3017871" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16462708" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+acarbose+in+patients+with+beta%E2%80%90thalassaemia+major+and+abnormal+glucose+homeostasis+&author=A+Mangiagli&author=S+Campisi&author=V+Sanctis&author=MC+Nicoletti&author=G+Cardinale&author=MC+Galati&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0017"> <div class="reference-title-banner"> <h4 class="title">Medizinische Klinik B study {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0058"> <div class="citation-other">2004‐002579‐17. <span class="citation-title">A double‐blind, randomised placebo controlled study of the effects of acarbose on endothelial function, hemostatic and fibrinolytic plasmatic factors in patients with stable coronary artery disease and either impaired glucose intolerance or newly diagnosed diabetes mellitus</span>. www.clinicaltrialsregister.eu/ctr‐search/trial/2004‐002579‐17/DE (accessed 11 July 2018). <a class="crsref citation-link central-link" data-crsref="9790354" href="" ref="info:x-wiley/crsRef/9790354" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0018"> <div class="reference-title-banner"> <h4 class="title">MM study {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0059"> <div class="citation-other">UMIN000010282. <span class="citation-title">Three‐arm comparative study of miglitol and mitiglinide alone and in combination ‐efficacy and safety studies</span>. upload.umin.ac.jp/cgi‐open‐bin/ctr_e/ctr_view.cgi?recptno=R000012031 (accessed 11 July 2018). <a class="crsref citation-link central-link" data-crsref="9790356" href="" ref="info:x-wiley/crsRef/9790356" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0019"> <div class="reference-title-banner"> <h4 class="title">Narita 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0060"> <div class="citation-other">UMIN000001671. <span class="citation-title">The comparative study of the effects of miglitol and voglibose (alpha‐glucosidase inhibitors) on incretins secretion</span>. upload.umin.ac.jp/cgi‐open‐bin/ctr_e/ctr_view.cgi?recptno=R000002020 (accessed 11 July 2018). <a class="crsref citation-link central-link" data-crsref="9790358" href="" ref="info:x-wiley/crsRef/9790358" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0020"> <div class="reference-title-banner"> <h4 class="title">NCT00417950 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0061"> <div class="citation-other">NCT00417950. <span class="citation-title">Additional glucose lowering and anti‐inflammatory effects by acarbose and alcohol in subjects with impaired glucose tolerance or mild type 2 diabetes</span>. www.clinicaltrials.gov/ct2/show/NCT00417950 (accessed 11 July 2018). <a class="crsref citation-link central-link" data-crsref="9790360" href="" ref="info:x-wiley/crsRef/9790360" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0021"> <div class="reference-title-banner"> <h4 class="title">Toyoda 2012 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0062"> <div class="citation-other">UMIN000008692. <span class="citation-title">Study of the combination use effect of DPP‐4 inhibitor and alpha‐glucosidase inhibitor</span>. upload.umin.ac.jp/cgi‐open‐bin/ctr_e/ctr_view.cgi?recptno=R000010217 (accessed 11 July 2018). <a class="crsref citation-link central-link" data-crsref="9790362" href="" ref="info:x-wiley/crsRef/9790362" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0022"> <div class="reference-title-banner"> <h4 class="title">Watada 2012 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0063"> <div class="citation-other">UMIN000008591. <span class="citation-title">Linagliptin study of effects on PPG, postprandial blood glucose control</span>. upload.umin.ac.jp/cgi‐open‐bin/ctr_e/ctr_view.cgi?recptno=R000010093 (accessed 11 July 2018). <a class="crsref citation-link central-link" data-crsref="9790364" href="" ref="info:x-wiley/crsRef/9790364" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD005061-bbs2-0023"> <div class="reference-title-banner"> <h4 class="title">Yang 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0064"> <div class="citation-journal">Yang W, Lin L, Qi J, Yu Z, Pei H, He G, et al. <span class="citation-title">The preventive effect of acarbose and metformin on the progression to diabetes mellitus in the IGT population: a 3‐year multicenter prospective study [Chinese translation from Bayer website www.stop‐niddm.com, accessed 13 September 2004, no longer available]</span>. <span class="citation"> Chinese Journal of Endocrinology and Metabolism </span><span class="pubYear">2001</span>;<span class="volume">17</span>(3):131‐6. <a class="crsref citation-link central-link" data-crsref="3017873" href="" ref="info:x-wiley/crsRef/3017873" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+preventive+effect+of+acarbose+and+metformin+on+the+progression+to+diabetes+mellitus+in+the+IGT+population:+a+3%E2%80%90year+multicenter+prospective+study+[Chinese+translation+from+Bayer+website+www.stop%E2%80%90niddm.com,+accessed+13+September+2004,+no+longer+available]+&author=W+Yang&author=L+Lin&author=J+Qi&author=Z+Yu&author=H+Pei&author=G+He&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD005061-bbs1-0003"> <h3 class="title">References to studies awaiting assessment</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD005061-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0004">additional references</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0005">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_awaitingAssessmentStudies" id="CD005061-bbs2-0024"> <div class="reference-title-banner"> <h4 class="title">NCT00221156 {published data only} </h4> </div> <div class="bibliography-section" id="CD005061-bib-0065"> <div class="citation-other">NCT00221156. <span class="citation-title">Acarbose and secondary prevention after coronary stenting</span>. www.clinicaltrials.gov/ct2/show/NCT00221156 (accessed 18 December 2018). <a class="crsref citation-link central-link" data-crsref="9790366" href="" ref="info:x-wiley/crsRef/9790366" target="_blank"><span style="display: none;">CENTRAL</span></a> <ul class="citation-link-group"> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD005061-bbs1-0004"> <h3 class="title">Additional references</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD005061-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0005">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0025"> <div class="reference-title-banner"> <h4 class="title">Abdul‐Ghani 2006</h4> </div> <div class="bibliography-section" id="CD005061-bib-0066"> <div class="citation-journal">Abdul‐Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA. <span class="citation-title">Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study</span>. <span class="citation"> Diabetes </span><span class="pubYear">2006</span>;<span class="volume">55</span>(5):1430‐5. [PUBMED: 16644701] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16644701" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+secretion+and+action+in+subjects+with+impaired+fasting+glucose+and+impaired+glucose+tolerance:+results+from+the+Veterans+Administration+Genetic+Epidemiology+Study+&author=MA+Abdul%E2%80%90Ghani&author=CP+Jenkinson&author=DK+Richardson&author=D+Tripathy&author=RA+DeFronzo&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0026"> <div class="reference-title-banner"> <h4 class="title">ADA 2003</h4> </div> <div class="bibliography-section" id="CD005061-bib-0067"> <div class="citation-journal">American Diabetes Association. <span class="citation-title">Standards of medical care for patients with diabetes mellitus</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(suppl 1):s33‐s50. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12502618" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0027"> <div class="reference-title-banner"> <h4 class="title">ADA 2010</h4> </div> <div class="bibliography-section" id="CD005061-bib-0068"> <div class="citation-journal">American Diabetes Association. <span class="citation-title">Diagnosis and classification of diabetes mellitus</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2010</span>;<span class="volume">33</span>(Suppl 1):S62‐9. [PUBMED: 20042775] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20042775" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0028"> <div class="reference-title-banner"> <h4 class="title">ADA 2014</h4> </div> <div class="bibliography-section" id="CD005061-bib-0069"> <div class="citation-other">American Diabetes Association. <span class="citation-title">Strategies for effective screening, intervention and follow‐up</span>. professional.diabetes.org/slidelibrary/prediabetes‐strategies‐effective‐screening‐intervention‐and‐follow 2014 (accessed 7 December 2017). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0029"> <div class="reference-title-banner"> <h4 class="title">ADA 2015</h4> </div> <div class="bibliography-section" id="CD005061-bib-0070"> <div class="citation-journal">American Diabetes Association. <span class="citation-title">Standards of medical care in diabetes‐2015</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2015</span>;<span class="volume">38</span>(Suppl 1):S1‐93. [PUBMED: 24357209] <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0030"> <div class="reference-title-banner"> <h4 class="title">Anderson 1991</h4> </div> <div class="bibliography-section" id="CD005061-bib-0071"> <div class="citation-journal">Anderson KM, Odell PM, Wilson PW, Kannel WB. <span class="citation-title">Cardiovascular disease risk profiles</span>. <span class="citation"> American Heart Journal </span><span class="pubYear">1991</span>;<span class="volume">121</span>(1 Pt 2):293‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1985385" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Cardiovascular+disease+risk+profiles&author=KM+Anderson&author=PM+Odell&author=PW+Wilson&author=WB+Kannel&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0031"> <div class="reference-title-banner"> <h4 class="title">Bell 2013</h4> </div> <div class="bibliography-section" id="CD005061-bib-0072"> <div class="citation-journal">Bell ML, McKenzie JE. <span class="citation-title">Designing psycho‐oncology randomised trials and cluster randomised trials: variance components and intra‐cluster correlation of commonly used psychosocial measures</span>. <span class="citation"> Psycho‐oncology </span><span class="pubYear">2013</span>;<span class="volume">22</span>:1738‐47. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23080401" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Designing+psycho%E2%80%90oncology+randomised+trials+and+cluster+randomised+trials:+variance+components+and+intra%E2%80%90cluster+correlation+of+commonly+used+psychosocial+measures+&author=ML+Bell&author=JE+McKenzie&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0032"> <div class="reference-title-banner"> <h4 class="title">Borenstein 2017a</h4> </div> <div class="bibliography-section" id="CD005061-bib-0073"> <div class="citation-journal">Borenstein M, Higgins JP, Hedges LV, Rothstein HR. <span class="citation-title">Basics of meta‐analysis: I² is not an absolute measure of heterogeneity</span>. <span class="citation"> Research Synthesis Methods </span><span class="pubYear">2017</span>;<span class="volume">8</span>(1):5‐18. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/28058794" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Basics+of+meta%E2%80%90analysis:+I%C2%B2+is+not+an+absolute+measure+of+heterogeneity&author=M+Borenstein&author=JP+Higgins&author=LV+Hedges&author=HR+Rothstein&publication_year=2017&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0033"> <div class="reference-title-banner"> <h4 class="title">Borenstein 2017b</h4> </div> <div class="bibliography-section" id="CD005061-bib-0074"> <div class="citation-other">Borenstein M. <span class="citation-title">Prediction intervals</span>. www.meta‐analysis.com/prediction (accessed 3 July 2017). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0034"> <div class="reference-title-banner"> <h4 class="title">Boutron 2014</h4> </div> <div class="bibliography-section" id="CD005061-bib-0075"> <div class="citation-journal">Boutron I, Altman DG, Hopewell S, Vera‐Badillo F, Tannock I, Ravaud P. <span class="citation-title">Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial</span>. <span class="citation"> Journal of Clinical Oncology </span><span class="pubYear">2014</span>;<span class="volume">32</span>:4120‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25403215" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Impact+of+spin+in+the+abstracts+of+articles+reporting+results+of+randomized+controlled+trials+in+the+field+of+cancer:+the+SPIIN+randomized+controlled+trial+&author=I+Boutron&author=DG+Altman&author=S+Hopewell&author=F+Vera%E2%80%90Badillo&author=I+Tannock&author=P+Ravaud&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0035"> <div class="reference-title-banner"> <h4 class="title">Caballero 2016</h4> </div> <div class="bibliography-section" id="CD005061-bib-0076"> <div class="citation-journal">Caballero AE. <span class="citation-title">Long‐term studies of treatments for type 2 diabetes</span>. <span class="citation"> Postgraduate Medicine </span><span class="pubYear">2016</span>;<span class="volume">129</span>(3):352‐65. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/27882816" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+studies+of+treatments+for+type+2+diabetes&author=AE+Caballero&publication_year=2016&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0036"> <div class="reference-title-banner"> <h4 class="title">CDC 2015</h4> </div> <div class="bibliography-section" id="CD005061-bib-0077"> <div class="citation-other">Centers for Disease Control and Prevention. <span class="citation-title">2014 National Diabetes Statistics Report</span>. www.cdc.gov/diabetes/pdfs/data/2014‐report‐estimates‐of‐diabetes‐and‐its‐burden‐in‐the‐united‐states.pdf (accessed 6 July 2018). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0037"> <div class="reference-title-banner"> <h4 class="title">Chiasson 1996</h4> </div> <div class="bibliography-section" id="CD005061-bib-0078"> <div class="citation-journal">Chiasson JL, Josse RG, Leiter LA, Mihic M, Nathan DM, Palmason C, et al. <span class="citation-title">The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1996</span>;<span class="volume">19</span>(11):1190‐3. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8908378" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+acarbose+on+insulin+sensitivity+in+subjects+with+impaired+glucose+tolerance&author=JL+Chiasson&author=RG+Josse&author=LA+Leiter&author=M+Mihic&author=DM+Nathan&author=C+Palmason&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0038"> <div class="reference-title-banner"> <h4 class="title">Colditz 1995</h4> </div> <div class="bibliography-section" id="CD005061-bib-0079"> <div class="citation-journal">Colditz GA, Willett WC, Rotnitzky A, Manson JE. <span class="citation-title">Weight gain as a risk factor for clinical diabetes mellitus in women</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1995</span>;<span class="volume">122</span>(7):481‐6. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7872581" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Weight+gain+as+a+risk+factor+for+clinical+diabetes+mellitus+in+women&author=GA+Colditz&author=WC+Willett&author=A+Rotnitzky&author=JE+Manson&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0039"> <div class="reference-title-banner"> <h4 class="title">Corbett 2014</h4> </div> <div class="bibliography-section" id="CD005061-bib-0080"> <div class="citation-journal">Corbett MS, Higgins JP, Woolacott NF. <span class="citation-title">Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool</span>. <span class="citation"> Research Synthesis Methods </span><span class="pubYear">2014</span>;<span class="volume">5</span>:79‐85. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/26054027" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Assessing+baseline+imbalance+in+randomised+trials:+implications+for+the+Cochrane+risk+of+bias+tool+&author=MS+Corbett&author=JP+Higgins&author=NF+Woolacott&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0040"> <div class="reference-title-banner"> <h4 class="title">Deeks 2017</h4> </div> <div class="bibliography-section" id="CD005061-bib-0081"> <div class="citation-other">Deeks JJ, Higgins JP, Altman DG (editors) on behalf of the Cochrane Statistical Methods Group. <span class="citation-title">Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017</span>. Available from www.training.cochrane.org/handbook. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0041"> <div class="reference-title-banner"> <h4 class="title">DeFronzo 1989</h4> </div> <div class="bibliography-section" id="CD005061-bib-0082"> <div class="citation-journal">DeFronzo RA, Ferrannini E, Simonson DC. <span class="citation-title">Fasting hyperglycemia in non‐insulin‐dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake</span>. <span class="citation"> Metabolism: Clinical and Experimental </span><span class="pubYear">1989</span>;<span class="volume">38</span>(4):387‐95. [PUBMED: 2657323] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2657323" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Fasting+hyperglycemia+in+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus:+contributions+of+excessive+hepatic+glucose+production+and+impaired+tissue+glucose+uptake+&author=RA+DeFronzo&author=E+Ferrannini&author=DC+Simonson&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0042"> <div class="reference-title-banner"> <h4 class="title">Diabetes Prevention Program 2002</h4> </div> <div class="bibliography-section" id="CD005061-bib-0083"> <div class="citation-journal">Knowler WC, Barrett‐Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Diabetes Prevention Program Research Group. <span class="citation-title">Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2002</span>;<span class="volume">346</span>(6):393‐403. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11832527" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Reduction+in+the+incidence+of+type+2+diabetes+with+lifestyle+intervention+or+metformin&author=WC+Knowler&author=E+Barrett%E2%80%90Connor&author=SE+Fowler&author=RF+Hamman&author=JM+Lachin&author=EA+Walker&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0043"> <div class="reference-title-banner"> <h4 class="title">Diabetes Prevention Program FU 2009</h4> </div> <div class="bibliography-section" id="CD005061-bib-0084"> <div class="citation-journal">Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, et al. Diabetes Prevention Program Research Group. <span class="citation-title">10‐year follow‐up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study</span>. <span class="citation"> Lancet </span><span class="pubYear">2009</span>;<span class="volume">374</span>(9702):1677‐86. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19878986" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=10%E2%80%90year+follow%E2%80%90up+of+diabetes+incidence+and+weight+loss+in+the+Diabetes+Prevention+Program+Outcomes+Study+&author=WC+Knowler&author=SE+Fowler&author=RF+Hamman&author=CA+Christophi&author=HJ+Hoffman&author=AT+Brenneman&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0044"> <div class="reference-title-banner"> <h4 class="title">Dunkley 2014</h4> </div> <div class="bibliography-section" id="CD005061-bib-0085"> <div class="citation-journal">Dunkley AJ, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ, et al. <span class="citation-title">Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta‐analysis</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2014</span>;<span class="volume">37</span>(4):922‐33. [PUBMED: 24652723] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/24652723" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetes+prevention+in+the+real+world:+effectiveness+of+pragmatic+lifestyle+interventions+for+the+prevention+of+type+2+diabetes+and+of+the+impact+of+adherence+to+guideline+recommendations:+a+systematic+review+and+meta%E2%80%90analysis+&author=AJ+Dunkley&author=DH+Bodicoat&author=CJ+Greaves&author=C+Russell&author=T+Yates&author=MJ+Davies&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0045"> <div class="reference-title-banner"> <h4 class="title">Finnish Diabetes Prevention Study Group 2001</h4> </div> <div class="bibliography-section" id="CD005061-bib-0086"> <div class="citation-journal">Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne‐Parikka P, et al. Finnish Diabetes Prevention Study Group. <span class="citation-title">Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2001</span>;<span class="volume">344</span>(18):1343‐50. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11333990" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prevention+of+type+2+diabetes+mellitus+by+changes+in+lifestyle+among+subjects+with+impaired+glucose+tolerance+&author=J+Tuomilehto&author=J+Lindstr%C3%B6m&author=JG+Eriksson&author=TT+Valle&author=H+H%C3%A4m%C3%A4l%C3%A4inen&author=P+Ilanne%E2%80%90Parikka&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0046"> <div class="reference-title-banner"> <h4 class="title">Gosmanov 2014</h4> </div> <div class="bibliography-section" id="CD005061-bib-0087"> <div class="citation-journal">Gosmanov AR, Wan J. <span class="citation-title">Low positive predictive value of hemoglobin A1c for diagnosis of prediabetes in clinical practice</span>. <span class="citation"> American Journal of the Medical Sciences </span><span class="pubYear">2014</span>;<span class="volume">348</span>(3):191‐4. [PUBMED: 24556928] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/24556928" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Low+positive+predictive+value+of+hemoglobin+A1c+for+diagnosis+of+prediabetes+in+clinical+practice+&author=AR+Gosmanov&author=J+Wan&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0047"> <div class="reference-title-banner"> <h4 class="title">GRADEproGDT 2015 [Computer program]</h4> </div> <div class="bibliography-section" id="CD005061-bib-0088"> <div class="citation-other">McMaster University, 2015 (developed by Evidence Prime, Inc.). <span class="citation-title">GRADEpro GDT</span>. Version accessed 6 July 2018. Hamilton (ON): McMaster University, 2015 (developed by Evidence Prime, Inc.), <span class="pubYear">2015</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0048"> <div class="reference-title-banner"> <h4 class="title">Hemmingsen 2016a</h4> </div> <div class="bibliography-section" id="CD005061-bib-0089"> <div class="citation-journal">Hemmingsen B, Sonne DP, Metzendorf MI, Richter B. <span class="citation-title">Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2016</span>, Issue 10. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD012151" target="_blank"><span>10.1002/14651858.CD012151</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+secretagogues+for+prevention+or+delay+of+type+2+diabetes+mellitus+and+its+associated+complications+in+persons+at+increased+risk+for+the+development+of+type+2+diabetes+mellitus+&author=B+Hemmingsen&author=DP+Sonne&author=MI+Metzendorf&author=B+Richter&publication_year=2016&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0049"> <div class="reference-title-banner"> <h4 class="title">Hemmingsen 2016b</h4> </div> <div class="bibliography-section" id="CD005061-bib-0090"> <div class="citation-journal">Hemmingsen B, Krogh J, Metzendorf MI, Richter B. <span class="citation-title">Sodium‐glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2016</span>, Issue 4. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD012106.pub2" target="_blank"><span>10.1002/14651858.CD012106.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Sodium%E2%80%90glucose+cotransporter+(SGLT)+2+inhibitors+for+prevention+or+delay+of+type+2+diabetes+mellitus+and+its+associated+complications+in+people+at+risk+for+the+development+of+type+2+diabetes+mellitus+&author=B+Hemmingsen&author=J+Krogh&author=MI+Metzendorf&author=B+Richter&publication_year=2016&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0050"> <div class="reference-title-banner"> <h4 class="title">Hemmingsen 2017a</h4> </div> <div class="bibliography-section" id="CD005061-bib-0091"> <div class="citation-journal">Hemmingsen B, Gimenez‐Perez G, Mauricio D, Roqué i Figuls M, Metzendorf MI, et al. <span class="citation-title">Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2017</span>, Issue 12. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD003054.pub4" target="_blank"><span>10.1002/14651858.CD003054.pub4</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diet,+physical+activity+or+both+for+prevention+or+delay+of+type+2+diabetes+mellitus+and+its+associated+complications+in+people+at+increased+risk+of+developing+type+2+diabetes+mellitus+&author=B+Hemmingsen&author=G+Gimenez%E2%80%90Perez&author=D+Mauricio&author=iFigulsM+Roqu%C3%A9&author=MI+Metzendorf&publication_year=2017&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0051"> <div class="reference-title-banner"> <h4 class="title">Hemmingsen 2017b</h4> </div> <div class="bibliography-section" id="CD005061-bib-0092"> <div class="citation-journal">Hemmingsen B, Sonne DP, Metzendorf MI, Richter B. <span class="citation-title">Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2017</span>, Issue 5. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD012204.pub2" target="_blank"><span>10.1002/14651858.CD012204.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Dipeptidyl%E2%80%90peptidase+(DPP)%E2%80%904+inhibitors+and+glucagon%E2%80%90like+peptide+(GLP)%E2%80%901+analogues+for+prevention+or+delay+of+type+2+diabetes+mellitus+and+its+associated+complications+in+people+at+increased+risk+for+the+development+of+type+2+diabetes+mellitus+&author=B+Hemmingsen&author=DP+Sonne&author=MI+Metzendorf&author=B+Richter&publication_year=2017&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0052"> <div class="reference-title-banner"> <h4 class="title">Higgins 2002</h4> </div> <div class="bibliography-section" id="CD005061-bib-0093"> <div class="citation-journal">Higgins JP, Thompson SG. <span class="citation-title">Quantifying heterogeneity in a meta‐analysis</span>. <span class="citation"> Statistics in Medicine </span><span class="pubYear">2002</span>;<span class="volume">21</span>(11):1539‐58. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12111919" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Quantifying+heterogeneity+in+a+meta%E2%80%90analysis&author=JP+Higgins&author=SG+Thompson&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0053"> <div class="reference-title-banner"> <h4 class="title">Higgins 2003</h4> </div> <div class="bibliography-section" id="CD005061-bib-0094"> <div class="citation-journal">Higgins JP, Thompson SG, Deeks JJ, Altman DG. <span class="citation-title">Measuring inconsistency in meta‐analysis</span>. <span class="citation"> BMJ </span><span class="pubYear">2003</span>;<span class="volume">327</span>(7414):557‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12958120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Measuring+inconsistency+in+meta%E2%80%90analysis&author=JP+Higgins&author=SG+Thompson&author=JJ+Deeks&author=DG+Altman&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0054"> <div class="reference-title-banner"> <h4 class="title">Higgins 2009</h4> </div> <div class="bibliography-section" id="CD005061-bib-0095"> <div class="citation-journal">Higgins JP, Thompson SG, Spiegelhalter DJ. <span class="citation-title">A re‐evaluation of random‐effects meta‐analysis</span>. <span class="citation"> Journal of the Royal Statistical Society: Series A (Statistics in Society) </span><span class="pubYear">2009</span>;<span class="volume">172</span>(1):137‐59. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+re%E2%80%90evaluation+of+random%E2%80%90effects+meta%E2%80%90analysis&author=JP+Higgins&author=SG+Thompson&author=DJ+Spiegelhalter&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0055"> <div class="reference-title-banner"> <h4 class="title">Higgins 2017</h4> </div> <div class="bibliography-section" id="CD005061-bib-0096"> <div class="citation-other">Higgins JP, Altman DG, Sterne JAC (editors). <span class="citation-title">Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017), Cochrane, 2017</span>. Available from www.training.cochrane.org/handbook. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0056"> <div class="reference-title-banner"> <h4 class="title">Hopper 2011</h4> </div> <div class="bibliography-section" id="CD005061-bib-0097"> <div class="citation-journal">Hopper I, Billah B, Skiba M, Krum H. <span class="citation-title">Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta‐analysis of randomised controlled clinical trials</span>. <span class="citation"> European Journal of Cardiovascular Prevention and Rehabilitation </span><span class="pubYear">2011</span>;<span class="volume">18</span>(6):813‐23. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21878448" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prevention+of+diabetes+and+reduction+in+major+cardiovascular+events+in+studies+of+subjects+with+prediabetes:+meta%E2%80%90analysis+of+randomised+controlled+clinical+trials+&author=I+Hopper&author=B+Billah&author=M+Skiba&author=H+Krum&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0057"> <div class="reference-title-banner"> <h4 class="title">Hróbjartsson 2013</h4> </div> <div class="bibliography-section" id="CD005061-bib-0098"> <div class="citation-journal">Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. <span class="citation-title">Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors</span>. <span class="citation"> Canadian Medical Association Journal </span><span class="pubYear">2013</span>;<span class="volume">185</span>(4):E201‐11. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23359047" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Observer+bias+in+randomized+clinical+trials+with+measurement+scale+outcomes:+a+systematic+review+of+trials+with+both+blinded+and+nonblinded+assessors+&author=A+Hr%C3%B3bjartsson&author=AS+Thomsen&author=F+Emanuelsson&author=B+Tendal&author=J+Hilden&author=I+Boutron&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0058"> <div class="reference-title-banner"> <h4 class="title">ICH 1997</h4> </div> <div class="bibliography-section" id="CD005061-bib-0099"> <div class="citation-other">International Conference on Harmonisation Expert Working Group. <span class="citation-title">International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice //1997 CFR &amp; ICH Guidelines</span>. PA 19063‐2043. USA: Barnett International/PAREXEL, <span class="pubYear">1997</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0059"> <div class="reference-title-banner"> <h4 class="title">IDF 2017</h4> </div> <div class="bibliography-section" id="CD005061-bib-0100"> <div class="citation-book">International Diabetes Federation. <span class="citation">IDF Diabetes Atlas</span>. 8th Edition. Brussels, Belgium: International Diabetes Federation, <span class="pubYear">2017</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0060"> <div class="reference-title-banner"> <h4 class="title">IEC 2009</h4> </div> <div class="bibliography-section" id="CD005061-bib-0101"> <div class="citation-journal">International Expert Committee. <span class="citation-title">International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2009</span>;<span class="volume">32</span>(7):1327‐34. [PUBMED: 19502545] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19502545" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0061"> <div class="reference-title-banner"> <h4 class="title">InterAct Consortium 2013</h4> </div> <div class="bibliography-section" id="CD005061-bib-0102"> <div class="citation-journal">InterAct Consortium, Scott RA, Langenberg C, Sharp SJ, Franks PW, Rolandsson O, et al. <span class="citation-title">The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC‐InterAct study</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2013</span>;<span class="volume">56</span>(1):60‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23052052" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+link+between+family+history+and+risk+of+type+2+diabetes+is+not+explained+by+anthropometric,+lifestyle+or+genetic+risk+factors:+the+EPIC%E2%80%90InterAct+study+&author=RA+Scott&author=C+Langenberg&author=SJ+Sharp&author=PW+Franks&author=O+Rolandsson&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0062"> <div class="reference-title-banner"> <h4 class="title">Jenney 1993</h4> </div> <div class="bibliography-section" id="CD005061-bib-0103"> <div class="citation-journal">Jenney A, Proietto J, O'Dea K, Nankervis A, Traianedes K, D'Embden H. <span class="citation-title">Low‐dose acarbose improves glycemic control in NIDDM patients without changes in insulin sensitivity</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1993</span>;<span class="volume">16</span>(2):499‐502. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8432223" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Low%E2%80%90dose+acarbose+improves+glycemic+control+in+NIDDM+patients+without+changes+in+insulin+sensitivity+&author=A+Jenney&author=J+Proietto&author=K+O'Dea&author=A+Nankervis&author=K+Traianedes&author=H+D'Embden&publication_year=1993&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0063"> <div class="reference-title-banner"> <h4 class="title">Jensen 2002</h4> </div> <div class="bibliography-section" id="CD005061-bib-0104"> <div class="citation-journal">Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE. <span class="citation-title">Beta‐cell function is a major contributor to oral glucose tolerance in high‐risk relatives of four ethnic groups in the U.S</span>. <span class="citation"> Diabetes </span><span class="pubYear">2002</span>;<span class="volume">51</span>(7):2170‐8. [PUBMED: 12086947] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12086947" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Beta%E2%80%90cell+function+is+a+major+contributor+to+oral+glucose+tolerance+in+high%E2%80%90risk+relatives+of+four+ethnic+groups+in+the+U.S+&author=CC+Jensen&author=M+Cnop&author=RL+Hull&author=WY+Fujimoto&author=SE+Kahn&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0064"> <div class="reference-title-banner"> <h4 class="title">Johnson 1996</h4> </div> <div class="bibliography-section" id="CD005061-bib-0105"> <div class="citation-journal">Johnson AB, Taylor R. <span class="citation-title">Does suppression of postprandial blood glucose excursions by the alpha‐glucosidase inhibitor miglitol improve insulin sensitivity in diet‐treated type II diabetic patients?</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2006</span>;<span class="volume">19</span>(6):559‐63. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Does+suppression+of+postprandial+blood+glucose+excursions+by+the+alpha%E2%80%90glucosidase+inhibitor+miglitol+improve+insulin+sensitivity+in+diet%E2%80%90treated+type+II+diabetic+patients?+&author=AB+Johnson&author=R+Taylor&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0065"> <div class="reference-title-banner"> <h4 class="title">Kaiser 2004</h4> </div> <div class="bibliography-section" id="CD005061-bib-0106"> <div class="citation-journal">Kaiser T, Sawicki PT. <span class="citation-title">Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP‐NIDDM data</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2004</span>;<span class="volume">47</span>(3):575‐80. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14727025" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Acarbose+for+prevention+of+diabetes,+hypertension+and+cardiovascular+events?+A+critical+analysis+of+the+STOP%E2%80%90NIDDM+data+&author=T+Kaiser&author=PT+Sawicki&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0066"> <div class="reference-title-banner"> <h4 class="title">Kirkham 2010</h4> </div> <div class="bibliography-section" id="CD005061-bib-0107"> <div class="citation-journal">Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. <span class="citation-title">The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews</span>. <span class="citation"> BMJ </span><span class="pubYear">2010</span>;<span class="volume">340</span>:c365. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136/bmj.c365" target="_blank"><span>10.1136/bmj.c365</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20156912" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+impact+of+outcome+reporting+bias+in+randomised+controlled+trials+on+a+cohort+of+systematic+reviews+&author=JJ+Kirkham&author=KM+Dwan&author=DG+Altman&author=C+Gamble&author=S+Dodd&author=R+Smyth&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0067"> <div class="reference-title-banner"> <h4 class="title">Kirkman 2006</h4> </div> <div class="bibliography-section" id="CD005061-bib-0108"> <div class="citation-journal">Kirkman MS, Shankar RR, Shankar S, Shen C, Brizendine E, Baron A, et al. <span class="citation-title">Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2006</span>;<span class="volume">29</span>(9):2095‐101. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16936159" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treating+postprandial+hyperglycemia+does+not+appear+to+delay+progression+of+early+type+2+diabetes:+the+Early+Diabetes+Intervention+Program+&author=MS+Kirkman&author=RR+Shankar&author=S+Shankar&author=C+Shen&author=E+Brizendine&author=A+Baron&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0068"> <div class="reference-title-banner"> <h4 class="title">Laakso 1999</h4> </div> <div class="bibliography-section" id="CD005061-bib-0109"> <div class="citation-journal">Laakso M. <span class="citation-title">Hyperglycemia and cardiovascular disease in type 2 diabetes</span>. <span class="citation"> Diabetes </span><span class="pubYear">1999</span>;<span class="volume">48</span>(5):937‐42. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10331395" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Hyperglycemia+and+cardiovascular+disease+in+type+2+diabetes&author=M+Laakso&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0069"> <div class="reference-title-banner"> <h4 class="title">Liberati 2009</h4> </div> <div class="bibliography-section" id="CD005061-bib-0110"> <div class="citation-journal">Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. <span class="citation-title">The PRISMA statement for reporting systematic and meta‐analyses of studies that evaluate interventions: explanation and elaboration</span>. <span class="citation"> PLoS Medicine </span><span class="pubYear">2009</span>;<span class="volume">6</span>(7):1‐28. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1371/journal.pmed.1000100" target="_blank"><span>10.1371/journal.pmed.1000100</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+PRISMA+statement+for+reporting+systematic+and+meta%E2%80%90analyses+of+studies+that+evaluate+interventions:+explanation+and+elaboration+&author=A+Liberati&author=DG+Altman&author=J+Tetzlaff&author=C+Mulrow&author=PC+G%C3%B8tzsche&author=JPA+Ioannidis&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0070"> <div class="reference-title-banner"> <h4 class="title">Mathieu 2009</h4> </div> <div class="bibliography-section" id="CD005061-bib-0111"> <div class="citation-journal">Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. <span class="citation-title">Comparison of registered and published primary outcomes in randomized controlled trials</span>. <span class="citation"> JAMA </span><span class="pubYear">2009</span>;<span class="volume">302</span>:977‐84. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19724045" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+registered+and+published+primary+outcomes+in+randomized+controlled+trials&author=S+Mathieu&author=I+Boutron&author=D+Moher&author=DG+Altman&author=P+Ravaud&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0071"> <div class="reference-title-banner"> <h4 class="title">Matsumoto 1998</h4> </div> <div class="bibliography-section" id="CD005061-bib-0112"> <div class="citation-journal">Matsumoto K, Yano M, Miyake S, Ueki Y, Yamaguchi Y, Akazawa S, et al. <span class="citation-title">Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non‐insulin‐treated NIDDM patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(2):256‐60. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9539992" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+voglibose+on+glycemic+excursions,+insulin+secretion,+and+insulin+sensitivity+in+non%E2%80%90insulin%E2%80%90treated+NIDDM+patients+&author=K+Matsumoto&author=M+Yano&author=S+Miyake&author=Y+Ueki&author=Y+Yamaguchi&author=S+Akazawa&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0072"> <div class="reference-title-banner"> <h4 class="title">Meader 2014</h4> </div> <div class="bibliography-section" id="CD005061-bib-0113"> <div class="citation-journal">Meader N, King K, Llewellyn A, Norman G, Brown J, Rodgers M, et al. <span class="citation-title">A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation</span>. <span class="citation"> Systematic Reviews </span><span class="pubYear">2014</span>;<span class="volume">3</span>:82. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25056145" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+checklist+designed+to+aid+consistency+and+reproducibility+of+GRADE+assessments:+development+and+pilot+validation+&author=N+Meader&author=K+King&author=A+Llewellyn&author=G+Norman&author=J+Brown&author=M+Rodgers&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0073"> <div class="reference-title-banner"> <h4 class="title">Meigs 2000</h4> </div> <div class="bibliography-section" id="CD005061-bib-0114"> <div class="citation-journal">Meigs JB, Cupples LA, Wilson PW. <span class="citation-title">Parental transmission of type 2 diabetes: the Framingham Offspring Study</span>. <span class="citation"> Diabetes </span><span class="pubYear">2000</span>;<span class="volume">49</span>(12):2201‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11118026" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Parental+transmission+of+type+2+diabetes:+the+Framingham+Offspring+Study&author=JB+Meigs&author=LA+Cupples&author=PW+Wilson&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0074"> <div class="reference-title-banner"> <h4 class="title">Meneilly 2000</h4> </div> <div class="bibliography-section" id="CD005061-bib-0115"> <div class="citation-journal">Meneilly GS, Ryan EA, Radziuk J, Lau DC, Yale JF, Morais J, et al. <span class="citation-title">Effect of acarbose on insulin sensitivity in elderly patients with diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(8):1162‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10937515" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+acarbose+on+insulin+sensitivity+in+elderly+patients+with+diabetes&author=GS+Meneilly&author=EA+Ryan&author=J+Radziuk&author=DC+Lau&author=JF+Yale&author=J+Morais&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0075"> <div class="reference-title-banner"> <h4 class="title">Morris 2013</h4> </div> <div class="bibliography-section" id="CD005061-bib-0116"> <div class="citation-journal">Morris DH, Khunti K, Achana F, Srinivasan B, Gray LJ, Davies MJ, et al. <span class="citation-title">Progression rates from HbA1c 6.0‐6.4% and other prediabetes definitions to type 2 diabetes: a meta‐analysis</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2013</span>;<span class="volume">56</span>(7):1489‐93. [PUBMED: 23584433] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/23584433" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Progression+rates+from+HbA1c+6.0%E2%80%906.4%+and+other+prediabetes+definitions+to+type+2+diabetes:+a+meta%E2%80%90analysis+&author=DH+Morris&author=K+Khunti&author=F+Achana&author=B+Srinivasan&author=LJ+Gray&author=MJ+Davies&publication_year=2013&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0076"> <div class="reference-title-banner"> <h4 class="title">Nguyen 2011</h4> </div> <div class="bibliography-section" id="CD005061-bib-0117"> <div class="citation-journal">Nguyen NT, Nguyen XM, Lane J, Wang P. <span class="citation-title">Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999‐2006</span>. <span class="citation"> Obesity Surgery </span><span class="pubYear">2011</span>;<span class="volume">21</span>(3):351‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21128002" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Relationship+between+obesity+and+diabetes+in+a+US+adult+population:+findings+from+the+National+Health+and+Nutrition+Examination+Survey,+1999%E2%80%902006+&author=NT+Nguyen&author=XM+Nguyen&author=J+Lane&author=P+Wang&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0077"> <div class="reference-title-banner"> <h4 class="title">Pan 2003</h4> </div> <div class="bibliography-section" id="CD005061-bib-0118"> <div class="citation-journal">Pan CY, Gao Y, Chen JW, Luo BY, Fu ZZ, Lu JM, et al. <span class="citation-title">Efficacy of acarbose in Chinese subjects with impaired glucose tolerance</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2003</span>;<span class="volume">61</span>:183–90. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12965108" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+acarbose+in+Chinese+subjects+with+impaired+glucose+tolerance&author=CY+Pan&author=Y+Gao&author=JW+Chen&author=BY+Luo&author=ZZ+Fu&author=JM+Lu&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0078"> <div class="reference-title-banner"> <h4 class="title">Quilici 2005</h4> </div> <div class="bibliography-section" id="CD005061-bib-0119"> <div class="citation-journal">Quilici S, Chancellor J, Maclaine G, McGuire A, Andersson D, Chiasson JL. <span class="citation-title">Cost‐effectiveness of acarbose for the management of impaired glucose tolerance in Sweden</span>. <span class="citation"> International Journal of Clinical Practice </span><span class="pubYear">2005</span>;<span class="volume">59</span>(10):1143‐52. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16178980" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Cost%E2%80%90effectiveness+of+acarbose+for+the+management+of+impaired+glucose+tolerance+in+Sweden+&author=S+Quilici&author=J+Chancellor&author=G+Maclaine&author=A+McGuire&author=D+Andersson&author=JL+Chiasson&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0079"> <div class="reference-title-banner"> <h4 class="title">RevMan 2014 [Computer program]</h4> </div> <div class="bibliography-section" id="CD005061-bib-0120"> <div class="citation-other">Nordic Cochrane Centre, The Cochrane Collaboration. <span class="citation-title">Review Manager 5 (RevMan 5)</span>. Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, <span class="pubYear">2014</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0080"> <div class="reference-title-banner"> <h4 class="title">Riley 2011</h4> </div> <div class="bibliography-section" id="CD005061-bib-0121"> <div class="citation-journal">Riley RD, Higgins JP, Deeks JJ. <span class="citation-title">Interpretation of random effects meta‐analyses</span>. <span class="citation"> BMJ </span><span class="pubYear">2011</span>;<span class="volume">342</span>:d549. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21310794" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Interpretation+of+random+effects+meta%E2%80%90analyses&author=RD+Riley&author=JP+Higgins&author=JJ+Deeks&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0081"> <div class="reference-title-banner"> <h4 class="title">Sawicki 2004</h4> </div> <div class="bibliography-section" id="CD005061-bib-0122"> <div class="citation-journal">Sawicki PT, Kaiser T. <span class="citation-title">Response to Chiasson et al.: acarbose for the prevention of type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP‐NIDDM Trial data</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2004</span>;<span class="volume">47</span>(6):976‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15150689" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Response+to+Chiasson+et+al.:+acarbose+for+the+prevention+of+type+2+diabetes,+hypertension+and+cardiovascular+disease+in+subjects+with+impaired+glucose+tolerance:+facts+and+interpretations+concerning+the+critical+analysis+of+the+STOP%E2%80%90NIDDM+Trial+data+&author=PT+Sawicki&author=T+Kaiser&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0082"> <div class="reference-title-banner"> <h4 class="title">Schünemann 2017</h4> </div> <div class="bibliography-section" id="CD005061-bib-0123"> <div class="citation-other">Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Akl E, et al. on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. <span class="citation-title">Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017</span>. Available from www.training.cochrane.org/handbook. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0083"> <div class="reference-title-banner"> <h4 class="title">Selvin 2011</h4> </div> <div class="bibliography-section" id="CD005061-bib-0124"> <div class="citation-journal">Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. <span class="citation-title">Racial differences in glycemic markers: a cross‐sectional analysis of community‐based data</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">2011</span>;<span class="volume">154</span>(5):303‐9. [PUBMED: 21357907] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21357907" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Racial+differences+in+glycemic+markers:+a+cross%E2%80%90sectional+analysis+of+community%E2%80%90based+data+&author=E+Selvin&author=MW+Steffes&author=CM+Ballantyne&author=RC+Hoogeveen&author=J+Coresh&author=FL+Brancati&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0084"> <div class="reference-title-banner"> <h4 class="title">Shinozaki 1996</h4> </div> <div class="bibliography-section" id="CD005061-bib-0125"> <div class="citation-journal">Shinozaki K, Suzuki M, Ikebuchi M, Hirose J, Hara Y, Harano Y. <span class="citation-title">Improvement of insulin sensitivity and dyslipidemia with a new alpha‐glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects</span>. <span class="citation"> Metabolism: Clinical and Experimental </span><span class="pubYear">1996</span>;<span class="volume">45</span>(6):731‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8637448" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improvement+of+insulin+sensitivity+and+dyslipidemia+with+a+new+alpha%E2%80%90glucosidase+inhibitor,+voglibose,+in+nondiabetic+hyperinsulinemic+subjects+&author=K+Shinozaki&author=M+Suzuki&author=M+Ikebuchi&author=J+Hirose&author=Y+Hara&author=Y+Harano&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0085"> <div class="reference-title-banner"> <h4 class="title">Stern 2002</h4> </div> <div class="bibliography-section" id="CD005061-bib-0126"> <div class="citation-journal">Stern MP, Williams K, Haffner SM. <span class="citation-title">Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">2002</span>;<span class="volume">136</span>(8):575‐81. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11955025" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Identification+of+persons+at+high+risk+for+type+2+diabetes+mellitus:+do+we+need+the+oral+glucose+tolerance+test?+&author=MP+Stern&author=K+Williams&author=SM+Haffner&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0086"> <div class="reference-title-banner"> <h4 class="title">Sterne 2011</h4> </div> <div class="bibliography-section" id="CD005061-bib-0127"> <div class="citation-journal">Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. <span class="citation-title">Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials</span>. <span class="citation"> BMJ </span><span class="pubYear">2011</span>;<span class="volume">343</span>:d4002. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21784880" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Recommendations+for+examining+and+interpreting+funnel+plot+asymmetry+in+meta%E2%80%90analyses+of+randomised+controlled+trials+&author=JA+Sterne&author=AJ+Sutton&author=JP+Ioannidis&author=N+Terrin&author=DR+Jones&author=J+Lau&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0087"> <div class="reference-title-banner"> <h4 class="title">Stevens 2015</h4> </div> <div class="bibliography-section" id="CD005061-bib-0128"> <div class="citation-journal">Stevens JW, Khunti K, Harvey R, Johnson M, Preston L, Woods HB, et al. <span class="citation-title">Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta‐analysis of lifestyle, pharmacological and surgical interventions</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2015</span>;<span class="volume">107</span>(3):320‐31. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25638454" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Preventing+the+progression+to+type+2+diabetes+mellitus+in+adults+at+high+risk:+a+systematic+review+and+network+meta%E2%80%90analysis+of+lifestyle,+pharmacological+and+surgical+interventions+&author=JW+Stevens&author=K+Khunti&author=R+Harvey&author=M+Johnson&author=L+Preston&author=HB+Woods&publication_year=2015&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0088"> <div class="reference-title-banner"> <h4 class="title">Stumvoll 2005</h4> </div> <div class="bibliography-section" id="CD005061-bib-0129"> <div class="citation-journal">Stumvoll M, Goldstein BJ, Haeften TW. <span class="citation-title">Type 2 diabetes: principles of pathogenesis and therapy</span>. <span class="citation"> Lancet </span><span class="pubYear">2005</span>;<span class="volume">365</span>(9467):1333‐46. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15823385" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Type+2+diabetes:+principles+of+pathogenesis+and+therapy&author=M+Stumvoll&author=BJ+Goldstein&author=TW+Haeften&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0089"> <div class="reference-title-banner"> <h4 class="title">Tabak 2012</h4> </div> <div class="bibliography-section" id="CD005061-bib-0130"> <div class="citation-journal">Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. <span class="citation-title">Prediabetes: a high‐risk state for diabetes development</span>. <span class="citation"> Lancet </span><span class="pubYear">2012</span>;<span class="volume">379</span>(9833):2279‐90. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22683128" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prediabetes:+a+high%E2%80%90risk+state+for+diabetes+development&author=AG+Tabak&author=C+Herder&author=W+Rathmann&author=EJ+Brunner&author=M+Kivimaki&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0090"> <div class="reference-title-banner"> <h4 class="title">Turnbull 2009</h4> </div> <div class="bibliography-section" id="CD005061-bib-0131"> <div class="citation-journal">Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, et al. <span class="citation-title">Intensive glucose control and macrovascular outcomes in type 2 diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2009</span>;<span class="volume">52</span>(11):2288‐98. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19655124" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intensive+glucose+control+and+macrovascular+outcomes+in+type+2+diabetes&author=FM+Turnbull&author=C+Abraira&author=RJ+Anderson&author=RP+Byington&author=JP+Chalmers&author=WC+Duckworth&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0091"> <div class="reference-title-banner"> <h4 class="title">Van de Laar 2005</h4> </div> <div class="bibliography-section" id="CD005061-bib-0132"> <div class="citation-journal">Laar FA, Lucassen PL, Akkermans RP, Lisdonk EH, Rutten GE, Weel C. <span class="citation-title">Alpha‐glucosidase inhibitors for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2005</span>, Issue 2. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD003639.pub2" target="_blank"><span>10.1002/14651858.CD003639.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15846673" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Alpha%E2%80%90glucosidase+inhibitors+for+type+2+diabetes+mellitus&author=FA+Laar&author=PL+Lucassen&author=RP+Akkermans&author=EH+Lisdonk&author=GE+Rutten&author=C+Weel&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0092"> <div class="reference-title-banner"> <h4 class="title">WHO 1985</h4> </div> <div class="bibliography-section" id="CD005061-bib-0133"> <div class="citation-other">World Health Organisation. <span class="citation-title">Technical Report Series No. 727. Report of a WHO Study Group</span>. WHO Expert Committee on Diabetes Mellitus<span class="pubYear">1985</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0093"> <div class="reference-title-banner"> <h4 class="title">WHO 1998</h4> </div> <div class="bibliography-section" id="CD005061-bib-0134"> <div class="citation-journal">Alberti KM, Zimmet PZ. <span class="citation-title">Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1998</span>;<span class="volume">15</span>:539‐53. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9686693" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Definition,+diagnosis+and+classification+of+diabetes+mellitus+and+its+complications.+Part+I:+diagnosis+and+classification+of+diabetes+mellitus.+Provisional+report+of+a+WHO+consultation+&author=KM+Alberti&author=PZ+Zimmet&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0094"> <div class="reference-title-banner"> <h4 class="title">WHO/IDF 2006</h4> </div> <div class="bibliography-section" id="CD005061-bib-0135"> <div class="citation-other">World Health Organization/International Diabetes Federation. <span class="citation-title">Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation</span>. www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf 2006 (accessed 6 July 2018). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0095"> <div class="reference-title-banner"> <h4 class="title">Wong 2006a</h4> </div> <div class="bibliography-section" id="CD005061-bib-0136"> <div class="citation-journal">Wong SS, Wilczynski NL, Haynes RB. <span class="citation-title">Comparison of top‐performing search strategies for detecting clinically sound treatment studies and systematic reviews in MEDLINE and Embase</span>. <span class="citation"> Journal of the Medical Library Association </span><span class="pubYear">2006</span>;<span class="volume">94</span>(4):451‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17082841" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+top%E2%80%90performing+search+strategies+for+detecting+clinically+sound+treatment+studies+and+systematic+reviews+in+MEDLINE+and+Embase+&author=SS+Wong&author=NL+Wilczynski&author=RB+Haynes&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0096"> <div class="reference-title-banner"> <h4 class="title">Wong 2006b</h4> </div> <div class="bibliography-section" id="CD005061-bib-0137"> <div class="citation-journal">Wong SSL, Wilczynski NL, Haynes RB. <span class="citation-title">Developing optimal search strategies for detecting clinically sound treatment studies in Embase</span>. <span class="citation"> Journal of the Medical Library Association </span><span class="pubYear">2006</span>;<span class="volume">94</span>(1):41‐7. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16404468" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Developing+optimal+search+strategies+for+detecting+clinically+sound+treatment+studies+in+Embase+&author=SSL+Wong&author=NL+Wilczynski&author=RB+Haynes&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0097"> <div class="reference-title-banner"> <h4 class="title">Wood 2008</h4> </div> <div class="bibliography-section" id="CD005061-bib-0138"> <div class="citation-journal">Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. <span class="citation-title">Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study</span>. <span class="citation"> BMJ </span><span class="pubYear">2008</span>;<span class="volume">336</span>(7644):601‐5. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18316340" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Empirical+evidence+of+bias+in+treatment+effect+estimates+in+controlled+trials+with+different+interventions+and+outcomes:+meta%E2%80%90epidemiological+study+&author=L+Wood&author=M+Egger&author=LL+Gluud&author=KF+Schulz&author=P+J%C3%BCni&author=DG+Altman&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD005061-bbs2-0098"> <div class="reference-title-banner"> <h4 class="title">Yudkin 2014</h4> </div> <div class="bibliography-section" id="CD005061-bib-0139"> <div class="citation-journal">Yudkin JS, Montori VM. <span class="citation-title">The epidemic of pre‐diabetes: the medicine and the politics</span>. <span class="citation"> BMJ </span><span class="pubYear">2014</span>;<span class="volume">349</span>:g4485. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/25028385" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+epidemic+of+pre%E2%80%90diabetes:+the+medicine+and+the+politics&author=JS+Yudkin&author=VM+Montori&publication_year=2014&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD005061-bbs1-0005"> <h3 class="title">References to other published versions of this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD005061-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0003">studies awaiting assessment</a></li> <li><a class="jump-to" href="#CD005061-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_otherVersions" id="CD005061-bbs2-0099"> <div class="reference-title-banner"> <h4 class="title">Van de Laar 2006</h4> </div> <div class="bibliography-section" id="CD005061-bib-0140"> <div class="citation-journal">Laar FA, Lucassen PLBJ, Akkermans RP, Lisdonk EH, Grauw WJC. <span class="citation-title">Alpha‐glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2006</span>, Issue 4. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD005061.pub2" target="_blank"><span>10.1002/14651858.CD005061.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17054235" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Alpha%E2%80%90glucosidase+inhibitors+for+people+with+impaired+glucose+tolerance+or+impaired+fasting+blood+glucose+&author=FA+Laar&author=PLBJ+Lucassen&author=RP+Akkermans&author=EH+Lisdonk&author=WJC+Grauw&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> </section> <section class="characteristicStudies" id="characteristicStudies"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title"> Characteristics of studies <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="characteristicIncludedStudiesContent" lang=""> <div class="section-header" id="CD005061-sec2-0037"> <h3 class="title">Characteristics of included studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD005061-sec2-0038" class="jump-to">excluded studies</a></li> <li><a href="#CD005061-sec2-0039" class="jump-to">awaiting classification</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">ABC 2017 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel RCT, randomisation ratio 1:1, superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: individuals with clinically overt MI, 21‐79 years old with IGT (fasting plasma glucose levels of ≤ 7.0 mmol/L, a 2‐h OGTT value of between 7.8‐11.1 mmol/L, and HbA1c levels of ≤ 6.5%) </p> <p><b>Exclusion criteria</b>: acute MI occurring within the last 7 d; patients with NYHA symptoms of ≥ class II or with a LVEF of ≤ 40%; suspected type I DM; patients scheduled for coronary angioplasty; history of coronary artery bypass graft surgery; serious liver or kidney damage; history of allergy or drug hypersensitivity; arteriosclerosis obliterans with Fontaine stage III or worse; and inability to understand and/or comply with trial medications, procedures, and/or follow‐up or any conditions that may render the participant unable to complete the trial in the opinion of the investigator </p> <p><b>Diagnostic criteria</b>: </p> <p>FPG ≤ 7.0 mmol/L and 2hPG of 7.8‐11.1 mmol/L (<a href="references#CD005061-bbs2-0094">WHO/IDF 2006</a>) </p> <p>HbA1c ≤ 6.5%</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of trial centres</b>: 112 </p> <p><b>Run‐in period</b>: no </p> <p><b>Extension period</b>: no </p> <p><b>Intervention:</b> </p> <p>AGI: 0.2 mg voglibose 3 times/d (in the event of gastrointestinal side effects the dosage was reduced to half or a quarter of the original dosage) </p> <p><b>Control:</b> diet and exercise therapy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Composite outcome measures reported</b>: yes, the time until the first cardiovascular composite endpoint of death from cardiovascular death, hospitalisation due to non‐fatal MI, non‐fatal unstable angina, non‐fatal stroke, or treatment with coronary revascularisation (percutaneous coronary intervention or coronary artery bypass graft) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Trial terminated early (because of lack of benefit):</b> yes </p> <p><b>Trial ID:</b><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNXGT5UJMNRXZ7DTNFRXZ63PM7YYG/ct2/show/study/NCT00212017?term=NCT00212017%26rank=1)" target="_blank">NCT00212017</a> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding:</b> non‐commercial funding </p> <p><b>Publication status:</b> peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication:</b> "... to evaluate effects of aggressive intervention with the alpha‐glucose inhibitor voglibose on cardiovascular events in patients with IGT and a history of MI" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "All patients were randomly assigned (1:1) through a web‐based central randomisation system using computer‐generated random numbers (NTT Data, Tokyo, Japan)" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "This study was open‐labeled, and allocation was unmasked to the patients and investigators, but masked to the event adjudication committee and the data and safety monitoring board (DSMB)" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: open‐label, but we judged the outcome unlikely to be influenced by lack of blinding </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: open‐label, but we judged the outcome unlikely to be influenced by lack of blinding </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: open‐label, but we judged the outcome unlikely to be influenced by lack of blinding </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: open‐label</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "...allocation was [...] masked to the event adjudication committee and the data and safety monitoring board (DSMB)" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "...allocation was [...] masked to the event adjudication committee and the data and safety monitoring board (DSMB)" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "...allocation was [...] masked to the event adjudication committee and the data and safety monitoring board (DSMB)" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "...allocation was [...] masked to the event adjudication committee and the data and safety monitoring board (DSMB)" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 424 completers and 4 dropouts in treatment group, 435 completers and 4 dropouts in control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 424 completers and 4 dropouts in treatment group, 435 completers and 4 dropouts in control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 424 completers and 4 dropouts in treatment group, 435 completers and 4 dropouts in control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 424 completers and 4 dropouts in treatment group, 435 completers and 4 dropouts in control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: the secondary outcomes mentioned in the trial register were slightly different in the publication (all‐cause mortality; hospitalisation due to heart failure, CAD, and cerebrovascular disease; progression of IGT to diabetes; development or deterioration of hypertension or hyperlipidaemia; and deterioration of renal function), compared to: all‐cause mortality; hospitalisation due to heart failure; death from cardiovascular disease, non‐fatal myocardial infarction, non‐fatal unstable angina, treatment with coronary revascularisation, non‐fatal stroke) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: the trial was terminated early and the main researchers received grants and personal fees from Pfizer and Takeda. </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">ACE 2017 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel RCT, randomisation ratio 1:1, superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: </p> <p> <ul id="CD005061-lst1-0025"> <li> <p>Male or female, aged ≥ 50 years</p> </li> <li> <p>Definite coronary heart disease, defined below:</p> </li> <li> <p>Previous MI or ACS, but not within the last 3 months, with any 2 of the following:</p> <ul id="CD005061-lst2-0001"> <li> <p>typical clinical presentation</p> </li> <li> <p>confirmatory ECG changes</p> </li> <li> <p>appropriate elevation of cardiac enzymes/biomarkers</p> </li> </ul> </li> <li> <p>Previous UA or ACS, but not within the last 3 months, with any 2 of the following:</p> <ul id="CD005061-lst2-0002"> <li> <p>typical clinical presentation</p> </li> <li> <p>confirmatory ECG changes</p> </li> <li> <p>either elevation of a cardiac biomarker or a &gt; 50% stenosis in ≥ 1 major epicardial coronary artery shown on coronary angiography or CT angiography. Where stenosis is reported in a qualitative manner, the categories 'moderate' and 'severe' will be taken as equating to &gt; 50% stenosis. </p> </li> </ul> </li> <li> <p>Current stable angina defined as:</p> <ul id="CD005061-lst2-0003"> <li> <p>typical clinical history with symptoms occurring within the last month, and</p> </li> <li> <p>a &gt; 50% stenosis in ≥ 1 major epicardial coronary artery shown on coronary angiography or CT angiography. Where stenosis is reported in a qualitative manner, the categories 'moderate' and 'severe' will be taken as equating to &gt; 50% stenosis. </p> </li> </ul> </li> <li> <p>IGT diagnosed on a single standard OGTT, defined as a 2hPG value ≥ 7.8 but &lt; 11.1 mol/L and a fasting plasma glucose (FPG) &lt; 7.0 mmol/L within 6 months prior to enrolment </p> </li> <li> <p>Optimised cardiovascular drug therapy</p> </li> <li> <p>At least 80% adherent to single‐blind placebo study medication during the run‐in period</p> </li> <li> <p>Provision of written informed consent</p> </li> </ul> </p> <p><b>Exclusion criteria</b>: </p> <p> <ul id="CD005061-lst1-0026"> <li> <p>Previous history of diabetes, other than gestational diabetes</p> </li> <li> <p>MI, UA, stroke or TIA within the previous 3 months</p> </li> <li> <p>Planned or anticipated coronary, cerebrovascular or peripheral arterial revascularisation or other major surgical intervention, at the time of randomisation </p> </li> <li> <p>NYHA class III or IV heart failure</p> </li> <li> <p>Evidence of severe hepatic disease</p> </li> <li> <p>Evidence of severe renal impairment or an eGFR &lt; 30 mL/min/1.73m² (derived using the Chinese MDRD equation) </p> </li> <li> <p>Any other condition likely to reduce adherence to the protocol e.g. alcoholism, major active psychiatric disorder, cognitive impairment or a condition likely to markedly limit life expectancy e.g. malignancy </p> </li> <li> <p>Pregnancy (or planned pregnancy within the next 5 years)</p> </li> <li> <p>Concurrent participation in any other clinical interventional trial. Note: participants who were treated previously with an alpha‐glucosidase inhibitor must have at least a 3‐month washout period before being randomised into the ACE trial </p> </li> <li> <p>Known intolerance to AGI or gastrointestinal problems</p> </li> <li> <p>Thought by the investigator for any reason to be unsuitable for participation in this clinical study </p> </li> </ul> </p> <p><b>Diagnostic criteria</b>: </p> <p>FPG &lt; 7.0 mmol/L and 2hPG of 7.8‐11.1 mmol/L (<a href="references#CD005061-bbs2-0094">WHO/IDF 2006</a>) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 176 </p> <p><b>Run‐in period</b>: 4 weeks with placebo medication, optimisation of cardiovascular therapy, and provision of lifestyle advice with respect to diet, exercise, and smoking </p> <p><b>Extension period</b>: no </p> <p><b>Intervention:</b> </p> <p>AGI: 50 mg acarbose 3 times/d with meals</p> <p>Control: placebo 3 times/d with meals</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Composite outcome measures reported</b>: yes, a 5‐point composite of cardiovascular death, non‐fatal MI, non‐fatal stroke, hospital admission for unstable angina, and hospital admission for heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Trial terminated early:</b> no </p> <p><b>Trial ID:</b><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNXGT5UJMNRXZ7DTNFRXZ63PM7YYG/ct2/show/NCT00829660" target="_blank">NCT00829660</a> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding:</b> commercial funding (Bayer) </p> <p><b>Publication status:</b> peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The Acarbose Cardiovascular Evaluation (ACE) trial was designed to examine whether acarbose could reduce cardiovascular events in Chinese patients with established coronary heart disease and IGT, and whether the incidence of type 2 diabetes could be reduced" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Participants were randomly assigned (1:1) by a centralised computer system to receive either acarbose or to matching placebo, in blocks of eight within site. The randomisation sequence (coded as A or B) was generated by a Diabetes Trials Unit statistician unconnected to the trial and uploaded to the electronic Rave Trial Management System (rTMS)" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Acarbose and matching placebo tablets were provided by Bayer AG, packaged in 4‐month quantities, each packet being labelled with a unique code. These codes were also uploaded to the rTMS with their corresponding A or B categorisation, which was not visible to study staff" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, using a matched placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> hypoglycaemia </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, using a matched placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, using a matched placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, using a matched placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, using a matched placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, using a matched placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, using a matched placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Potential cardiovascular endpoint events were reviewed and adjudicated by an independent cardiovascular endpoint adjudication committee, which was masked to treatment allocation" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> hypoglycaemia </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "...at subsequent study visits, investigators were instructed by the rTMS which study medication packet should be given to each participant. They were required to enter two letters printed alongside the unique code on the packet label so that the rTMS could confirm the correct study medication had been dispensed. Up until database lock, the assignation of A or B to active or placebo was known only to the Bayer AG study medication packaging group and the data and safety monitoring board" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "An independent diabetes endpoint adjudication committee masked to treatment group allocation reviewed cases in which diabetes was diagnosed, or in which participants were commenced on other glucose‐lowering drugs, outside of the trial to decide if a diagnosis of diabetes was warranted" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "...at subsequent study visits, investigators were instructed by the rTMS which study medication packet should be given to each participant. They were required to enter two letters printed alongside the unique code on the packet label so that the rTMS could confirm the correct study medication had been dispensed. Up until database lock, the assignation of A or B to active or placebo was known only to the Bayer AG study medication packaging group and the data and safety monitoring board" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Potential cardiovascular endpoint events were reviewed and adjudicated by an independent cardiovascular endpoint adjudication committee, which was masked to treatment allocation" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "...at subsequent study visits, investigators were instructed by the rTMS which study medication packet should be given to each participant. They were required to enter two letters printed alongside the unique code on the packet label so that the rTMS could confirm the correct study medication had been dispensed. Up until database lock, the assignation of A or B to active or placebo was known only to the Bayer AG study medication packaging group and the data and safety monitoring board" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "...at subsequent study visits, investigators were instructed by the rTMS which study medication packet should be given to each participant. They were required to enter two letters printed alongside the unique code on the packet label so that the rTMS could confirm the correct study medication had been dispensed. Up until database lock, the assignation of A or B to active or placebo was known only to the Bayer AG study medication packaging group and the data and safety monitoring board" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3092 completers and 180 dropouts in treatment group, 3064 completers and 186 dropouts in control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> hypoglycaemia </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3092 completers and 180 dropouts in treatment group, 3064 completers and 186 dropouts in control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3092 completers and 180 dropouts in treatment group, 3064 completers and 186 dropouts in control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3092 completers and 180 dropouts in treatment group, 3064 completers and 186 dropouts in control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3092 completers and 180 dropouts in treatment group, 3064 completers and 186 dropouts in control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3092 completers and 180 dropouts in treatment group, 3064 completers and 186 dropouts in control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3092 completers and 180 dropouts in treatment group, 3064 completers and 186 dropouts in control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no changes between design paper and final publication, except for the original primary composite cardiovascular outcome, a 3‐point MACE outcome, which was changed to a 5‐point major cardiovascular event, but this change was explained in the final publication </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: the main researcher received grants from Bayer</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">DAISI 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel RCT, randomisation ratio 1:1, superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: IGT (a mean fasting plasma glucose level &gt; 5.5 mmol/L and &lt; 7.8 mmol/L, a mean 2‐h PG level of 8.6‐11.1 mmol/L, an HbA1c level ≤ 7.0% and aged 45–70 years)<br> At the end of the qualification period, participants were considered eligible if they met the following criteria: having complied with the study procedures, having taken more than 80% of the prescribed medication during week 3–6 of the qualification period (as determined from returned tablet blisters), and having reported no adverse effects that could threaten future compliance </p> <p><b>Exclusion criteria</b>: diseases or conditions likely to prevent completion of the study, known uncorrected endocrine disorders, documented gastrointestinal diseases, cholesterol &gt; 10 mmol/L or triglycerides &gt; 10 mmol/L, treatment with lipid‐lowering medication (with the exception of statins), MI within the previous 6 months, impaired liver function (AST/ALT &gt; 50 units/L), or impaired kidney function (creatinine &gt; 150 mmol/L) </p> <p><b>Diagnostic criteria</b>: </p> <p>FPG &lt; 7.8 mmol/L (<a href="references#CD005061-bbs2-0092">WHO 1985</a>)<br> 2hPG: 8.6 to 11.1 mmol/L </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: single centre </p> <p><b>Run‐in period</b>: a qualification period over 6 weeks with acarbose treatment for all participants, and a wash‐out period over 4 weeks with placebo treatment for all participants </p> <p><b>Extension period</b>: no </p> <p><b>Intervention:</b> </p> <p>AGI: 50 mg acarbose 3 times/d</p> <p>Control: placebo 3 times/d</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Composite outcome measures reported</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Trial terminated early:</b> no </p> <p><b>Trial ID:</b><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7VG8LUJN34A/trialsearch/Trial2.aspx?TrialID=NTR150" target="_blank">NTR150</a> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding:</b> commercial funding (Bayer) </p> <p><b>Publication status:</b> peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "To investigate the effects of acarbose on the distribution of the 2‐h plasma glucose level following an intake of 75 g of glucose, the incidence of conversion to type 2 dm, on insulin secretion induced by hyperglycemia and on insulin sensitivity" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Study numbers were randomly assigned to the placebo or the acarbose group generated by a computer at Bayer’s biometric unit. The numbers were assigned in ascending order in the sequence of the subject’s entry into the intervention study." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Study numbers were randomly assigned to the placebo or the acarbose group generated by a computer at Bayer’s biometric unit. The numbers were assigned in ascending order in the sequence of the subject’s entry into the intervention study." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Double‐blind. [...] Placebo tablets matched the acarbose tablets in size, shape, and colour" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Double‐blind. [...] Placebo tablets matched the acarbose tablets in size, shape, and colour" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Double‐blind. [...] Placebo tablets matched the acarbose tablets in size, shape, and colour" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Double‐blind. [...] Placebo tablets matched the acarbose tablets in size, shape, and colour" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Double‐blind. [...] Placebo tablets matched the acarbose tablets in size, shape, and colour" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Double‐blind. [...] Placebo tablets matched the acarbose tablets in size, shape, and colour" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The identity of the treatment groups was concealed until the final statistical analysis" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The identity of the treatment groups was concealed until the final statistical analysis" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The identity of the treatment groups was concealed until the final statistical analysis" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The identity of the treatment groups was concealed until the final statistical analysis" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The identity of the treatment groups was concealed until the final statistical analysis" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The identity of the treatment groups was concealed until the final statistical analysis" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 30 completers and 30 dropouts in treatment group, 36 completers and 22 dropouts in control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &gt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 30 completers and 30 dropouts in treatment group, 36 completers and 22 dropouts in control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &gt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 30 completers and 30 dropouts in treatment group, 36 completers and 22 dropouts in control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &gt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 30 completers and 30 dropouts in treatment group, 36 completers and 22 dropouts in control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &gt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 30 completers and 30 dropouts in treatment group, 36 completers and 22 dropouts in control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &gt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 30 completers and 30 dropouts in treatment group, 36 completers and 22 dropouts in control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &gt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: outcomes in trial register and publications are the same</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: possible funding bias</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">EDIT 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Factorial RCT, randomisation ratio 1:1, superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: 30‐70 years, "at risk for developing diabetes", 2 consecutive FPG levels of 5.5‐7.7 mmol/L </p> <p><b>Exclusion criteria</b>: unclear </p> <p><b>Diagnostic criteria</b>: </p> <p>FPG: 5.5 to 7.7 mmol/L</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres:</b> 9 </p> <p><b>Run‐in period</b>: unclear </p> <p><b>Extension period</b>: no </p> <p><b>Intervention:</b> </p> <p>AGI: 50 mg acarbose 3 times/d + placebo 3 times/d</p> <p>Control 1: placebo 3 times/d + placebo 3 times/d</p> <p>Control 2: 500 mg metformin 3 times/d + placebo 3 times/d</p> <p>Control 3: 500 mg metformin 3 times/d + 50 mg acarbose 3 times/d</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Composite outcome measures reported</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Trial terminated early:</b> no </p> <p><b>Trial ID:</b><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUJPN3GG7DPF3SX85B/ISRCTN96631607" target="_blank">ISRCTN96631607</a> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding:</b> commercial funding (Bayer and Merck‐Lipha) </p> <p><b>Publication status:</b> other (website, abstracts) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "…to determine whether deterioration in glycaemic tolerance towards diabetes can be delayed or prevented using acarbose or metformin" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> health‐related quality of life </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Double‐blind"</p> <p>Comment: not enough information</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Double‐blind"</p> <p>Comment: not enough information, but we judged the outcome unlikely to be influenced by lack of blinding </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Double‐blind"</p> <p>Comment: not enough information, but we judged the outcome unlikely to be influenced by lack of blinding </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Double‐blind"</p> <p>Comment: not enough information</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> health‐related quality of life </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: trial was finished over 10 years ago and has still not been published</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: possible funding bias</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Fang 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel, 2x2 factorial RCT, randomisation ratio 1:1, superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: IGT in accordance with the diagnostic criteria of DM set by WHO in 1985 </p> <p><b>Exclusion criteria:</b> severe somatological disease, mental disease or history of mental disease, severe intellectual or cognitive disorders, drug or alcohol dependence </p> <p><b>Diagnostic criteria</b>: </p> <p>FPG &lt; 7.8 mmol/L and/or 2hPG of 7.8 mmol/L‐11.1 mmol/L (<a href="references#CD005061-bbs2-0092">WHO 1985</a>) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: single centre </p> <p><b>Run‐in period</b>: no </p> <p><b>Extension period</b>: no </p> <p><b>Intervention:</b> </p> <p>AGI: 25‐50 mg acarbose 3 times/d</p> <p>Control 1: no intervention ("common DM prevention education")</p> <p>Control 2: 125 to 250 mg flumamine (= metformin) 3 times/d</p> <p>Control 3: diet and exercise</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Composite outcome measures reported</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Trial terminated early:</b> no </p> <p><b>Trial ID:</b> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: Chinese </p> <p><b>Funding:</b> unclear </p> <p><b>Publication status:</b> peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "To observe influence of medicine intervention and non‐medicine intervention on the outcomes of the crowd with impaired glucose tolerance (IGT), and explore which intervention can prevent IGT from developing to diabetes mellitus more effectively" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: trialists used random number table method, but there was baseline imbalance, which suggests randomisation was not adequate. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: not enough details</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 45 completers and 5 dropouts in the treatment group, 35 completers and 5 dropouts in the no‐intervention group, 44 completers and 4 dropouts in the metformin group, and 36 completers and 4 dropouts in the diet and exercise group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 45 completers and 5 dropouts in the treatment group, 35 completers and 5 dropouts in the no‐intervention group, 44 completers and 4 dropouts in the metformin group, and 36 completers and 4 dropouts in the diet and exercise group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 45 completers and 5 dropouts in the treatment group, 35 completers and 5 dropouts in the no‐intervention group, 44 completers and 4 dropouts in the metformin group, and 36 completers and 4 dropouts in the diet and exercise group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no protocol available</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no other bias determined</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kawamori 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel RCT, randomisation ratio 1:1, superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: </p> <p>IGT:</p> <p> <ul id="CD005061-lst1-0027"> <li> <p>FPG &lt; 6.9 mmol/L</p> </li> <li> <p>2hPG: 7.8‐11.0 mmol/L</p> </li> <li> <p>HbA1c &lt; 6.5%</p> </li> </ul> </p> <p>≥ 1 of the following risk factors for T2DM:</p> <p> <ul id="CD005061-lst1-0028"> <li> <p>high normal blood pressure (systolic ≥ 130 mmHg or diastolic ≥ 85 mmHg) or being treated for hypertension </p> </li> <li> <p>dyslipidaemia (concentrations of total cholesterol ≥ 5.7 mmol/L, triglyceride ≥ 1.7 mmol/L, or HDL cholesterol &lt; 1.04 mmol/L) </p> </li> <li> <p>obesity (BMI ≥ 25 kg/m²)</p> </li> <li> <p>family history of diabetes (in a first‐degree or second‐degree relative)</p> </li> </ul> </p> <p><b>Exclusion criteria</b>: diabetes or a disease likely to impair glucose tolerance </p> <p><b>Diagnostic criteria</b>: </p> <p>FPG &lt; 6.9 mmol/L and 2hPG of 7.8‐11.0 mmol/L (<a href="references#CD005061-bbs2-0094">WHO/IDF 2006</a>)<br> HbA1c &lt; 6.5% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 103 Japanese institutions </p> <p><b>Run‐in period</b>: 4‐week observation. Moreover, "4–8 weeks before the start of treatment, each person was given advice about appropriate nutrition and exercise programmes (interview, survey of lifestyle, and individualised guidance on future lifestyle habits based on intensity of daily activity categories defined by the Japanese Ministry of Health and Labour)" </p> <p><b>Extension period</b>: no </p> <p><b>Intervention:</b> </p> <p>AGI: 0.2 mg voglibose 3 times/d</p> <p>Control: placebo 3 times/d</p> <p><b>Additional therapy</b>: participants were given advice about appropriate nutrition and exercise programmes (interview, survey of lifestyle, and individualised guidance on future lifestyle habits based on intensity of daily activity categories defined by the Japanese Ministry of Health and Labour) and adherence to these was assessed at each visit. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Composite outcome measures reported</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Trial terminated early (for benefit):</b> yes </p> <p><b>Trial ID:</b><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PWZGZ55BMRYHK5LJNZYGCZ3PNJZA/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001296" target="_blank">UMIN000001109</a> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding:</b> non‐commercial funding </p> <p><b>Publication status:</b> peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "We therefore investigated the effectiveness of voglibose, an α‐glucosidase inhibitor that reduces diurnal insulin secretion, for prevention of the development of type 2 diabetes in Japanese patients with impaired glucose tolerance" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Randomisation was done with a stratified allocation procedure designed to balance the two treatment groups in each institution with respect to the number of risk factors (≤ 2 or ≥ 3), which were hypertension or high normal blood pressure, dyslipidaemia, obesity, a family history of diabetes, and a 2hPG greater than 9.4 mmol/L (a concentration associated with an increased risk of developing type 2 diabetes in Japan) to 11.0 mmol/L. An independent statistician computer‐generated the random sequence and this was maintained securely until the study was unmasked" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Allocation was concealed with sealed opaque envelopes"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, with an identical‐looking placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, with an identical‐looking placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, with an identical‐looking placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, with an identical‐looking placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, with an identical‐looking placebo</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 768 completers and 129 dropouts in the treatment group, 737 completers and 146 dropouts in the control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 768 completers and 129 dropouts in the treatment group, 737 completers and 146 dropouts in the control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 768 completers and 129 dropouts in the treatment group, 737 completers and 146 dropouts in the control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 768 completers and 129 dropouts in the treatment group, 737 completers and 146 dropouts in the control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 768 completers and 129 dropouts in the treatment group, 737 completers and 146 dropouts in the control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: data were not reported for some measured outcomes (FPG, HbA1c, triglycerides, total cholesterol, HDL‐cholesterol, blood pressure, and body weight) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: the trial was terminated early</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Koyasu 2010 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel RCT, randomisation ratio 1:1, superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: stable angina pectoris, CAD (≥ 50% stenosis on quantitative coronary angiography), and newly diagnosed IGT or mild T2DM </p> <p><b>Exclusion criteria</b>: age &gt; 70 years, active inflammatory disease, previous treatment with antidiabetic agents, a previous diagnosis of DM, HbA1c ≥ 6.5%, previous cerebrovascular disease, acute coronary syndrome, renal dysfunction (serum creatinine &gt; 1.5 mg/dL), and history or presence of cancer </p> <p><b>Diagnostic criteria</b>: </p> <p>IGT: FPG &lt; 7 mmol/L and 2hPG 7.77 to 11.05 mmol/L (<a href="references#CD005061-bbs2-0094">WHO/IDF 2006</a>)<br> Mild T2DM: FPG &lt; 7 mmol/L, 2hPG &gt; 11.1 mmol/L and HbA1c &lt; 6.5% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: single centre </p> <p><b>Run‐in period</b>: no </p> <p><b>Extension period</b>: no </p> <p><b>Intervention:</b> </p> <p>AGI: 50 mg acarbose 3 times/d</p> <p>Control: no intervention</p> <p><b>Additional therapy</b>: participants were encouraged to exercise, stop smoking, restrict fat intake, increase dietary fibre intake, and reduce between‐meal snacks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Composite outcome measures reported</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Trial terminated early:</b> no </p> <p><b>Trial ID:</b><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PWZGZ55BMRYHK5LJNZYGCZ3PNJZA/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000658" target="_blank">UMIN000000544</a> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding:</b> non‐commercial funding </p> <p><b>Publication status:</b> peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "The present study examined the effect of acarbose therapy on carotid IMT in patients with established CAD who had been newly diagnosed with IGT or mild T2DM" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Randomization was performed using a simple sealed‐envelope method"</p> <p>Comment: not enough information</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Randomization was performed using a simple sealed‐envelope method."</p> <p>Comment: not enough information</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "This was a 1‐year, prospective, randomised, open‐label, parallel‐group study..."</p> <p>Comment: we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "This was a 1‐year, prospective, randomised, open‐label, parallel‐group study..."</p> <p>Comment: we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "This was a 1‐year, prospective, randomised, open‐label, parallel‐group study..."</p> <p>Comment: we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The primary and secondary end points were evaluated by blinded evaluators"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The primary and secondary end points were evaluated by blinded evaluators"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "The primary and secondary end points were evaluated by blinded evaluators"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 42 completers and 3 dropouts in the treatment group, 39 completers and 6 dropouts in the control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 42 completers and 3 dropouts in the treatment group, 39 completers and 6 dropouts in the control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 42 completers and 3 dropouts in the treatment group, 39 completers and 6 dropouts in the control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: the primary outcomes in the trial register are: the incidence of cardiovascular events (defined as "new onset myocardial infarction, worsening anginal status and/or angiographic restenosis") and the carotid intima‐medial thickness (IMT). In the publication the only primary outcome is the change in IMT measured in the right and left common carotid arteries. There are also differences in the secondary outcomes </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no other bias determined</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">STOP‐NIDDM 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel RCT, randomisation ratio 1:1, superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: men and women aged 40‐70 years, with BMI of 25‐40 kg/m², IGT, and FPG of 5.6‐7.7 mmol/L </p> <p><b>Exclusion criteria</b>: serum creatinine level ≥ 130 µmol/L, a fasting serum triglycerides ≥ 10 mmol/L, liver enzymes elevated to ≥ 1.8 times the ULN or a TSH ≥ 1.5 times above ULN or below the lower limit of normal (&lt; 0.3 mU/L). Participants who had been treated within the last 3 months with systemic glucocorticoids, beta‐blockers, thiazide diuretics, and nicotinic acid were also excluded. Key exclusion criteria were based on the use of drugs that were likely to be associated with abnormal intestinal motility or altered absorption of nutrients. All participants with a recent cardiovascular event were also excluded </p> <p><b>Diagnostic criteria</b>: </p> <p>2hPG: 7.8 to 11.1 mmol/L (<a href="references#CD005061-bbs2-0092">WHO 1985</a>) </p> <p>FPG: 5.6 to 7.7 mmol/L</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: multicentre </p> <p><b>Run‐in period</b>: no </p> <p><b>Extension period:</b> no </p> <p><b>Intervention:</b> </p> <p>AGI: 100 mg or maximum tolerated dose acarbose 3 times/d</p> <p><b>Control:</b> placebo </p> <p><b>Additional therapy</b>: all participants were instructed to go on a weight‐reduction or weight‐maintenance diet and were encouraged to exercise regularly; these instructions were reinforced at each visit. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Composite outcome measures reported</b>: yes, major cardiovascular events, including coronary heart disease (MI, new angina, revascularisation procedures), cardiovascular death, congestive heart failure, cerebrovascular events, and peripheral vascular disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Trial terminated early:</b> no </p> <p><b>Trial ID:</b> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding:</b> commercial funding (Bayer) </p> <p><b>Publication status:</b> peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "…to assess the effect of acarbose on conversion of impaired glucose tolerance to type 2 diabetes" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "We used a computer program to generate the random allocation sequence, which was stratified by centre. Randomisation was done in blocks of four and six" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "Numbered drug containers were used to implement the random allocation process. Since the random code was stratified by center, the patients were randomized sequentially at each center. The random codes were concealed in 4‐part container labels that were stored separately in the event that the investigator needed to know the treatment of a patient. The allocation sequence was generated by an independent statistician who was a member of the data safety and quality review committee" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, with a placebo similar in size, shape and colour</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, with a placebo similar in size, shape and colour</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, with a placebo similar in size, shape and colour</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, with a placebo similar in size, shape and colour</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: double‐blind, with a placebo similar in size, shape and colour</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "These events were ascertained by an independent adjudicating committee of 3 cardiologists blinded to treatment" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "These events were ascertained by an independent adjudicating committee of 3 cardiologists blinded to treatment" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "These events were ascertained by an independent adjudicating committee of 3 cardiologists blinded to treatment" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "These events were ascertained by an independent adjudicating committee of 3 cardiologists blinded to treatment" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "These events were ascertained by an independent adjudicating committee of 3 cardiologists blinded to treatment" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 471 completers and 211 dropouts in the treatment group, 556 completers and 130 dropouts in the control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &gt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 471 completers and 211 dropouts in the treatment group, 556 completers and 130 dropouts in the control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &gt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 471 completers and 211 dropouts in the treatment group, 556 completers and 130 dropouts in the control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &gt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 471 completers and 211 dropouts in the treatment group, 556 completers and 130 dropouts in the control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &gt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 471 completers and 211 dropouts in the treatment group, 556 completers and 130 dropouts in the control group. Dropout rate is &gt; 15%. Difference in dropout rates between groups &gt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: the definition of the outcome cardiovascular events was different in the publication (coronary heart disease, cardiovascular death, congestive heart failure, cerebrovascular event, and peripheral arterial disease) compared to the design paper (RCT, cerebrovascular accident, congestive heart failure) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: possible funding bias</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Wang 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel RCT, randomisation ratio 1:1, superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: unclear </p> <p><b>Exclusion criteria</b>: unclear </p> <p><b>Diagnostic criteria</b>: </p> <p>FPG &lt; 7.8 mmol/L and/or 2hPG of 7.8 to 11.1 mmol/L (<a href="references#CD005061-bbs2-0092">WHO 1985</a>) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: unclear </p> <p><b>Run‐in period</b>: unclear </p> <p><b>Extension period</b>: unclear </p> <p><b>Intervention:</b> </p> <p>AGI: 50 mg acarbose 3 times/d</p> <p><b>Control:</b> no intervention </p> <p><b>Additional therapy</b>: participants received a minimal of 5 h training about diet to treat and prevent T2DM </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Composite outcome measures reported</b>: no </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Trial terminated early:</b> no </p> <p><b>Trial ID:</b> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: Chinese </p> <p><b>Funding:</b> unclear </p> <p><b>Publication status:</b> peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "Observe the change of acarbose to IGT and explore the possibility of DM second class prevention" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "divide them into 2 groups stochastically"</p> <p>Comment: not enough information</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no blinding, but we judged the outcome unlikely to be influenced by lack of blinding </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no blinding, but we judged the outcome unlikely to be influenced by lack of blinding </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> incidence of T2DM </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 30 completers and 1 dropout in the treatment group, 30 completers and no dropouts in the control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 30 completers and 1 dropout in the treatment group, 30 completers and no dropouts in the control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 30 completers and 1 dropout in the treatment group, 30 completers and no dropouts in the control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10 </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no protocol available</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no other bias determined</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Yun 2016 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Parallel RCT, randomisation ratio 1:1, superiority design</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Inclusion criteria</b>: admission to hospital with acute coronary syndrome (ACS) and IGT. ACS was diagnosed by the presence of acute ischaemic symptoms lasting ≥ 20 min within 48 h before admission to hospital and electrocardiographic changes consistent with ACS. Acute RCT (AMI) was diagnosed when creatine kinase‐muscle/brain levels increased to at least twice the ULN or when troponin T levels were &gt; 0.1 ng/mL. Participants without AMI were considered to have unstable angina pectoris (all cases confirmed by percutaneous or computed tomography coronary angiography) </p> <p><b>Exclusion criteria</b>: cardiogenic shock or pulmonary edema (Killip classification ≥ II) at admission; history of diabetes; history of hepatic diseases or/and renal dysfunction (serum creatinine level &gt; 2 mg/dL); severe gastrointestinal disease or malignant tumours; female participants given sex hormone replacement therapy </p> <p><b>Diagnostic criteria</b>: </p> <p>FPG &lt; 6.1 mmol/L<br> 2hPG: 7.8 mmol/L to 11.1 mmol/L (<a href="references#CD005061-bbs2-0094">WHO/IDF 2006</a>) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Number of study centres</b>: 2 centres </p> <p><b>Run‐in period</b>: unclear </p> <p><b>Extension period</b>: no </p> <p><b>Intervention:</b> </p> <p>AGI: 50 mg acarbose 3 times/d</p> <p><b>Control:</b> no intervention </p> <p><b>Additional therapy</b>: all participants were guided to take diet and exercise therapy, and having outpatient clinic or telephone follow‐up for 1.0‐4.5 years. Each group was given standard medical therapy of CAD (including nitrate medications, ACE‐I/ARB, β‐blockers, statins, and antiplatelet drugs) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Composite outcome measures reported</b>: yes, MACE: cardiovascular death, non‐fatal reinfarction, new‐onset angina, cerebral stroke, and severe heart failure </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Trial terminated early:</b> no </p> <p><b>Trial ID:</b> ‐ </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Publication details</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Language of publication</b>: English </p> <p><b>Funding:</b> unclear </p> <p><b>Publication status:</b> peer‐reviewed journal </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Stated aim for study</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p><b>Quote from publication</b>: "the goal of present study is to determine whether acarbose can reduce the risk of recurrent MACE in ACS patients with newly diagnosed IGT" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Quote: "135 IGT patients were randomly allocated, using random numbers generated by a computer" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no blinding, but we judged the outcome unlikely to be influenced by lack of blinding </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no blinding, but we judged the outcome unlikely to be influenced by lack of blinding </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no blinding, but we judged the outcome unlikely to be influenced by lack of blinding </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no blinding, but we judged the outcome unlikely to be influenced by lack of blinding </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: unclear, but we judged the outcome unlikely to be influenced by lack of blinding</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> all‐cause/cardiovascular mortality </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 60 completers and 7 dropouts in the treatment group, 64 completers and 4 dropouts in the control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> measures of blood glucose control </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 60 completers and 7 dropouts in the treatment group, 64 completers and 4 dropouts in the control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐fatal myocardial infarction/stroke, congestive heart failure </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 60 completers and 7 dropouts in the treatment group, 64 completers and 4 dropouts in the control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> non‐serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 60 completers and 7 dropouts in the treatment group, 64 completers and 4 dropouts in the control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> serious adverse events </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: 60 completers and 7 dropouts in the treatment group, 64 completers and 4 dropouts in the control group. Dropout rate is &lt; 15%. Difference in dropout rates between groups &lt; 10% </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no protocol available</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other bias</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment: no other bias determined</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>"‐" denotes not reported</p> <p>2hPG: 2‐hour plasma glucose; <b>ACE‐I</b>: angiotensin‐converting‐enzyme inhibitor; <b>ACS:</b> acute coronary syndrome; <b>AGI</b>: alpha‐glucosidase inhibitor<br> <b>ARB</b>: angiotensin II receptor blocker; <b>AST/ALT</b>: aspartate transaminase/alanine transaminase; <b>BMI</b>: body mass index; <b>CT:</b> computed tomography; <b>CAD:</b> coronary artery disease; <b>DAISI</b>: Dutch Acarbose Intervention Study in IGT; <b>DM</b>: diabetes mellitus; <b>ECG</b>: electrocardiogram; <b>eGFR</b>: estimated glomerular filtration rate; <b>FPG</b>: fasting plasma glucose; <b>HbA1c</b>: glycosylated haemoglobin A1c; <b>HDL</b>: high‐density lipoprotein; <b>IGT</b>: impaired glucose tolerance; <b>LVEF:</b> left ventricular ejection fraction; <b>MACE:</b> major adverse cardiovascular events; <b>MDRD</b>: modification of diet and renal disease; <b>MI:</b> myocardial infarction; <b>NYHA</b>: New York Heart Association classification; <b>RCT:</b> randomised controlled trial; <b>rTMS</b>: rave Trial Management System; <b>T2DM</b>: type 2 diabetes mellitus; <b>TIA:</b> transient ischaemic attack; <b>TSH</b>: thyroid‐stimulating hormone; <b>UA:</b> unstable angina; <b>ULN:</b> upper limit of normal </p> </div> </div> </p> </section> <section class="characteristicsOfExcludedStudies" lang=""> <div class="section-header" id="CD005061-sec2-0038"> <h3 class="title">Characteristics of excluded studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD005061-sec2-0037" class="jump-to">included studies</a></li> <li><a href="#CD005061-sec2-0039" class="jump-to">awaiting classification</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reason for exclusion</p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0011">ABDOMEN study</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All enrolled participants had T2DM</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0012">Aoki 2010</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All enrolled participants had T2DM</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0013">EDIP</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All enrolled participants had T2DM (as defined by a 2‐h post‐load plasma glucose ≥ 11.1 mmol/L) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0014">JEDIS study</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial never completed</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0015">Kataoka 2012</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Population consisted of both people with T2DM and people with IGT. Attempts to contact the trial author failed (no reply) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0016">Mangiagli 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial was not randomised</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0017">Medizinische Klinik B study</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial never completed</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0018">MM study</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All enrolled participants had T2DM</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0019">Narita 2009</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All enrolled participants had T2DM</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0020">NCT00417950</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial never completed</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0021">Toyoda 2012</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All enrolled participants had T2DM</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0022">Watada 2012</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All enrolled participants had T2DM</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD005061-bbs2-0023">Yang 2001</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No mention of randomisation in the translated manuscript. Attempts to contact the trial authors failed (emails were rejected) </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>EDIP</b>: Early Diabetes Intervention Program; <b>JEDIS</b>: Japan Early Diabetes Intervention Study; <b>MM</b>: miglitol and mitiglinide; <b>T2DM:</b> type 2 diabetes </p> </div> </div> </p> </section> <section class="characteristicsOfAwaitingStudies" lang=""> <div class="section-header" id="CD005061-sec2-0039"> <h3 class="title">Characteristics of studies awaiting assessment [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD005061-sec2-0037" class="jump-to">included studies</a></li> <li><a href="#CD005061-sec2-0038" class="jump-to">excluded studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">NCT00221156 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomised open‐label clinical trial with 300 participants</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Patients with abnormal glucose tolerance and recent coronary artery stents due to coronary artery disease </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Acarbose versus standard lifestyle modification</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Primary outcome</b>: cardiovascular event free survival time </p> <p><b>Secondary outcomes</b>: 1. conversion of abnormal glucose tolerance to type 2 diabetes; 2. all cause of death; 3. occurrence of every cardiovascular event; 4. occurrence of in‐stent restenosis; 5. change in fasting, 2‐hour blood glucose and insulin level; 6. change in homeostasis model assessment of insulin resistance; 7. change in hemoglobin A1c (HbA1c); 8. change in lipid profile </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study details</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Trials register identifier:</b><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNXGT5UJMNRXZ7DTNFRXZ63PM7YYG/ct2/show/NCT00221156" target="_blank">NCT00221156</a><br> <b>Official title:</b> Effects of Acarbose Long‐Term Therapy on Prevention of Cardiovascular Events in Abnormal Glucose Tolerance With Coronary Artery Disease (ALERT Study)<br> <b>Study start date:</b> May 2005<br> <b>Actual study dompletion date:</b> April 2009<br> <b>Investigators:</b> principal investigator: Koichi Tamita, MD. Division of Cardiology, Kobe General Hospital; study director: Minako Katayama, MD Division of Clinical Research Promotion, Institute of Biomedical Research and Innovation; study director: Yutaka Furukawa, MD Division of Cardiology, Kobe General Hospital </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>As of December 2018 there were no publications available on this trial</p> </td> </tr> </tbody> </table> </div> </p> </section> </section> <section class="dataAndAnalyses" id="dataAndAnalyses"> <section class="dataAndAnalyses" lang="en"> <div class="section-header section-collapse-header" id="CD005061-sec1-0011"> <h2 class="title section-collapse-title">Data and analyses<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <div class="table" id="CD005061-tbl-0003"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">AGI versus placebo</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9847</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.24 [0.53, 2.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-01.png?filename=nCD005061-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%201%20All%E2%80%90cause%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.1</div> </div> <hr class="top"><img data-id="CD005061-fig-00101" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-01.png" alt="Comparison 1 AGI versus placebo, Outcome 1 All‐cause mortality."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 1 All‐cause mortality.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8069</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.98 [0.82, 1.18]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1778</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.77 [0.72, 226.31]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Incidence of type 2 diabetes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9786</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.59, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00102"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-02.png?filename=nCD005061-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%202%20Incidence%20of%20type%202%20diabetes.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.2</div> </div> <hr class="top"><img data-id="CD005061-fig-00102" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-02.png" alt="Comparison 1 AGI versus placebo, Outcome 2 Incidence of type 2 diabetes."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 2 Incidence of type 2 diabetes.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8008</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.82 [0.75, 0.89]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1778</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.46 [0.34, 0.64]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8403</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.12 [0.97, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00103"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-03.png?filename=nCD005061-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%203%20Serious%20adverse%20events.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.3</div> </div> <hr class="top"><img data-id="CD005061-fig-00103" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-03.png" alt="Comparison 1 AGI versus placebo, Outcome 3 Serious adverse events."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 3 Serious adverse events.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6625</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.12 [0.97, 1.29]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1778</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.46 [0.48, 12.62]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Cardiovascular mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9847</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.72, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00104"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-04.png?filename=nCD005061-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%204%20Cardiovascular%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.4</div> </div> <hr class="top"><img data-id="CD005061-fig-00104" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-04.png" alt="Comparison 1 AGI versus placebo, Outcome 4 Cardiovascular mortality."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 4 Cardiovascular mortality.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8069</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.88 [0.71, 1.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1778</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.95 [0.12, 72.23]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Non‐fatal myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1486</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.10 [0.02, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00105"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-05.png?filename=nCD005061-CMP-001-05.ppt&amp;title=1.5&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%205%20Non%E2%80%90fatal%20myocardial%20infarction.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.5</div> </div> <hr class="top"><img data-id="CD005061-fig-00105" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-05.png" alt="Comparison 1 AGI versus placebo, Outcome 5 Non‐fatal myocardial infarction."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 5 Non‐fatal myocardial infarction.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Non‐fatal stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1368</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.50 [0.09, 2.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00106"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-06.png?filename=nCD005061-CMP-001-06.ppt&amp;title=1.6&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%206%20Non%E2%80%90fatal%20stroke.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.6</div> </div> <hr class="top"><img data-id="CD005061-fig-00106" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-06.png" alt="Comparison 1 AGI versus placebo, Outcome 6 Non‐fatal stroke."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 6 Non‐fatal stroke.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Congestive heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7890</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.63, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00107"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-07.png?filename=nCD005061-CMP-001-07.ppt&amp;title=1.7&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%207%20Congestive%20heart%20failure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.7</div> </div> <hr class="top"><img data-id="CD005061-fig-00107" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-07.png" alt="Comparison 1 AGI versus placebo, Outcome 7 Congestive heart failure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 7 Congestive heart failure.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Non‐serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3328</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.04 [1.02, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00108"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-08.png?filename=nCD005061-CMP-001-08.ppt&amp;title=1.8&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%208%20Non%E2%80%90serious%20adverse%20events.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.8</div> </div> <hr class="top"><img data-id="CD005061-fig-00108" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-08.png" alt="Comparison 1 AGI versus placebo, Outcome 8 Non‐serious adverse events."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 8 Non‐serious adverse events.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1550</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.04 [1.01, 1.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1778</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.06 [1.02, 1.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6522</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.01 [0.89, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00109"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-09.png?filename=nCD005061-CMP-001-09.ppt&amp;title=1.9&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%209%20Hypoglycaemia.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.9</div> </div> <hr class="top"><img data-id="CD005061-fig-00109" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-09.png" alt="Comparison 1 AGI versus placebo, Outcome 9 Hypoglycaemia."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 9 Hypoglycaemia.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 Fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7368</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.12, ‐0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00110"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-10.png?filename=nCD005061-CMP-001-10.ppt&amp;title=1.10&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2010%20Fasting%20plasma%20glucose.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.10</div> </div> <hr class="top"><img data-id="CD005061-fig-00110" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-10.png" alt="Comparison 1 AGI versus placebo, Outcome 10 Fasting plasma glucose."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 10 Fasting plasma glucose.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 2‐h glucose measurements <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6498</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.53 [‐0.92, ‐0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00111"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-11.png?filename=nCD005061-CMP-001-11.ppt&amp;title=1.11&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2011%202%E2%80%90h%20glucose%20measurements.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.11</div> </div> <hr class="top"><img data-id="CD005061-fig-00111" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-11.png" alt="Comparison 1 AGI versus placebo, Outcome 11 2‐h glucose measurements."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 11 2‐h glucose measurements.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6833</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00112"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-12.png?filename=nCD005061-CMP-001-12.ppt&amp;title=1.12&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2012%20HbA1c.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.12</div> </div> <hr class="top"><img data-id="CD005061-fig-00112" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-12.png" alt="Comparison 1 AGI versus placebo, Outcome 12 HbA1c."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 12 HbA1c.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">13 Change in total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6815</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.05 [‐0.10, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00113"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-13.png?filename=nCD005061-CMP-001-13.ppt&amp;title=1.13&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2013%20Change%20in%20total%20cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.13</div> </div> <hr class="top"><img data-id="CD005061-fig-00113" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-13.png" alt="Comparison 1 AGI versus placebo, Outcome 13 Change in total cholesterol."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 13 Change in total cholesterol.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">14 Change in HDL‐cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6807</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.00, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00114"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-14.png?filename=nCD005061-CMP-001-14.ppt&amp;title=1.14&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2014%20Change%20in%20HDL%E2%80%90cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.14</div> </div> <hr class="top"><img data-id="CD005061-fig-00114" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-14.png" alt="Comparison 1 AGI versus placebo, Outcome 14 Change in HDL‐cholesterol."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 14 Change in HDL‐cholesterol.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">15 Change in LDL‐cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6699</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.03 [‐0.07, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00115"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-15.png?filename=nCD005061-CMP-001-15.ppt&amp;title=1.15&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2015%20Change%20in%20LDL%E2%80%90cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.15</div> </div> <hr class="top"><img data-id="CD005061-fig-00115" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-15.png" alt="Comparison 1 AGI versus placebo, Outcome 15 Change in LDL‐cholesterol."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 15 Change in LDL‐cholesterol.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">16 Change in triglycerides <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6843</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.17, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00116"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-16.png?filename=nCD005061-CMP-001-16.ppt&amp;title=1.16&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2016%20Change%20in%20triglycerides.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.16</div> </div> <hr class="top"><img data-id="CD005061-fig-00116" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-16.png" alt="Comparison 1 AGI versus placebo, Outcome 16 Change in triglycerides."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 16 Change in triglycerides.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">17 Change in body weight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6959</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.67 [‐1.57, 0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00117"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-17.png?filename=nCD005061-CMP-001-17.ppt&amp;title=1.17&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2017%20Change%20in%20body%20weight.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.17</div> </div> <hr class="top"><img data-id="CD005061-fig-00117" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-17.png" alt="Comparison 1 AGI versus placebo, Outcome 17 Change in body weight."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 17 Change in body weight.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">18 Change in body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6953</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.18 [‐0.39, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00118"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-18.png?filename=nCD005061-CMP-001-18.ppt&amp;title=1.18&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2018%20Change%20in%20body%20mass%20index.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.18</div> </div> <hr class="top"><img data-id="CD005061-fig-00118" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-18.png" alt="Comparison 1 AGI versus placebo, Outcome 18 Change in body mass index."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 18 Change in body mass index.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">19 Change in diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7452</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.29 [‐0.78, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00119"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-19.png?filename=nCD005061-CMP-001-19.ppt&amp;title=1.19&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2019%20Change%20in%20diastolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.19</div> </div> <hr class="top"><img data-id="CD005061-fig-00119" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-19.png" alt="Comparison 1 AGI versus placebo, Outcome 19 Change in diastolic blood pressure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 19 Change in diastolic blood pressure.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">20 Change in systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7452</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐1.26, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00120"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-20.png?filename=nCD005061-CMP-001-20.ppt&amp;title=1.20&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2020%20Change%20in%20systolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.20</div> </div> <hr class="top"><img data-id="CD005061-fig-00120" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-20.png" alt="Comparison 1 AGI versus placebo, Outcome 20 Change in systolic blood pressure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 20 Change in systolic blood pressure.</p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD005061-tbl-0004"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">AGI versus metformin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00201"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-01.png?filename=nCD005061-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%201%20All%E2%80%90cause%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.1</div> </div> <hr class="top"><img data-id="CD005061-fig-00201" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-01.png" alt="Comparison 2 AGI versus metformin, Outcome 1 All‐cause mortality."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 1 All‐cause mortality.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Incidence of type 2 diabetes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00202"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-02.png?filename=nCD005061-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%202%20Incidence%20of%20type%202%20diabetes.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.2</div> </div> <hr class="top"><img data-id="CD005061-fig-00202" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-02.png" alt="Comparison 2 AGI versus metformin, Outcome 2 Incidence of type 2 diabetes."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 2 Incidence of type 2 diabetes.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00203"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-03.png?filename=nCD005061-CMP-002-03.ppt&amp;title=2.3&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%203%20Fasting%20plasma%20glucose.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.3</div> </div> <hr class="top"><img data-id="CD005061-fig-00203" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-03.png" alt="Comparison 2 AGI versus metformin, Outcome 3 Fasting plasma glucose."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 3 Fasting plasma glucose.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 2‐h glucose measurements <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00204"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-04.png?filename=nCD005061-CMP-002-04.ppt&amp;title=2.4&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%204%202%E2%80%90h%20glucose%20measurements.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.4</div> </div> <hr class="top"><img data-id="CD005061-fig-00204" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-04.png" alt="Comparison 2 AGI versus metformin, Outcome 4 2‐h glucose measurements."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 4 2‐h glucose measurements.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Change in total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00205"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-05.png?filename=nCD005061-CMP-002-05.ppt&amp;title=2.5&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%205%20Change%20in%20total%20cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.5</div> </div> <hr class="top"><img data-id="CD005061-fig-00205" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-05.png" alt="Comparison 2 AGI versus metformin, Outcome 5 Change in total cholesterol."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 5 Change in total cholesterol.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Change in triglycerides <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00206"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-06.png?filename=nCD005061-CMP-002-06.ppt&amp;title=2.6&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%206%20Change%20in%20triglycerides.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.6</div> </div> <hr class="top"><img data-id="CD005061-fig-00206" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-06.png" alt="Comparison 2 AGI versus metformin, Outcome 6 Change in triglycerides."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 6 Change in triglycerides.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Change in body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00207"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-07.png?filename=nCD005061-CMP-002-07.ppt&amp;title=2.7&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%207%20Change%20in%20body%20mass%20index.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.7</div> </div> <hr class="top"><img data-id="CD005061-fig-00207" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-07.png" alt="Comparison 2 AGI versus metformin, Outcome 7 Change in body mass index."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 7 Change in body mass index.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Change in diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00208"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-08.png?filename=nCD005061-CMP-002-08.ppt&amp;title=2.8&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%208%20Change%20in%20diastolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.8</div> </div> <hr class="top"><img data-id="CD005061-fig-00208" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-08.png" alt="Comparison 2 AGI versus metformin, Outcome 8 Change in diastolic blood pressure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 8 Change in diastolic blood pressure.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Change in systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00209"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-09.png?filename=nCD005061-CMP-002-09.ppt&amp;title=2.9&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%209%20Change%20in%20systolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.9</div> </div> <hr class="top"><img data-id="CD005061-fig-00209" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-09.png" alt="Comparison 2 AGI versus metformin, Outcome 9 Change in systolic blood pressure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 9 Change in systolic blood pressure.</p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD005061-tbl-0005"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">AGI versus diet and exercise</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00301"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-01.png?filename=nCD005061-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%201%20All%E2%80%90cause%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.1</div> </div> <hr class="top"><img data-id="CD005061-fig-00301" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-01.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 1 All‐cause mortality."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 1 All‐cause mortality.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Incidence of type 2 diabetes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00302"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-02.png?filename=nCD005061-CMP-003-02.ppt&amp;title=3.2&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%202%20Incidence%20of%20type%202%20diabetes.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.2</div> </div> <hr class="top"><img data-id="CD005061-fig-00302" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-02.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 2 Incidence of type 2 diabetes."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 2 Incidence of type 2 diabetes.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Cardiovascular mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00303"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-03.png?filename=nCD005061-CMP-003-03.ppt&amp;title=3.3&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%203%20Cardiovascular%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.3</div> </div> <hr class="top"><img data-id="CD005061-fig-00303" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-03.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 3 Cardiovascular mortality."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 3 Cardiovascular mortality.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Non‐fatal myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00304"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-04.png?filename=nCD005061-CMP-003-04.ppt&amp;title=3.4&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%204%20Non%E2%80%90fatal%20myocardial%20infarction.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.4</div> </div> <hr class="top"><img data-id="CD005061-fig-00304" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-04.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 4 Non‐fatal myocardial infarction."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 4 Non‐fatal myocardial infarction.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Non‐fatal stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00305"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-05.png?filename=nCD005061-CMP-003-05.ppt&amp;title=3.5&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%205%20Non%E2%80%90fatal%20stroke.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.5</div> </div> <hr class="top"><img data-id="CD005061-fig-00305" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-05.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 5 Non‐fatal stroke."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 5 Non‐fatal stroke.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Congestive heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00306"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-06.png?filename=nCD005061-CMP-003-06.ppt&amp;title=3.6&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%206%20Congestive%20heart%20failure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.6</div> </div> <hr class="top"><img data-id="CD005061-fig-00306" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-06.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 6 Congestive heart failure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 6 Congestive heart failure.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Non‐serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00307"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-07.png?filename=nCD005061-CMP-003-07.ppt&amp;title=3.7&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%207%20Non%E2%80%90serious%20adverse%20events.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.7</div> </div> <hr class="top"><img data-id="CD005061-fig-00307" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-07.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 7 Non‐serious adverse events."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 7 Non‐serious adverse events.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>509</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.33 [‐2.15, ‐0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00308"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-08.png?filename=nCD005061-CMP-003-08.ppt&amp;title=3.8&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%208%20Fasting%20plasma%20glucose.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.8</div> </div> <hr class="top"><img data-id="CD005061-fig-00308" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-08.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 8 Fasting plasma glucose."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 8 Fasting plasma glucose.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.37 [‐2.24, ‐0.50]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>428</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.0 [‐3.44, 1.44]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 2‐h glucose measurements <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>472</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.74 [‐3.74, ‐1.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00309"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-09.png?filename=nCD005061-CMP-003-09.ppt&amp;title=3.9&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%209%202%E2%80%90h%20glucose%20measurements.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.9</div> </div> <hr class="top"><img data-id="CD005061-fig-00309" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-09.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 9 2‐h glucose measurements."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 9 2‐h glucose measurements.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.79 [‐3.79, ‐1.79]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>391</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.7 [‐7.53, 8.93]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00310"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-10.png?filename=nCD005061-CMP-003-10.ppt&amp;title=3.10&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2010%20HbA1c.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.10</div> </div> <hr class="top"><img data-id="CD005061-fig-00310" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-10.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 10 HbA1c."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 10 HbA1c.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 Change in total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>586</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.49 [‐1.32, 0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00311"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-11.png?filename=nCD005061-CMP-003-11.ppt&amp;title=3.11&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2011%20Change%20in%20total%20cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.11</div> </div> <hr class="top"><img data-id="CD005061-fig-00311" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-11.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 11 Change in total cholesterol."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 11 Change in total cholesterol.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.50 [‐1.33, 0.33]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>505</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [‐6.47, 6.47]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 Change in triglycerides <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>612</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.76, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00312"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-12.png?filename=nCD005061-CMP-003-12.ppt&amp;title=3.12&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2012%20Change%20in%20triglycerides.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.12</div> </div> <hr class="top"><img data-id="CD005061-fig-00312" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-12.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 12 Change in triglycerides."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 12 Change in triglycerides.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.76, 0.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>531</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.1 [‐17.03, 16.83]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">13 Change in HDL‐cholesterol [mmol/L] <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>545</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [‐2.51, 2.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00313"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-13.png?filename=nCD005061-CMP-003-13.ppt&amp;title=3.13&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2013%20Change%20in%20HDL%E2%80%90cholesterol%20%5Bmmol%2FL%5D.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.13</div> </div> <hr class="top"><img data-id="CD005061-fig-00313" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-13.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 13 Change in HDL‐cholesterol [mmol/L]."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 13 Change in HDL‐cholesterol [mmol/L].</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">14 Change in body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00314"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-14.png?filename=nCD005061-CMP-003-14.ppt&amp;title=3.14&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2014%20Change%20in%20body%20mass%20index.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.14</div> </div> <hr class="top"><img data-id="CD005061-fig-00314" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-14.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 14 Change in body mass index."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 14 Change in body mass index.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">15 Change in diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>667</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.25 [‐1.65, 4.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00315"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-15.png?filename=nCD005061-CMP-003-15.ppt&amp;title=3.15&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2015%20Change%20in%20diastolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.15</div> </div> <hr class="top"><img data-id="CD005061-fig-00315" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-15.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 15 Change in diastolic blood pressure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 15 Change in diastolic blood pressure.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">16 Change in systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>668</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.94 [‐8.71, 4.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00316"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-16.png?filename=nCD005061-CMP-003-16.ppt&amp;title=3.16&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2016%20Change%20in%20systolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.16</div> </div> <hr class="top"><img data-id="CD005061-fig-00316" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-16.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 16 Change in systolic blood pressure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 16 Change in systolic blood pressure.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐6.00 [‐12.23, 0.23]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>587</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.0 [‐1.92, 3.92]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD005061-tbl-0006"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">AGI versus no intervention</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>171</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00401"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-01.png?filename=nCD005061-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%201%20All%E2%80%90cause%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.1</div> </div> <hr class="top"><img data-id="CD005061-fig-00401" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-01.png" alt="Comparison 4 AGI versus no intervention, Outcome 1 All‐cause mortality."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 1 All‐cause mortality.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Incidence of type 2 diabetes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>140</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.31 [0.14, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00402"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-02.png?filename=nCD005061-CMP-004-02.ppt&amp;title=4.2&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%202%20Incidence%20of%20type%202%20diabetes.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.2</div> </div> <hr class="top"><img data-id="CD005061-fig-00402" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-02.png" alt="Comparison 4 AGI versus no intervention, Outcome 2 Incidence of type 2 diabetes."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 2 Incidence of type 2 diabetes.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Cardiovascular mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00403"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-03.png?filename=nCD005061-CMP-004-03.ppt&amp;title=4.3&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%203%20Cardiovascular%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.3</div> </div> <hr class="top"><img data-id="CD005061-fig-00403" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-03.png" alt="Comparison 4 AGI versus no intervention, Outcome 3 Cardiovascular mortality."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 3 Cardiovascular mortality.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Non‐fatal myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00404"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-04.png?filename=nCD005061-CMP-004-04.ppt&amp;title=4.4&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%204%20Non%E2%80%90fatal%20myocardial%20infarction.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.4</div> </div> <hr class="top"><img data-id="CD005061-fig-00404" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-04.png" alt="Comparison 4 AGI versus no intervention, Outcome 4 Non‐fatal myocardial infarction."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 4 Non‐fatal myocardial infarction.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Non‐fatal stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00405"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-05.png?filename=nCD005061-CMP-004-05.ppt&amp;title=4.5&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%205%20Non%E2%80%90fatal%20stroke.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.5</div> </div> <hr class="top"><img data-id="CD005061-fig-00405" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-05.png" alt="Comparison 4 AGI versus no intervention, Outcome 5 Non‐fatal stroke."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 5 Non‐fatal stroke.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Congestive heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>205</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.27, 2.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00406"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-06.png?filename=nCD005061-CMP-004-06.ppt&amp;title=4.6&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%206%20Congestive%20heart%20failure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.6</div> </div> <hr class="top"><img data-id="CD005061-fig-00406" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-06.png" alt="Comparison 4 AGI versus no intervention, Outcome 6 Congestive heart failure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 6 Congestive heart failure.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Non‐serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00407"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-07.png?filename=nCD005061-CMP-004-07.ppt&amp;title=4.7&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%207%20Non%E2%80%90serious%20adverse%20events.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.7</div> </div> <hr class="top"><img data-id="CD005061-fig-00407" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-07.png" alt="Comparison 4 AGI versus no intervention, Outcome 7 Non‐serious adverse events."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 7 Non‐serious adverse events.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00408"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-08.png?filename=nCD005061-CMP-004-08.ppt&amp;title=4.8&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%208%20Hypoglycaemia.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.8</div> </div> <hr class="top"><img data-id="CD005061-fig-00408" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-08.png" alt="Comparison 4 AGI versus no intervention, Outcome 8 Hypoglycaemia."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 8 Hypoglycaemia.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.35 [‐0.79, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00409"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-09.png?filename=nCD005061-CMP-004-09.ppt&amp;title=4.9&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%209%20Fasting%20plasma%20glucose.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.9</div> </div> <hr class="top"><img data-id="CD005061-fig-00409" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-09.png" alt="Comparison 4 AGI versus no intervention, Outcome 9 Fasting plasma glucose."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 9 Fasting plasma glucose.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 2‐h glucose measurements <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.50 [‐4.18, ‐0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00410"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-10.png?filename=nCD005061-CMP-004-10.ppt&amp;title=4.10&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2010%202%E2%80%90h%20glucose%20measurements.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.10</div> </div> <hr class="top"><img data-id="CD005061-fig-00410" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-10.png" alt="Comparison 4 AGI versus no intervention, Outcome 10 2‐h glucose measurements."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 10 2‐h glucose measurements.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00411"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-11.png?filename=nCD005061-CMP-004-11.ppt&amp;title=4.11&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2011%20HbA1c.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.11</div> </div> <hr class="top"><img data-id="CD005061-fig-00411" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-11.png" alt="Comparison 4 AGI versus no intervention, Outcome 11 HbA1c."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 11 HbA1c.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 Change in total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.32 [‐0.74, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00412"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-12.png?filename=nCD005061-CMP-004-12.ppt&amp;title=4.12&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2012%20Change%20in%20total%20cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.12</div> </div> <hr class="top"><img data-id="CD005061-fig-00412" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-12.png" alt="Comparison 4 AGI versus no intervention, Outcome 12 Change in total cholesterol."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 12 Change in total cholesterol.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">13 Change in HDL‐cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00413"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-13.png?filename=nCD005061-CMP-004-13.ppt&amp;title=4.13&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2013%20Change%20in%20HDL%E2%80%90cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.13</div> </div> <hr class="top"><img data-id="CD005061-fig-00413" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-13.png" alt="Comparison 4 AGI versus no intervention, Outcome 13 Change in HDL‐cholesterol."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 13 Change in HDL‐cholesterol.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">14 Change in LDL‐cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>205</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.03 [‐0.22, 0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00414"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-14.png?filename=nCD005061-CMP-004-14.ppt&amp;title=4.14&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2014%20Change%20in%20LDL%E2%80%90cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.14</div> </div> <hr class="top"><img data-id="CD005061-fig-00414" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-14.png" alt="Comparison 4 AGI versus no intervention, Outcome 14 Change in LDL‐cholesterol."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 14 Change in LDL‐cholesterol.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">15 Change in triglycerides <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.22 [‐0.40, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00415"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-15.png?filename=nCD005061-CMP-004-15.ppt&amp;title=4.15&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2015%20Change%20in%20triglycerides.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.15</div> </div> <hr class="top"><img data-id="CD005061-fig-00415" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-15.png" alt="Comparison 4 AGI versus no intervention, Outcome 15 Change in triglycerides."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 15 Change in triglycerides.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">16 Change in body weight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00416"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-16.png?filename=nCD005061-CMP-004-16.ppt&amp;title=4.16&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2016%20Change%20in%20body%20weight.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.16</div> </div> <hr class="top"><img data-id="CD005061-fig-00416" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-16.png" alt="Comparison 4 AGI versus no intervention, Outcome 16 Change in body weight."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 16 Change in body weight.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">17 Change in body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.65 [‐1.01, ‐0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00417"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-17.png?filename=nCD005061-CMP-004-17.ppt&amp;title=4.17&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2017%20Change%20in%20body%20mass%20index.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.17</div> </div> <hr class="top"><img data-id="CD005061-fig-00417" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-17.png" alt="Comparison 4 AGI versus no intervention, Outcome 17 Change in body mass index."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 17 Change in body mass index.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">18 Change in diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.26 [‐3.80, 3.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00418"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-18.png?filename=nCD005061-CMP-004-18.ppt&amp;title=4.18&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2018%20Change%20in%20diastolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.18</div> </div> <hr class="top"><img data-id="CD005061-fig-00418" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-18.png" alt="Comparison 4 AGI versus no intervention, Outcome 18 Change in diastolic blood pressure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 18 Change in diastolic blood pressure.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">19 Change in systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐3.68 [‐6.46, ‐0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD005061-fig-00419"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-19.png?filename=nCD005061-CMP-004-19.ppt&amp;title=4.19&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2019%20Change%20in%20systolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.19</div> </div> <hr class="top"><img data-id="CD005061-fig-00419" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-19.png" alt="Comparison 4 AGI versus no intervention, Outcome 19 Change in systolic blood pressure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 19 Change in systolic blood pressure.</p> </div> </div> </div> </td> </tr> </tbody> </table> </div> </section> </section> <div class="figures-list"> <div class="figure" id="CD005061-fig-0001"> <img data-id="CD005061-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-AFig-FIG01.png" alt="Trial flow diagram"> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Trial flow diagram</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-fig-0001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-AFig-FIG01.png?filename=nCD005061-AFig-FIG01.ppt&amp;title=1&amp;caption=Trial%20flow%20diagram&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-AFig-FIG01.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-0002"><img data-id="CD005061-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-AFig-FIG02.png" alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not measured in some trials).T2DM: type 2 diabetes mellitus"> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not measured in some trials). </p> <p><b>T2DM</b>: type 2 diabetes mellitus </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-fig-0002" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-AFig-FIG02.png?filename=nCD005061-AFig-FIG02.ppt&amp;title=2&amp;caption=Risk%20of%20bias%20graph%3A%20review%20authors%27%20judgements%20about%20each%20risk%20of%20bias%20item%20presented%20as%20percentages%20across%20all%20included%20trials%20%28blank%20cells%20indicate%20that%20the%20particular%20outcome%20was%20not%20measured%20in%20some%20trials%29.%20T2DM%3A%20type%202%20diabetes%20mellitus&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-AFig-FIG02.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-0003"><img data-id="CD005061-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-AFig-FIG03.png" alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the particular outcome was not measured in some trials)ABC: Alpha‐glucosidase‐inhiT2DM: type 2 diabetes mellitus"> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the particular outcome was not measured in some trials) </p> <p><b>ABC</b>: Alpha‐glucosidase‐inhi<b>T2DM</b>: type 2 diabetes mellitus </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-fig-0003" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-AFig-FIG03.png?filename=nCD005061-AFig-FIG03.ppt&amp;title=3&amp;caption=Risk%20of%20bias%20summary%3A%20review%20authors%27%20judgements%20about%20each%20risk%20of%20bias%20item%20for%20each%20included%20trial%20%28blank%20cells%20indicate%20that%20the%20particular%20outcome%20was%20not%20measured%20in%20some%20trials%29%20ABC%3A%20Alpha%E2%80%90glucosidase%E2%80%90inhiT2DM%3A%20type%202%20diabetes%20mellitus&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-AFig-FIG03.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00101"><img data-id="CD005061-fig-00101" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-01.png" alt="Comparison 1 AGI versus placebo, Outcome 1 All‐cause mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 1 All‐cause mortality.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-01.png?filename=nCD005061-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%201%20All%E2%80%90cause%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00102"><img data-id="CD005061-fig-00102" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-02.png" alt="Comparison 1 AGI versus placebo, Outcome 2 Incidence of type 2 diabetes."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 2 Incidence of type 2 diabetes.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00102" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-02.png?filename=nCD005061-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%202%20Incidence%20of%20type%202%20diabetes.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00103"><img data-id="CD005061-fig-00103" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-03.png" alt="Comparison 1 AGI versus placebo, Outcome 3 Serious adverse events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 3 Serious adverse events.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00103" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-03.png?filename=nCD005061-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%203%20Serious%20adverse%20events.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00104"><img data-id="CD005061-fig-00104" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-04.png" alt="Comparison 1 AGI versus placebo, Outcome 4 Cardiovascular mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 4 Cardiovascular mortality.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00104" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-04.png?filename=nCD005061-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%204%20Cardiovascular%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00105"><img data-id="CD005061-fig-00105" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-05.png" alt="Comparison 1 AGI versus placebo, Outcome 5 Non‐fatal myocardial infarction."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 5 Non‐fatal myocardial infarction.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00105" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-05.png?filename=nCD005061-CMP-001-05.ppt&amp;title=1.5&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%205%20Non%E2%80%90fatal%20myocardial%20infarction.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00106"><img data-id="CD005061-fig-00106" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-06.png" alt="Comparison 1 AGI versus placebo, Outcome 6 Non‐fatal stroke."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 6 Non‐fatal stroke.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00106" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-06.png?filename=nCD005061-CMP-001-06.ppt&amp;title=1.6&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%206%20Non%E2%80%90fatal%20stroke.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00107"><img data-id="CD005061-fig-00107" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-07.png" alt="Comparison 1 AGI versus placebo, Outcome 7 Congestive heart failure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 7 Congestive heart failure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00107" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-07.png?filename=nCD005061-CMP-001-07.ppt&amp;title=1.7&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%207%20Congestive%20heart%20failure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-07.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00108"><img data-id="CD005061-fig-00108" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-08.png" alt="Comparison 1 AGI versus placebo, Outcome 8 Non‐serious adverse events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 8 Non‐serious adverse events.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00108" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-08.png?filename=nCD005061-CMP-001-08.ppt&amp;title=1.8&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%208%20Non%E2%80%90serious%20adverse%20events.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-08.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00109"><img data-id="CD005061-fig-00109" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-09.png" alt="Comparison 1 AGI versus placebo, Outcome 9 Hypoglycaemia."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 9 Hypoglycaemia.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00109" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-09.png?filename=nCD005061-CMP-001-09.ppt&amp;title=1.9&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%209%20Hypoglycaemia.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-09.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00110"><img data-id="CD005061-fig-00110" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-10.png" alt="Comparison 1 AGI versus placebo, Outcome 10 Fasting plasma glucose."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 10 Fasting plasma glucose.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00110" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-10.png?filename=nCD005061-CMP-001-10.ppt&amp;title=1.10&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2010%20Fasting%20plasma%20glucose.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-10.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00111"><img data-id="CD005061-fig-00111" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-11.png" alt="Comparison 1 AGI versus placebo, Outcome 11 2‐h glucose measurements."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 11 2‐h glucose measurements.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00111" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-11.png?filename=nCD005061-CMP-001-11.ppt&amp;title=1.11&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2011%202%E2%80%90h%20glucose%20measurements.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-11.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00112"><img data-id="CD005061-fig-00112" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-12.png" alt="Comparison 1 AGI versus placebo, Outcome 12 HbA1c."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 12 HbA1c.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00112" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-12.png?filename=nCD005061-CMP-001-12.ppt&amp;title=1.12&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2012%20HbA1c.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-12.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00113"><img data-id="CD005061-fig-00113" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-13.png" alt="Comparison 1 AGI versus placebo, Outcome 13 Change in total cholesterol."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 13 Change in total cholesterol.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00113" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-13.png?filename=nCD005061-CMP-001-13.ppt&amp;title=1.13&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2013%20Change%20in%20total%20cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-13.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00114"><img data-id="CD005061-fig-00114" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-14.png" alt="Comparison 1 AGI versus placebo, Outcome 14 Change in HDL‐cholesterol."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 14 Change in HDL‐cholesterol.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00114" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-14.png?filename=nCD005061-CMP-001-14.ppt&amp;title=1.14&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2014%20Change%20in%20HDL%E2%80%90cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-14.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00115"><img data-id="CD005061-fig-00115" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-15.png" alt="Comparison 1 AGI versus placebo, Outcome 15 Change in LDL‐cholesterol."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 15 Change in LDL‐cholesterol.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00115" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-15.png?filename=nCD005061-CMP-001-15.ppt&amp;title=1.15&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2015%20Change%20in%20LDL%E2%80%90cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-15.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00116"><img data-id="CD005061-fig-00116" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-16.png" alt="Comparison 1 AGI versus placebo, Outcome 16 Change in triglycerides."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 16 Change in triglycerides.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00116" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-16.png?filename=nCD005061-CMP-001-16.ppt&amp;title=1.16&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2016%20Change%20in%20triglycerides.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-16.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00117"><img data-id="CD005061-fig-00117" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-17.png" alt="Comparison 1 AGI versus placebo, Outcome 17 Change in body weight."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 17 Change in body weight.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00117" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-17.png?filename=nCD005061-CMP-001-17.ppt&amp;title=1.17&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2017%20Change%20in%20body%20weight.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-17.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00118"><img data-id="CD005061-fig-00118" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-18.png" alt="Comparison 1 AGI versus placebo, Outcome 18 Change in body mass index."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 18 Change in body mass index.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00118" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-18.png?filename=nCD005061-CMP-001-18.ppt&amp;title=1.18&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2018%20Change%20in%20body%20mass%20index.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-18.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00119"><img data-id="CD005061-fig-00119" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-19.png" alt="Comparison 1 AGI versus placebo, Outcome 19 Change in diastolic blood pressure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 19 Change in diastolic blood pressure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00119" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-19.png?filename=nCD005061-CMP-001-19.ppt&amp;title=1.19&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2019%20Change%20in%20diastolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-19.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00120"><img data-id="CD005061-fig-00120" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-20.png" alt="Comparison 1 AGI versus placebo, Outcome 20 Change in systolic blood pressure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 AGI versus placebo, Outcome 20 Change in systolic blood pressure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00120" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-001-20.png?filename=nCD005061-CMP-001-20.ppt&amp;title=1.20&amp;caption=Comparison%201%20AGI%20versus%20placebo%2C%20Outcome%2020%20Change%20in%20systolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-001-20.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00201"><img data-id="CD005061-fig-00201" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-01.png" alt="Comparison 2 AGI versus metformin, Outcome 1 All‐cause mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 1 All‐cause mortality.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00201" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-01.png?filename=nCD005061-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%201%20All%E2%80%90cause%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00202"><img data-id="CD005061-fig-00202" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-02.png" alt="Comparison 2 AGI versus metformin, Outcome 2 Incidence of type 2 diabetes."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 2 Incidence of type 2 diabetes.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00202" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-02.png?filename=nCD005061-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%202%20Incidence%20of%20type%202%20diabetes.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00203"><img data-id="CD005061-fig-00203" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-03.png" alt="Comparison 2 AGI versus metformin, Outcome 3 Fasting plasma glucose."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 3 Fasting plasma glucose.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00203" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-03.png?filename=nCD005061-CMP-002-03.ppt&amp;title=2.3&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%203%20Fasting%20plasma%20glucose.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00204"><img data-id="CD005061-fig-00204" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-04.png" alt="Comparison 2 AGI versus metformin, Outcome 4 2‐h glucose measurements."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 4 2‐h glucose measurements.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00204" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-04.png?filename=nCD005061-CMP-002-04.ppt&amp;title=2.4&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%204%202%E2%80%90h%20glucose%20measurements.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00205"><img data-id="CD005061-fig-00205" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-05.png" alt="Comparison 2 AGI versus metformin, Outcome 5 Change in total cholesterol."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 5 Change in total cholesterol.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00205" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-05.png?filename=nCD005061-CMP-002-05.ppt&amp;title=2.5&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%205%20Change%20in%20total%20cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00206"><img data-id="CD005061-fig-00206" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-06.png" alt="Comparison 2 AGI versus metformin, Outcome 6 Change in triglycerides."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 6 Change in triglycerides.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00206" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-06.png?filename=nCD005061-CMP-002-06.ppt&amp;title=2.6&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%206%20Change%20in%20triglycerides.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00207"><img data-id="CD005061-fig-00207" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-07.png" alt="Comparison 2 AGI versus metformin, Outcome 7 Change in body mass index."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 7 Change in body mass index.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00207" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-07.png?filename=nCD005061-CMP-002-07.ppt&amp;title=2.7&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%207%20Change%20in%20body%20mass%20index.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-07.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00208"><img data-id="CD005061-fig-00208" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-08.png" alt="Comparison 2 AGI versus metformin, Outcome 8 Change in diastolic blood pressure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 8 Change in diastolic blood pressure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00208" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-08.png?filename=nCD005061-CMP-002-08.ppt&amp;title=2.8&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%208%20Change%20in%20diastolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-08.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00209"><img data-id="CD005061-fig-00209" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-09.png" alt="Comparison 2 AGI versus metformin, Outcome 9 Change in systolic blood pressure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 AGI versus metformin, Outcome 9 Change in systolic blood pressure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00209" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-002-09.png?filename=nCD005061-CMP-002-09.ppt&amp;title=2.9&amp;caption=Comparison%202%20AGI%20versus%20metformin%2C%20Outcome%209%20Change%20in%20systolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-002-09.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00301"><img data-id="CD005061-fig-00301" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-01.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 1 All‐cause mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 1 All‐cause mortality.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00301" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-01.png?filename=nCD005061-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%201%20All%E2%80%90cause%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00302"><img data-id="CD005061-fig-00302" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-02.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 2 Incidence of type 2 diabetes."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 2 Incidence of type 2 diabetes.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00302" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-02.png?filename=nCD005061-CMP-003-02.ppt&amp;title=3.2&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%202%20Incidence%20of%20type%202%20diabetes.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00303"><img data-id="CD005061-fig-00303" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-03.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 3 Cardiovascular mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 3 Cardiovascular mortality.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00303" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-03.png?filename=nCD005061-CMP-003-03.ppt&amp;title=3.3&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%203%20Cardiovascular%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00304"><img data-id="CD005061-fig-00304" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-04.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 4 Non‐fatal myocardial infarction."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 4 Non‐fatal myocardial infarction.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00304" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-04.png?filename=nCD005061-CMP-003-04.ppt&amp;title=3.4&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%204%20Non%E2%80%90fatal%20myocardial%20infarction.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00305"><img data-id="CD005061-fig-00305" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-05.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 5 Non‐fatal stroke."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 5 Non‐fatal stroke.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00305" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-05.png?filename=nCD005061-CMP-003-05.ppt&amp;title=3.5&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%205%20Non%E2%80%90fatal%20stroke.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00306"><img data-id="CD005061-fig-00306" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-06.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 6 Congestive heart failure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 6 Congestive heart failure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00306" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-06.png?filename=nCD005061-CMP-003-06.ppt&amp;title=3.6&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%206%20Congestive%20heart%20failure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00307"><img data-id="CD005061-fig-00307" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-07.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 7 Non‐serious adverse events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 7 Non‐serious adverse events.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00307" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-07.png?filename=nCD005061-CMP-003-07.ppt&amp;title=3.7&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%207%20Non%E2%80%90serious%20adverse%20events.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-07.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00308"><img data-id="CD005061-fig-00308" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-08.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 8 Fasting plasma glucose."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 8 Fasting plasma glucose.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00308" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-08.png?filename=nCD005061-CMP-003-08.ppt&amp;title=3.8&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%208%20Fasting%20plasma%20glucose.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-08.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00309"><img data-id="CD005061-fig-00309" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-09.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 9 2‐h glucose measurements."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 9 2‐h glucose measurements.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00309" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-09.png?filename=nCD005061-CMP-003-09.ppt&amp;title=3.9&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%209%202%E2%80%90h%20glucose%20measurements.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-09.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00310"><img data-id="CD005061-fig-00310" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-10.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 10 HbA1c."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 10 HbA1c.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00310" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-10.png?filename=nCD005061-CMP-003-10.ppt&amp;title=3.10&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2010%20HbA1c.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-10.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00311"><img data-id="CD005061-fig-00311" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-11.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 11 Change in total cholesterol."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 11 Change in total cholesterol.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00311" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-11.png?filename=nCD005061-CMP-003-11.ppt&amp;title=3.11&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2011%20Change%20in%20total%20cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-11.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00312"><img data-id="CD005061-fig-00312" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-12.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 12 Change in triglycerides."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 12 Change in triglycerides.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00312" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-12.png?filename=nCD005061-CMP-003-12.ppt&amp;title=3.12&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2012%20Change%20in%20triglycerides.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-12.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00313"><img data-id="CD005061-fig-00313" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-13.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 13 Change in HDL‐cholesterol [mmol/L]."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 13 Change in HDL‐cholesterol [mmol/L].</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00313" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-13.png?filename=nCD005061-CMP-003-13.ppt&amp;title=3.13&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2013%20Change%20in%20HDL%E2%80%90cholesterol%20%5Bmmol%2FL%5D.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-13.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00314"><img data-id="CD005061-fig-00314" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-14.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 14 Change in body mass index."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 14 Change in body mass index.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00314" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-14.png?filename=nCD005061-CMP-003-14.ppt&amp;title=3.14&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2014%20Change%20in%20body%20mass%20index.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-14.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00315"><img data-id="CD005061-fig-00315" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-15.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 15 Change in diastolic blood pressure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 15 Change in diastolic blood pressure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00315" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-15.png?filename=nCD005061-CMP-003-15.ppt&amp;title=3.15&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2015%20Change%20in%20diastolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-15.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00316"><img data-id="CD005061-fig-00316" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-16.png" alt="Comparison 3 AGI versus diet and exercise, Outcome 16 Change in systolic blood pressure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 AGI versus diet and exercise, Outcome 16 Change in systolic blood pressure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00316" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-003-16.png?filename=nCD005061-CMP-003-16.ppt&amp;title=3.16&amp;caption=Comparison%203%20AGI%20versus%20diet%20and%20exercise%2C%20Outcome%2016%20Change%20in%20systolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-003-16.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00401"><img data-id="CD005061-fig-00401" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-01.png" alt="Comparison 4 AGI versus no intervention, Outcome 1 All‐cause mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 1 All‐cause mortality.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00401" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-01.png?filename=nCD005061-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%201%20All%E2%80%90cause%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00402"><img data-id="CD005061-fig-00402" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-02.png" alt="Comparison 4 AGI versus no intervention, Outcome 2 Incidence of type 2 diabetes."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 2 Incidence of type 2 diabetes.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00402" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-02.png?filename=nCD005061-CMP-004-02.ppt&amp;title=4.2&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%202%20Incidence%20of%20type%202%20diabetes.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00403"><img data-id="CD005061-fig-00403" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-03.png" alt="Comparison 4 AGI versus no intervention, Outcome 3 Cardiovascular mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 3 Cardiovascular mortality.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00403" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-03.png?filename=nCD005061-CMP-004-03.ppt&amp;title=4.3&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%203%20Cardiovascular%20mortality.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00404"><img data-id="CD005061-fig-00404" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-04.png" alt="Comparison 4 AGI versus no intervention, Outcome 4 Non‐fatal myocardial infarction."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 4 Non‐fatal myocardial infarction.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00404" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-04.png?filename=nCD005061-CMP-004-04.ppt&amp;title=4.4&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%204%20Non%E2%80%90fatal%20myocardial%20infarction.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00405"><img data-id="CD005061-fig-00405" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-05.png" alt="Comparison 4 AGI versus no intervention, Outcome 5 Non‐fatal stroke."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 5 Non‐fatal stroke.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00405" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-05.png?filename=nCD005061-CMP-004-05.ppt&amp;title=4.5&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%205%20Non%E2%80%90fatal%20stroke.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00406"><img data-id="CD005061-fig-00406" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-06.png" alt="Comparison 4 AGI versus no intervention, Outcome 6 Congestive heart failure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 6 Congestive heart failure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00406" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-06.png?filename=nCD005061-CMP-004-06.ppt&amp;title=4.6&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%206%20Congestive%20heart%20failure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00407"><img data-id="CD005061-fig-00407" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-07.png" alt="Comparison 4 AGI versus no intervention, Outcome 7 Non‐serious adverse events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 7 Non‐serious adverse events.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00407" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-07.png?filename=nCD005061-CMP-004-07.ppt&amp;title=4.7&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%207%20Non%E2%80%90serious%20adverse%20events.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-07.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00408"><img data-id="CD005061-fig-00408" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-08.png" alt="Comparison 4 AGI versus no intervention, Outcome 8 Hypoglycaemia."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 8 Hypoglycaemia.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00408" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-08.png?filename=nCD005061-CMP-004-08.ppt&amp;title=4.8&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%208%20Hypoglycaemia.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-08.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00409"><img data-id="CD005061-fig-00409" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-09.png" alt="Comparison 4 AGI versus no intervention, Outcome 9 Fasting plasma glucose."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 9 Fasting plasma glucose.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00409" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-09.png?filename=nCD005061-CMP-004-09.ppt&amp;title=4.9&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%209%20Fasting%20plasma%20glucose.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-09.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00410"><img data-id="CD005061-fig-00410" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-10.png" alt="Comparison 4 AGI versus no intervention, Outcome 10 2‐h glucose measurements."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 10 2‐h glucose measurements.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00410" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-10.png?filename=nCD005061-CMP-004-10.ppt&amp;title=4.10&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2010%202%E2%80%90h%20glucose%20measurements.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-10.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00411"><img data-id="CD005061-fig-00411" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-11.png" alt="Comparison 4 AGI versus no intervention, Outcome 11 HbA1c."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 11 HbA1c.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00411" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-11.png?filename=nCD005061-CMP-004-11.ppt&amp;title=4.11&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2011%20HbA1c.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-11.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00412"><img data-id="CD005061-fig-00412" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-12.png" alt="Comparison 4 AGI versus no intervention, Outcome 12 Change in total cholesterol."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 12 Change in total cholesterol.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00412" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-12.png?filename=nCD005061-CMP-004-12.ppt&amp;title=4.12&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2012%20Change%20in%20total%20cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-12.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00413"><img data-id="CD005061-fig-00413" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-13.png" alt="Comparison 4 AGI versus no intervention, Outcome 13 Change in HDL‐cholesterol."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.13</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 13 Change in HDL‐cholesterol.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00413" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-13.png?filename=nCD005061-CMP-004-13.ppt&amp;title=4.13&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2013%20Change%20in%20HDL%E2%80%90cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-13.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00414"><img data-id="CD005061-fig-00414" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-14.png" alt="Comparison 4 AGI versus no intervention, Outcome 14 Change in LDL‐cholesterol."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.14</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 14 Change in LDL‐cholesterol.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00414" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-14.png?filename=nCD005061-CMP-004-14.ppt&amp;title=4.14&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2014%20Change%20in%20LDL%E2%80%90cholesterol.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-14.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00415"><img data-id="CD005061-fig-00415" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-15.png" alt="Comparison 4 AGI versus no intervention, Outcome 15 Change in triglycerides."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.15</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 15 Change in triglycerides.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00415" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-15.png?filename=nCD005061-CMP-004-15.ppt&amp;title=4.15&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2015%20Change%20in%20triglycerides.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-15.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00416"><img data-id="CD005061-fig-00416" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-16.png" alt="Comparison 4 AGI versus no intervention, Outcome 16 Change in body weight."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.16</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 16 Change in body weight.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00416" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-16.png?filename=nCD005061-CMP-004-16.ppt&amp;title=4.16&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2016%20Change%20in%20body%20weight.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-16.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00417"><img data-id="CD005061-fig-00417" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-17.png" alt="Comparison 4 AGI versus no intervention, Outcome 17 Change in body mass index."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.17</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 17 Change in body mass index.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00417" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-17.png?filename=nCD005061-CMP-004-17.ppt&amp;title=4.17&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2017%20Change%20in%20body%20mass%20index.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-17.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00418"><img data-id="CD005061-fig-00418" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-18.png" alt="Comparison 4 AGI versus no intervention, Outcome 18 Change in diastolic blood pressure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.18</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 18 Change in diastolic blood pressure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00418" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-18.png?filename=nCD005061-CMP-004-18.ppt&amp;title=4.18&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2018%20Change%20in%20diastolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-18.png">Open in new tab</a></div> </div> <div class="figure" id="CD005061-fig-00419"><img data-id="CD005061-fig-00419" src="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-19.png" alt="Comparison 4 AGI versus no intervention, Outcome 19 Change in systolic blood pressure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.19</div> <div class="figure-caption"> <p>Comparison 4 AGI versus no intervention, Outcome 19 Change in systolic blood pressure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-fig-00419" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/ppt/CDSR/CD005061/image_n/nCD005061-CMP-004-19.png?filename=nCD005061-CMP-004-19.ppt&amp;title=4.19&amp;caption=Comparison%204%20AGI%20versus%20no%20intervention%2C%20Outcome%2019%20Change%20in%20systolic%20blood%20pressure.&amp;citation=Moelands SVL, Lucassen PLBJ, Akkermans RP, De Grauw WJC, Van de Laar FA. Alpha%E2%80%90glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2018, 12. Art. No.: CD005061. DOI: http://dx.doi.org/10.1002/14651858.CD005061.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD005061.pub3/media/CDSR/CD005061/image_n/nCD005061-CMP-004-19.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD005061-tbl-0001" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>&nbsp;<span class="table-title">Acarbose compared to placebo</span></div> <tbody> <tr class="separated"> <td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Acarbose for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk of developing of type 2 diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> people at risk of developing type 2 diabetes mellitus </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> alpha‐glucosidase inhibitors (acarbose) </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Placebo</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Acarbose</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Number of participants</b> </p> <p><b>Trials</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Certainty of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All‐cause mortality</b> </p> <p>Follow‐up: 3‐5 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>56 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>55 per 1000</b> (44 to 66) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.98</b> (0.82 to 1.18) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8069</p> <p>3 RCTs</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> V<b>ery low<sup>a</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Incidence of T2DM</b> </p> <p>Follow‐up: 3‐5 years</p> <p>Definition of intermediate hyperglycaemia (definition of T2DM incidence):</p> <p><a href="./references#CD005061-bbs2-0002">ACE 2017</a>: FPG &lt; 7.0 mmol/L; 2hPG ≥ 7.8 ‐ &lt; 11.1 mmol/L (FPG ≥7.0 mmol/L; 2hPG ≥ 11.1 mmol/L)<br> <a href="./references#CD005061-bbs2-0003">DAISI 2008</a>: FPG &lt; 7.8 mmol/L; 2hPG 7.8–11.1 mmol/L; HbA1c ≤ 7.0% (FPG ≥ 7.8 mmol/L; 2hPG ≥ 11.1 mmol/L)<br> <a href="./references#CD005061-bbs2-0008">STOP‐NIDDM 2002</a>: FPG 5.6‐7.7 mmol/L; 2hPG ≥ 7.8 ≤ 11.1 mmol/L (2hPG ≥ 11.1 mmol/L) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>203 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>167 per 1000</b> (152 to 181) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.82</b> (0.75 to 0.89) </p> <p>(95% prediction interval: 0.48 to 1.40)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8008</p> <p>3 RCTs</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br> M<b>oderate<sup>b</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="./references#CD005061-bbs2-0002">ACE 2017</a> included participants with coronary heart disease and contributed 64.0% of cases </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Serious adverse events</b> </p> <p>Follow‐up: 3.3‐5 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>95 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>106 per 1000</b> (92 to 122) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.12</b> (0.97 to 1.29) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6625</p> <p>2 RCTs</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> L<b>ow<sup>c</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Cardiovascular mortality</b> </p> <p>Follow‐up: 3.3‐5 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>42 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>37 per 1000</b> (29 to 46) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.88</b> (0.71 to 1.10) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8069</p> <p>3 RCTs</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> V<b>ery low<sup>a</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>(a)<b>Non‐fatal myocardial infarction</b> </p> <p>(b)<b>Non‐fatal stroke</b> </p> <p>(c)<b>Congestive heart failure</b> </p> <p>Follow‐up: 3.3 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>(a) <b>20 per 1000</b> </p> <p>(b) <b>6 per 1000</b> </p> <p>(c) <b>19 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>(a) <b>1 per 1000</b> (0 to 11) </p> <p>(b) <b>3 per 1000</b> (1 to 16) </p> <p>(c) <b>16 per 1000</b> (12 to 21) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>(a) <b>RR 0.10</b> (0.02 to 0.53) </p> <p>(b) <b>RR 0.50</b> (0.09 to 2.74) </p> <p>(c) <b>RR 0.87</b> (0.63 to 1.12) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>(a) 1486</p> <p>2 RCTs</p> <p>(b) 1368</p> <p>1 RCT</p> <p>(c) 7890</p> <p>2 RCTs</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>(a) ⊕⊝⊝⊝</p> <p><b>Very low<sup>d</sup> </b><br> (b) ⊕⊝⊝⊝<br> V<b>ery low<sup>d</sup> </b> </p> <p>(c) ⊕⊕⊝⊝<br> L<b>ow<sup>e</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Health‐related quality of life</b> </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Socioeconomic effects</b> </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across trials) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>2hPG:</b> 2‐hour plasma glucose; <b>CI:</b> confidence interval; <b>FPG:</b> fasting plasma glucose;<b>HbA1c:</b> glycosylated haemoglobin A1c; <b>IGT</b>: impaired glucose tolerance; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio; <b>T2DM</b>: type 2 diabetes mellitus </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level because of inconsistency in direction of effect and by two levels because of serious imprecision (confidence interval consistent with benefit and harm and small number of trials). See <a href="./appendices#CD005061-sec2-0032">Appendix 17</a>.<br> <sup>b</sup>Downgraded by one level because of imprecision (small number of trials). See <a href="./appendices#CD005061-sec2-0032">Appendix 17</a>.<br> <sup>c</sup>Downgraded by two levels because of serious imprecision (confidence interval consistent with benefit and harm and small number of trials). See <a href="./appendices#CD005061-sec2-0032">Appendix 17</a>.<br> <sup>d</sup>Downgraded by two levels because of serious risk of bias (attrition bias and reporting bias), and by one level because of imprecision (small number of trials). See <a href="./appendices#CD005061-sec2-0032">Appendix 17</a>.<br> <sup>e</sup>Downgraded by two levels because of serious imprecision (confidence interval consistent with benefit and harm and small number of trials). See <a href="./appendices#CD005061-sec2-0032">Appendix 17</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>&nbsp;<span class="table-title">Acarbose compared to placebo</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD005061-tbl-0002" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span>&nbsp;<span class="table-title">Acarbose compared to no intervention</span></div> <tbody> <tr class="separated"> <td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Acarbose for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk of developing type 2 diabetes mellitus</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:</b> people at risk of developing type 2 diabetes mellitus </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> alpha‐glucosidase inhibitors (acarbose) </p> <p><b>Comparison:</b> no intervention </p> </td> </tr> <tr class="table-header separated"> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>No intervention</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Acarbose</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Number of participants</b> </p> <p><b>Trials</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Certainty of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-header"> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All‐cause mortality</b> </p> <p>Follow‐up: 1‐5 years</p> </td> <td align="" valign="top" colspan="3" rowspan="1" class="table-tint table-highlight"> <p>See comment</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>171</p> <p>2 RCTs</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> V<b>ery low<sup>a</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2 of 4 trials reported mortality. No deaths occurred.</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Incidence of T2DM</b> </p> <p>Follow‐up: 1‐5 years</p> <p>Definition of intermediate hyperglycaemia (definition of T2DM incidence):</p> <p><a href="./references#CD005061-bbs2-0005">Fang 2004</a> and <a href="./references#CD005061-bbs2-0009">Wang 2000</a>: FPG &lt; 7.8 mmol/L; 2hPG ≥ 7.8 ≤ 11.1 mmol/L (FPG ≥ 7.8 mmol/L; 2hPG ≥ 11.1 mmol/L) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>277 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>86 per 1000</b> (39 to 191) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.31</b> (0.14 to 0.69) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>140</p> <p>2 RCTs</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> V<b>ery low<sup>b</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Serious adverse events</b> </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Cardiovascular mortality</b> </p> <p>Follow‐up: 1‐4.5 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>49 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>31 per 1000</b> (8 to 124) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.64</b> (0.16 to 2.56) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>205</p> <p>2 RCTs</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> V<b>ery low<sup>c</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>(a)<b>Non‐fatal myocardial infarction</b> </p> <p>(b)<b>Non‐fatal stroke</b> </p> <p>(c)<b>Congestive heart failure</b> </p> <p>Follow‐up: 1‐4.5 years</p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>(a) <b>68 per 1000</b> </p> <p>(b) <b>39 per 1000</b> </p> <p>(c) <b>58 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>(a) <b>20 per 1000</b> (5 to 96) </p> <p>(b) <b>21 per 1000</b> (4 to 109) </p> <p>(c) 51<b>per 1000</b> (16 to 159) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>(a) <b>RR 0.30</b> (0.07 to 1.41) </p> <p>(b) <b>RR 0.53</b> (0.10 to 2.81) </p> <p>(c) <b>RR 0.87</b> (0.27 to 2.73) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>(a) 205</p> <p>2 RCTs</p> <p>(b) 205</p> <p>2 RCTs</p> <p>(c) 205</p> <p>2 RCTs</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>(a) ⊕⊝⊝⊝</p> <p><b>Very low<sup>c</sup> </b><br> (b) ⊕⊝⊝⊝<br> V<b>ery low<sup>c</sup> </b> </p> <p>(c) ⊕⊝⊝⊝<br> V<b>ery low<sup>c</sup> </b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Health‐related quality of life</b> </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Socioeconomic effects</b> </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across trials) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br> <b>2hPG:</b> 2‐hour plasma glucose; <b>CI:</b> confidence interval; <b>FPG:</b> fasting plasma glucose;<b>HbA1c:</b> glycosylated haemoglobin A1c; <b>RCT:</b> randomised controlled trials; <b>RR:</b> risk ratio; <b>T2DM</b>: type 2 diabetes mellitus </p> </td> </tr> <tr class="separated"> <td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br> <b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br> <b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br> <b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br> <b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level because of risk of bias (unclear selection bias and selective reporting), and by two levels because of serious imprecision (small number of trials, small sample size and the outcome not being a common event). See <a href="./appendices#CD005061-sec2-0033">Appendix 18</a>.<br> <sup>b</sup>Downgraded by one level because of risk of bias (unclear selection bias and selective reporting), and by two levels because of serious imprecision (small number of trials and small sample size). See <a href="./appendices#CD005061-sec2-0033">Appendix 18</a>.<br> <sup>c</sup>Downgraded by one level because of risk of bias (unclear selection bias and selective reporting), and by two levels because of serious imprecision (small number of trials, small sample size and CI consistent with benefit and harm). See <a href="./appendices#CD005061-sec2-0033">Appendix 18</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span>&nbsp;<span class="table-title">Acarbose compared to no intervention</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-tbl-0002" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD005061-tbl-0007"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Overview of trial populations</span></div> <tbody> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Trial ID<br> (design)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Short description of power and sample size calculation</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Screened/eligible<br> (N)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Randomised<br> (N)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>ITT<br> (N)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Analysed<br> (N)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Finishing trial<br> (N)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Randomised finishing trial<br> (%)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Follow‐up<br> (extended follow‐up)<sup>a</sup> </b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD005061-bbs2-0001">ABC 2017</a> (parallel RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention 1: voglibose</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>"Given a hazard ratio (HR) of 0.717 with survival rates of 89% at 24 months in the control group, we estimated the total sample size of 3000 subjects along with 325 events (1500 per group), providing 85% power of one‐sided log‐rank test of 2.5% significance level to detect the assumed reduction, assuming the loss of patients during the follow‐up to be 15%" </p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐/870</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>428</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>424</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>424</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>424</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>99.1</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>2 years</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 1: diet and exercise</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>442</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>435</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>435</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>435</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>98.4</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>870</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>859</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>859</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>859</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>98.7</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD005061-bbs2-0002">ACE 2017</a>(parallel RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention 1: acarbose</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>"7268 patients were required with 904 adjudicated primary composite cardiovascular end points to achieve 90% power. The population size was reduced from 7500 to 6500, with an estimated 728 confirmed composite primary outcome required to have at least 85% power to detect a 20% risk reduction for acarbose, compared with placebo (two‐sided α=0·05)" </p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>15204/7671</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3272</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3272</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3272</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3092</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>94.5</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>Median of 5 years</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 1: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3250</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3250</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3250</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3064</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>94.3</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6522</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6522</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6522</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6156</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>94.3</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD005061-bbs2-0010">Yun 2016</a>(parallel RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention 1: acarbose</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>426/135</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>67</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>60</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>60</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>89.55</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>1‐4.5 years</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 1: no intervention</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>68</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>64</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>94.12</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>135</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>124</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>124</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>91.85</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD005061-bbs2-0007">Koyasu 2010</a>(parallel RCT) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention 1: acarbose</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐/90</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>45</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>93.33</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>1 year</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 1: no intervention</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>45</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>39</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>39</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>86.67</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>90</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>90</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD005061-bbs2-0006">Kawamori 2009</a><b>(parallel RCT)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention 1: voglibose</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>"Assuming a conversion rate of 7.7% per year, a study duration of 4.9 years, and a drop‐out rate of 5%, the planned sample size was 864 (90% power to detect a 40% reduction in the primary endpoint with a two‐sided type I error of 0·05). Due to greater improvement to normoglycaemia than expected, sample size increased to 1728" </p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>4582/1780</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>897</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>897</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>768</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>85.62</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>Until diagnosis of normoglycaemia or diabetes type 2, or at least 3 years</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 1: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>883</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>881</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>737</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>83.47</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1780</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1778</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1505</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>84.55</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="5" bgcolor="#ffffff"> <p><a href="./references#CD005061-bbs2-0005">Fang 2004</a><b>(parallel RCT)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention 1: acarbose</p> </td> <td align="" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>‐/‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>45</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>45</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>90</p> </td> <td align="" valign="top" colspan="1" rowspan="5" bgcolor="#ffffff"> <p>5 years</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 1: no intervention</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>87.5</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 2: metformin</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>48</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>91.67</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 3: diet and exercise</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>90</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>178</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>160</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>160</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>89.89</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD005061-bbs2-0009">Wang 2000</a><b>(parallel RCT)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention 1: acarbose</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>‐/61</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>96.77</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>1 year</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 1: No intervention</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>100</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>61</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>60</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>60</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>98.36</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD005061-bbs2-0003">DAISI 2008</a><b>(parallel RCT)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention 1: acarbose</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>47 participants in each treatment group with alpha (2‐sided) = 0.05 and beta = 0.05</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>6651/118</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>60</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>60</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>60</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>3 years</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 1: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>p8</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>58</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>58</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>62.07</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>118</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>118</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>118</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>66</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>55.93</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="5" bgcolor="#ffffff"> <p><a href="./references#CD005061-bbs2-0004">EDIT 1997</a><b>(factorial RCT)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention 1: acarbose + placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="4" bgcolor="#ffffff"> <p>‐/631</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>157</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="5" bgcolor="#ffffff"> <p>6 years</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 1: placebo + placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>159</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 2: metformin + placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>160</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 3: metformin + acarbose</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>155</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>631</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>522</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>82.73</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD005061-bbs2-0008">STOP‐NIDDM 2002</a><b>(parallel RCT)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intervention 1: acarbose</p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>"It was estimated that 600 patients would be required in each treatment group for a 2‐tailed alpha of .05 and a 1‐beta of 90% assuming a conversion rate of 7% per year, a 36% risk reduction, and a drop‐out rate of 10%" </p> </td> <td align="" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>14742/1429</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>714</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>682</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>682</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>471</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>65.97</p> </td> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>mean 3.3 years</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comparator 1: placebo</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>715</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>686</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>686</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>556</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>77.76</p> </td> </tr> <tr> <td align="right" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b>total:</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1429</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1368</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1368</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1027</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>71.87</p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><b>Grand total</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All interventions</b> </p> </td> <td align="" valign="top" colspan="2" rowspan="3" bgcolor="#ffffff"></td> <td align="center" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>5721</b> </p> </td> <td align="" valign="top" colspan="2" rowspan="3" bgcolor="#ffffff"></td> <td align="center" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>4962 </b><b>(excl. </b><a href="./references#CD005061-bbs2-0004">EDIT 1997</a><b><i>)</i> </b> </p> </td> <td align="" valign="top" colspan="2" rowspan="3" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All comparators</b> </p> </td> <td align="center" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>6093</b> </p> </td> <td align="center" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>5076 </b><b>(excl. </b><a href="./references#CD005061-bbs2-0004">EDIT 1997</a><b><i>)</i> </b> </p> </td> </tr> <tr> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All interventions and comparators</b> </p> </td> <td align="center" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>11,814</b> </p> </td> <td align="center" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>10,038 (excl. </b><a href="./references#CD005061-bbs2-0004">EDIT 1997</a><b><i>)</i> </b> </p> <p><b>10,560 (incl. </b><a href="./references#CD005061-bbs2-0004">EDIT 1997</a><b><i>)</i> </b> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>‐ denotes not reported; <b>ITT</b>: intention‐to‐treat; <b>RCT</b>: randomised controlled trial </p> <p><sup>a</sup>Follow‐up under randomised conditions until end of trial ( (= duration of intervention + follow‐up post‐intervention or identical to duration of intervention); extended follow‐up refers to follow‐up of participants once the original trial was terminated as specified in the power calculation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Overview of trial populations</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/full#CD005061-tbl-0007" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD005061-tbl-0003" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">AGI versus placebo</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9847</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.24 [0.53, 2.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8069</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.98 [0.82, 1.18]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1778</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.77 [0.72, 226.31]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Incidence of type 2 diabetes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9786</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.59, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8008</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.82 [0.75, 0.89]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1778</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.46 [0.34, 0.64]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8403</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.12 [0.97, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6625</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.12 [0.97, 1.29]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1778</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.46 [0.48, 12.62]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Cardiovascular mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9847</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.72, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8069</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.88 [0.71, 1.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1778</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.95 [0.12, 72.23]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Non‐fatal myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1486</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.10 [0.02, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Non‐fatal stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1368</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.50 [0.09, 2.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Congestive heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7890</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.63, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Non‐serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3328</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.04 [1.02, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1550</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.04 [1.01, 1.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1778</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.06 [1.02, 1.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6522</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.01 [0.89, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 Fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7368</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.12, ‐0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 2‐h glucose measurements <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6498</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.53 [‐0.92, ‐0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6833</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">13 Change in total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6815</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.05 [‐0.10, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">14 Change in HDL‐cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6807</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.00, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">15 Change in LDL‐cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6699</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.03 [‐0.07, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">16 Change in triglycerides <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6843</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.17, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">17 Change in body weight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6959</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.67 [‐1.57, 0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">18 Change in body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6953</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.18 [‐0.39, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">19 Change in diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7452</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.29 [‐0.78, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">20 Change in systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7452</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐1.26, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">AGI versus placebo</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-tbl-0003" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD005061-tbl-0004" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">AGI versus metformin</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Incidence of type 2 diabetes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 2‐h glucose measurements <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Change in total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Change in triglycerides <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Change in body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Change in diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Change in systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">AGI versus metformin</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-tbl-0004" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD005061-tbl-0005" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">AGI versus diet and exercise</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Incidence of type 2 diabetes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Cardiovascular mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Non‐fatal myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Non‐fatal stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Congestive heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Non‐serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>509</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.33 [‐2.15, ‐0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.37 [‐2.24, ‐0.50]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>428</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.0 [‐3.44, 1.44]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 2‐h glucose measurements <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>472</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.74 [‐3.74, ‐1.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.79 [‐3.79, ‐1.79]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>391</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.7 [‐7.53, 8.93]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 Change in total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>586</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.49 [‐1.32, 0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.50 [‐1.33, 0.33]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>505</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [‐6.47, 6.47]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 Change in triglycerides <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>612</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.76, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.76, 0.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>531</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.1 [‐17.03, 16.83]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">13 Change in HDL‐cholesterol [mmol/L] <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>545</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [‐2.51, 2.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">14 Change in body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">15 Change in diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>667</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.25 [‐1.65, 4.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">16 Change in systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>668</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.94 [‐8.71, 4.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16.1 Acarbose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>81</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐6.00 [‐12.23, 0.23]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16.2 Voglibose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>587</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.0 [‐1.92, 3.92]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">AGI versus diet and exercise</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-tbl-0005" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD005061-tbl-0006" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">AGI versus no intervention</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>171</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Incidence of type 2 diabetes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>140</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.31 [0.14, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Cardiovascular mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Non‐fatal myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Non‐fatal stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Congestive heart failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>205</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.27, 2.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Non‐serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.35 [‐0.79, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 2‐h glucose measurements <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.50 [‐4.18, ‐0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 Change in total cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.32 [‐0.74, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">13 Change in HDL‐cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">14 Change in LDL‐cholesterol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>205</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.03 [‐0.22, 0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">15 Change in triglycerides <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.22 [‐0.40, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">16 Change in body weight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">17 Change in body mass index <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.65 [‐1.01, ‐0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">18 Change in diastolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.26 [‐3.80, 3.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">19 Change in systolic blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>285</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐3.68 [‐6.46, ‐0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">AGI versus no intervention</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD005061.pub3/references#CD005061-tbl-0006" class="tableList">Navigate to table in Review</a></div> </div> </div> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD005061-note-1205">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD005061-note-1209">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD005061-note-1208">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD005061-note-1207">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD005061-note-1206">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_citeulike at300b btn btn-link">CiteULike</a></li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <h4>Copy or download citation</h4> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/">
<img class="footer-logo logo-part-1" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> <nav class="footer-links"> <ul class="root"> <li class="footer-item"> <a class="footer-item-link" href="/about-cochrane1">About Cochrane</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/evidence" target="_blank">Cochrane.org</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank">Who we are</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NJYXT5SPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Get involved</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX665WNWTYE63PMNYXG4DTMFYGKLUQPJUB/" target="_blank">Consumer Network</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-funders-and-partners" target="_blank">Partners</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYXZ5DQPF4XT7LNF3SX8Z5IPJRX63JPN73GH/" target="_blank">Colloquium</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news" target="_blank">In the news</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/publications">Publications</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="/library">Cochrane Library</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/" target="_blank">Library Homepage</a> </li> <li class="footer-item"> <a class="footer-item-link" href="cdsr/about-cdsr" target="_blank">Cochrane Reviews (CDSR)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/central" target="_blank">Trials (CENTRAL)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cca/about" target="_blank">Cochrane Clinical Answers</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/cochrane-library-app" target="_blank">Cochrane Library App</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cdsr/journal-club" target="_blank">Journal Club</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/podcasts" target="_blank">Podcasts</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/community">Community</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Community</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MF3GG4DJMVYGG55DNB3GC5UFF3YYE3D/" target="_blank">Archie log-in</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/PS3GC4LPNFYGPLUDN7SXR6UBN3TT655TMH/" target="_blank">Training and support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/NWTYI4DQMS3T6Z5QMNVHEZLPMVYG86UH/" target="_blank">Methods</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/help" target="_blank">Software</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news/jobs" target="_blank">Jobs and opportunities</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/contact-us">Contact Us</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/contact" target="_blank">General enquiries</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/help/contact-us" target="_blank">Cochrane Library support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/chief-executive-officers-office/team" target="_blank">Chief Executive Officer</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/editorial-methods/team" target="_blank">Editor in Chief</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-global-community" target="_blank">Cochrane groups</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/media" target="_blank">Media</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/accessibility" target="_blank">Accessibility</a> </li> </ul> </li> </ul> </nav> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2020 by <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUYNFXGK8JPMNYXN/" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUYNFXGK8JPMNYXN/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MW4T675JNSTYTLUDN7XB/"><img class="logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1581422282000" type="text/javascript"></script> <!--<![endif]--> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/theme.js?t=1581422282000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/checkout.js"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MN3G865UNWRYE43NMNTG6LUDPJYYG65TMWUC655TMH/widget/v2.0/widget.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MRZXE8DIHB4XC63SNWYHPN3PMNXG87LEM33G85UVF3YGK7A/assets/embed.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718249000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718249000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005061\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005061\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005061\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005061\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005061\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581422282000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=EfT7x5RD&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005061.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005061.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD005061.pub3/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD005061.pub3/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005061.pub3%2Freferences" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1583244600686" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x2f;references" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1583244600690" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD005061&#x2e;pub3&#x2f;references" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD005061.pub3";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 